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Abstract  
Background: Prediction of motor outcomes and cerebral palsy (CP) in infants born very preterm is 
needed to identify infants that may benefit from targeted intervention. Brain MRI at term equivalent 
age in very preterm infants has demonstrated predictive value for CP and adverse motor outcomes. 
Accuracy is further enhanced when MRI is combined with clinical measures of motor or 
neurological function. There is a need to determine if MRI and clinical biomarkers earlier than term 
equivalent age can determine motor outcomes. This would create a new window for possible 
intervention at a time of greater neuroplasticity and brain development. 
Aims: To: i) systematically review the evidence for early MRI to identify infants with adverse 
motor outcomes or CP; ii) validate a structural MRI scoring system of brain injury and growth 
impairment (Kidokoro et al, 2013) at 29-35 weeks postmenstrual age (PMA, ‘Early MRI’); iii) 
elucidate motor, neurological and neurobehavioural associations with structural MRI scores at Early 
and Term (40-42 weeks PMA) MRI; and iv) examine relationships between Early and Term MRI 
diffusion measures in the corpus callosum, posterior limb of the internal capsule (PLIC) and 
cerebral peduncle, and 12 month motor outcomes.  
Research design and methodology: A prospective cohort study was conducted of infants born <31 
weeks gestational age. Infants underwent Early and Term 3T MRI without sedation utilising an 
MRI compatible incubator. Concurrent clinical assessment performed within a week of each MRI 
consisted of the General Movements assessment (GMs), Hammersmith Neonatal Neurological 
Examination and the NICU Neonatal Neurobehavioural Scale. The Premie-Neuro was performed 
following Early MRI and the Test of Infant Motor Performance (TIMP) and a visual assessment at 
Term. Follow up at 3 months corrected age consisted of the GMs, TIMP and a visual assessment. 
At 12 months corrected age, infants were evaluated by a paediatrician for evidence of CP using a 
structured neurological examination. The Bayley Scales of Infant and Toddler Development 3rd 
edition (Bayley III), Alberta Infant Motor Scale (AIMS) and Neurosensory Motor Developmental 
Assessment (NSMDA) were conducted. 
The structural MRI scoring system generated white matter (WM), cortical gray matter (GM), deep 
GM, cerebellar and global scores. Inter- and intrarater reliability and agreement of each of the MRI 
subscale scores and the overall global score were evaluated. The relationship between MRI scores 
and 12 month motor and cognitive outcomes were examined. Associations with concurrent clinical 
measures were assessed. Fractional anisotropy (FA) and mean diffusivity (MD) were calculated for 
the corpus callosum, PLIC and cerebral peduncle, where regions were extracted using registration 
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to the Johns Hopkins University neonatal Atlas. Relationships with 12 month motor and 
neurological outcomes were examined. 
Results: The systematic review and meta-analyses revealed that Early structural MRI had 
satisfactory sensitivity and specificity to determine adverse motor outcomes and CP but that 
evidence for diffusion MRI was still emerging. Reproducibility was demonstrated for the structural 
MRI scoring system with good reliability and agreement for the overall score and all subscales 
except for cortical GM. Early MRI global, WM, and deep GM scores were negatively associated 
with Bayley III motor (regression coefficient for global score ß=-1.31; 95%CI=-2.39, -0.23; p=0.02; 
r2=0.07), cognitive (ß=-1.52; 95%CI=-2.39, -0.65; p<0.01; r2=0.16) and NSMDA outcomes (ß=-
1.73; 95%CI=-3.19, -0.28; p=0.02; r2=0.09). Early MRI cerebellar scores were negatively 
associated with the NSMDA (ß = -5.99; 95% CI, -11.82, -0.16; p = 0.04; r2=0.08). Associations 
were reconfirmed at Term MRI and cerebellar scores were also associated with Bayley III and 
NSMDA outcomes.  
Structural MRI scores were associated with concurrent motor, neurological and neurobehavioral 
function at Early and Term MRI. At Early MRI, cerebellar scores demonstrated the strongest 
associations with clinical measures, displaying associations with neurological and motor items but 
not neurobehavioural items. At Term MRI, the strongest associations were with motor performance 
measured with the TIMP. White matter abnormality scores were related to motor and neurological 
performance at Term but not at Early MRI. 
Early MRI FA and MD in the defined regions were not associated with motor or neurological 
outcomes. Term MRI FA was not associated with outcomes. Term MRI MD in the left corpus 
callosum was associated with neurological outcome. Term MRI MD in the right cerebral peduncle 
was associated with motor outcome on the AIMS and NSMDA.  
Conclusions: Early structural MRI is clinically accessible; however, limited reporting of diagnostic 
accuracy in Early MRI studies currently restricts clinical utility and translation to clinical practice. 
The Early structural MRI scoring system is valid for use between 29 and 35 weeks PMA, and is the 
first to incorporate qualitative evaluation of brain injury and evidence of growth impairment; as 
well as assessment of deep GM and the cerebellum. Early MRI diffusion measures of FA and MD 
in the corpus callosum, PLIC and cerebral peduncle were not associated with motor or neurological 
outcomes. The use of automatic segmentation methods to derive brain regions of interest resulted in 
exclusion of infants with significant structural brain lesions, possibly limiting the ability to find 
associations between the diffusion measures and 12 month motor outcomes. 
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Chapter 1: Introduction, thesis outline and aims 
1.1 Introduction 
Preterm infants face a broad and diverse range of neurodevelopmental outcomes including 
cognitive, behavioural and motor deficits and cerebral palsy (CP) 1-5. Identifying those at risk of 
adverse outcomes enables targeted interventions to be initiated and family supports to be instituted. 
Earlier identification of potential adverse outcomes ensures families receive adequate support and 
enables limited healthcare funds to be appropriately utilised.  
Brain MRI in recent years has improved the ability to predict motor outcomes and determine infants 
at high risk of CP. A substantial body of evidence now exists for brain MRI at term-equivalent age 
(TEA) in infants born very preterm 6-8. Structural MRI provides qualitative information of white 
and gray matter injuries and brain macrostructure9-11. Diffusion MRI and advanced diffusion 
acquisition and analysis techniques provide detailed information on brain microstructural 
development and maturation. Relationships with clinical biomarkers have been reported at TEA and 
predictive validity for later neurodevelopmental outcomes has been established 12-20. 
The principal rationale for this thesis was to determine if it was possible to identify infants at risk of 
adverse motor outcomes and CP earlier than TEA using earlier MRI and clinical biomarkers. If 
achieved, a new window for interventions would be available at a time of rapid brain development 
and plasticity. Additionally, with the increasing propensity for very preterm infants being 
discharged prior to TEA, an earlier MRI assessment would allow for MRI prior to discharge from 
the neonatal intensive care unit. This would facilitate follow up and reduce the risk of loss to follow 
up, ensuring more infants undergo MRI rather than requiring families to return for assessment at 
TEA. 
The most relevant study design to achieve this was a prospective cohort study. Structural and 
diffusion MRI were acquired at 30-32 weeks postmenstrual age (PMA, ‘Early MRI’), and 40-42 
weeks PMA (‘Term MRI’). Concurrent clinical measures of motor, neurological and 
neurobehavioural function were obtained. Follow up at 12 months corrected age (CA) using 
validated tools and a neurological assessment was conducted to determine motor outcomes and the 
risk of CP. It was acknowledged that 12 months corrected age was too early for a reliable diagnosis 
of CP. Added to the trend of a decreasing incidence of CP in very preterm infants21-23, it was 
recognised that prevalence of CP was likely to be low in our contemporaneous cohort. For these 
reasons, the focus of this thesis will be motor outcomes measured using validated tools. 
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Aims of this thesis were to: i) systematically review the literature to evaluate the current evidence 
for Early MRI to determine adverse motor outcomes and CP; ii) validate a structural MRI scoring 
system of brain injury and growth impairment (Kidokoro et al, 2013) for use at 29-35 weeks 
postmenstrual age (PMA, ‘Early MRI’) by demonstrating reproducibility and associations with 12 
month neurodevelopmental outcomes; iii) elucidate motor, neurological and neurobehavioural 
correlates for structural MRI scores at Early and Term (40-42 weeks PMA) MRI; and iv) examine 
the relationships between Early and Term MRI diffusion measures in the corpus callosum, posterior 
limb of the internal capsule (PLIC) and cerebral peduncle, and 12 month motor outcomes. In order 
to address these aims, this thesis presents the following: 
 A systematic review of the literature which examined the relationships between Early MRI 
and motor outcomes in infants born very preterm in Chapter 2. 
 A detailed study protocol which described the methodology for the broader prospective 
cohort study within which this thesis is embedded, in Chapter 3. 
 Validation of an MRI brain injury and growth scoring system for Early MRI structural 
images. This was achieved by demonstrating associations with later motor and cognitive 
outcomes at 12 months CA and is presented in Chapter 4. 
 Results of the relationships between the Early structural MRI scores and concurrent 
neuromotor, neurological and neurobehavioral function in Chapter 5. 
 Results of the relationships between Early and Term MRI diffusion measures of brain 
microstructure and 12-month motor outcome in Chapter 6. 
 A grand discussion which synthesises the study findings, highlights study strengths and 
limitations and details clinical and research implications, in Chapter 7. 
 
1.2 Aims  
Aim 1 
To examine the diagnostic accuracy of early MRI (<36 weeks PMA) to determine adverse motor 
outcomes or a confirmed diagnosis of CP, at or beyond one year CA in infants born preterm.  
Aim 2 
To validate a structural MRI scoring system previously developed for very preterm infants at TEA 
in a cohort of infants born <31 weeks PMA with MRI between 29 and 35 weeks PMA. The study 
aimed to establish predictive validity for motor and cognitive outcomes at 12 months CA. 
Secondary aims were to examine inter- and intrarater reproducibility and to examine relationships 
between global brain abnormality categories and known perinatal risk factors.  
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Aim 3 
To examine the structure-function relationships between structural MRI brain abnormality scores 
and concurrent clinical measures of neuromotor, neurological and neurobehavioral performance at 
30-32 weeks PMA (Early MRI) and again at 40-42 weeks PMA (Term MRI). A secondary aim was 
to evaluate which clinical measures demonstrated the strongest association with a) Early MRI and 
b) Term MRI.  
 Aim 4 
To evaluate brain microstructure on Early and Term MRI in regions known to be involved in motor 
function, the corpus callosum, posterior limb of the internal capsule, and cerebral peduncle and then 
examine the association of these early microstructural measures with motor outcome at 12 months 
CA. A secondary aim was to compare preterm brain microstructure in the 3 defined regions at Term 
MRI with a term born reference sample imaged at approximately 40-42 weeks PMA.  
 
1.3 Format of Thesis 
This thesis consists of a sequence of papers published or submitted to peer-reviewed journals. 
Chapter 2 presents a systematic review of the literature which examined the associations between 
early MRI and later motor outcomes or cerebral palsy, and addressed the first aim of the thesis. 
Chapter 3 introduces the study protocol. The conclusion to Chapter 3 details the order in which this 
thesis was completed in parallel to progress of the prospective cohort study. It outlines in detail why 
different papers used different sample sizes as adequate thresholds were reached to address each 
specified aim. Chapter 4 presents the validation of an MRI scoring system for structural MR images 
at 29-35 weeks PMA. Chapter 5 then examines the cross-sectional relationships between the 
validated MRI scores and concurrent clinical measures of motor, neurological and neurobehavioural 
function. Chapter 6 evaluates brain microstructure using diffusion MRI, and in a similar process to 
the validation of structural MRI scoring, examines relationships with 12 month motor outcomes. 
The conclusion of Chapter six includes evaluation of the representativeness of the overall cohort, 
and comparisons between each sub-sample included in the separate papers and the overall recruited 
sample. The grand discussion in Chapter 7 synthesizes the findings in a detailed summary and 
conclusion, followed by study limitations, implications for clinical practise and recommendations 
for future research.  
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Chapter 2: Diagnostic accuracy of early MRI to determine motor outcomes in 
infants born preterm: a systematic review and meta-analysis  
2.1 Introduction to Chapter 2 
In order to review the current literature on early MRI in babies born preterm and the ability of MRI 
to determine motor outcome on validated tools, a systematic review and meta-analysis was 
undertaken.  
2.2 Paper 1:  
This manuscript has been submitted to the journal Developmental Medicine and Child Neurology 
and is currently under review (journal impact factor 3.615). 
 
George JM, Pannek K, Rose SE, Ware RS, Colditz PB, Boyd RN. Diagnostic accuracy of early 
MRI to determine motor outcomes in infants born preterm: a systematic review and meta-analysis. 
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Diagnostic accuracy of early MRI to determine motor outcomes in infants born preterm: a 
systematic review and meta-analysis 
George JM, Pannek K, Rose SE, Ware RS, Colditz PB, Boyd RN  
 
Abstract 
Aim To examine the diagnostic ability of early MRI (<36 weeks postmenstrual age) to detect later 
adverse motor outcomes or cerebral palsy (CP) in infants born preterm. 
Method Studies of preterm infants with MRI <36 weeks postmenstrual age and quantitative motor 
data or a diagnosis of CP ≥one year corrected age were identified. Study details were extracted and 
meta-analyses performed where possible. Quality of included studies was evaluated with the 
QUADAS-2 tool. 
Results Thirty articles met criteria of which five reported diagnostic accuracy and five reported data 
sufficient for calculation of diagnostic accuracy. Early structural MRI global scores detected a later 
diagnosis of CP with pooled sensitivity 100% (95% confidence interval CI 86-100%) and 
specificity 89% (95%CI 54-100%). Global structural MRI scores determined adverse motor 
outcomes with pooled sensitivity 89% (95%CI 44-100%) and specificity 96% (95%CI 85-100%). 
White matter scores determined adverse motor outcomes with pooled sensitivity 33% (95% CI 20-
48%) and specificity 83% (95% CI 78-88%). 
Interpretation Early structural MRI has reasonable sensitivity and specificity to determine adverse 
motor outcomes and CP in infants born preterm. Greater reporting of diagnostic accuracy in studies 
examining relationships with motor outcomes and CP is required to facilitate clinical utility of early 
MRI.  
 
What this paper adds  
 Early MRI has reasonable sensitivity and specificity to determine later adverse motor 
outcomes and CP in infants born preterm; 
 Detection of infants who progressed to CP was stronger than motor outcomes; 
 Global MRI scores discriminated between infants with normal and adverse motor outcomes 
more accurately than WM scores; 
 Few studies report diagnostic accuracy of early MRI findings; 
 Diagnostic accuracy is required to draw clinically meaningful conclusions from studies 
reporting associations between early MRI and motor outcomes/CP. 
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Cerebral palsy (CP) results from an early brain injury that in approximately 70 percent of cases 
occurs in the third trimester of pregnancy or around birth1. Preterm birth is the single greatest risk 
factor for CP with approximately 43% of infants diagnosed with CP born preterm2. The risk of CP 
increases with decreasing gestational age (GA) at birth, with approximately 5-10% of infants born 
<30 weeks GA developing CP3, 4. In infants born <30 weeks postmenstrual age (PMA) who do not 
develop CP, there is a significant risk for adverse motor outcomes which range from mild to severe 
motor impairment5. Early identification of infants at risk of adverse motor outcomes and CP is 
required to counsel families and refer them to early interventions. 
 
Magnetic resonance imaging (MRI) at term equivalent age (TEA) has been shown to identify 
infants with CP and motor outcomes at or beyond two years corrected age (CA) in infants born very 
preterm 3, 6-8. In a systematic review of tests to predict CP in high risk cohorts, MRI at TEA 
determined a later outcome of CP with a sensitivity of 86-100% and specificity of 89-97%6, 7, 9. 
Another systematic review of TEA MRI in preterm born infants reported a sensitivity of 77% and 
specificity of 79% to determine an outcome of CP, and sensitivity 72% and specificity 62% to 
determine motor outcome10.  
 
A recent systematic review of advanced neuroimaging at TEA summarized biomarkers associated 
with neurodevelopmental outcomes in preterm infants11. Biomarkers identified included tissue 
volumes and metrics of microstructural integrity and maturation based on diffusion MRI such as 
fractional anisotropy (FA) and/or mean, radial or axial diffusivity (MD, RD, AD)11. Brain regions 
with evidence in three or more studies included the corpus callosum, cerebellum, centrum 
semiovale, sensorimotor white matter (WM), subcortical nuclei and posterior limb of the internal 
capsule (PLIC)11. A number of non-systematic reviews have summarized structural and diffusion 
imaging at TEA and the associations with neurodevelopmental outcomes in infants born very 
preterm12-14. Structural MRI at TEA was strongly associated with neurodevelopmental outcomes, 
while evidence of advanced imaging biomarkers to determine neurodevelopmental outcomes was 
emerging12-14. 
 
To date, one systematic review has evaluated MRI earlier in the neonatal period (<36 weeks 
PMA)15. The authors concluded that TEA MRI afforded greater prognostic information than early 
MRI, and emphasized the importance of early MRI for research into early brain injury and 
development. Early MRI (before 36 weeks PMA) has become more widespread with the increasing 
availability of MR compatible incubators16. Further systematic evaluation of the literature to 
determine the ability of early MRI to accurately determine neurodevelopmental outcomes and CP is 
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warranted. The aim of this systematic review was to examine the diagnostic accuracy of early MRI 
(<36 weeks PMA) to determine adverse motor outcomes or a confirmed diagnosis of CP at or 
beyond one year CA in infants born preterm.  
 
METHOD 
Search Strategy 
Databases searched were PubMed, EMBASE, Cochrane, CINAHL and Scopus from inception to 31 
March 2017. Keywords (preterm OR infant, premature) AND (MRI OR magnetic resonance 
imaging OR MR OR magnetic resonance OR dti OR diffusion) AND (motor OR neuromotor OR 
Bayley OR AIMS OR NSMDA OR Griffith OR MABC OR cerebral palsy OR CP) were used and 
studies were limited to those published in English (Supplementary Material A). 
  
Studies were eligible for inclusion if participants were born preterm (<36 weeks PMA) and the 
sample size was ≥10. The participant’s MRI was performed at <36 weeks PMA with structural, 
diffusion, spectroscopic (MRS) and/or functional MRI (fMRI) sequences acquired and MRI 
analysis by a reproducible qualitative or quantitative method. Quantitative motor outcome data from 
validated tools and/or a confirmed diagnosis of CP at or beyond 12 months corrected age was the 
final eligibility criteria. Studies of normative samples of preterm infants, i.e. no evidence of brain 
injury and normal motor outcomes on standardised tests, were excluded. Studies were excluded if 
brain injuries were the result of acute/traumatic brain injury or congenital malformations. 
 
Data extraction and analysis 
Three reviewers (JG, KP, and RB) independently screened the titles and abstracts, then examined 
full text articles where required to determine eligibility. Disagreements were resolved through 
discussion. Demographic data extracted included: study design, sample size, GA at birth, birth 
weight, sex, and PMA at early MRI. The MRI details extracted were MRI field strength, acquisition 
type, analysis type and qualitative or quantitative MRI findings. Motor outcome data included: 
number of participants with follow up data, age at follow up, validated tool utilized, quantitative 
motor data, number of participants diagnosed with CP and detail of CP motor distribution and 
severity where available. Where participants were assessed at more than one time point >12 months 
CA, the data from the later assessment was utilized.  
 
Diagnostic accuracy can be characterized using a number of possible measures. In this review, 
sensitivity and specificity were chosen a priori as the primary outcome measures as they are not 
affected by the prevalence of the underlying condition, and consequently data from heterogeneous 
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populations could be combined. Sensitivity and specificity of MRI abnormalities to determine 
adverse motor outcomes and/or a diagnosis of CP was extracted where reported, or calculated from 
raw data. Positive and negative predictive values were not reported as the prevalence of adverse 
motor outcomes and CP in a cohort affects the ability to predict outcomes from early MRI, which 
limits the external validity of results17, 18. Diagnostic statistics are presented as a point estimate and 
95% confidence interval (95%CI). Quality of included studies was evaluated with the QUADAS-2 
tool, which is comprised of four domains: patient selection, index test, reference standard, and flow 
and timing19. Each domain is assessed in terms of risk of bias, and the first three domains are also 
assessed in terms of concerns regarding applicability. Each domain is given one of three possible 
ratings: low risk, high risk, or unclear risk. Meta-analysis was conducted where possible using Stata 
version 14 (StataCorp, College Station, TX, USA). 
 
RESULTS 
Search results 
The title and abstracts of 813 records and 114 full text articles were retrieved and reviewed to assess 
eligibility (On-line Figure 1). Twenty-five studies met the inclusion criteria and five further studies 
were identified by manual review of references of included papers20-24. Demographic and clinical 
data extracted from the 30 studies included in this review are presented in Table 1. The type of 
imaging modalities utilized in included studies are presented in Figure 1. 
 
Characteristics of included studies  
Of the 30 included studies, 16 distinct cohorts were identified and a further 14 studies reported data 
of different analyses of either the same or partially overlapping cohorts. The predominant study 
design was prospective cohort study. Sample sizes ranged from 23-193 participants, with all but two 
studies recruiting only infants born <36 weeks PMA. Excluding the studies with infants born ≥36 
weeks PMA, birthweight ranged from 370-2965 grams. The proportion of males ranged from 38-
76%. The PMA at early MRI ranged from 25.9-46.3 weeks. Thirteen studies of six distinct cohorts 
had a range of PMA at early MRI that included TEA, although median and interquartile ranges of 
PMA at MRI were all <36 weeks. Motor outcomes and the number of infants diagnosed with CP 
are presented in Supplementary Table 1. Few studies reported the number of infants who died as 
most only included infants alive at the time of outcome assessment. The percentage of infants in 
each cohort with adverse motor outcomes and/or a later diagnosis of CP varied considerably 
between studies. Cohorts with low prevalence of adverse motor outcomes frequently excluded 
infants with destructive brain lesions in recruitment22, 25, 26. Studies with a high prevalence of CP 
chose study participants based on the presence of defined brain lesions23, 27-30.  
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Structural MRI studies  
Twenty-five studies acquired early structural MRI data21-28, 30-46. Results of meta-analyses are 
presented in Table 2 and Figure 2. Sensitivity and specificity of early MRI findings in individual 
studies to determine later motor outcomes and/or a diagnosis of CP are presented in Table 3. 
Associations with adverse motor outcomes are presented in Supplementary Table 2. Early MRI 
global scores detected infants with a later diagnosis of CP with pooled sensitivity 100% (95%CI 86-
100%) and specificity 89% (95%CI 54-100%) (total participants n=68)27, 37, 46. Global structural 
MRI scores determined adverse motor outcomes using a cut point of < -2 standard deviations (SD) 
on the Bayley Scales of Infant and Toddler Development 2nd edition (BSID-II; n=43), with pooled 
sensitivity 89% (95%CI 44-100%) and specificity 96% (95%CI 85-100%)37, 46. Meta-analysis of an 
MRI WM score to determine motor outcome on the Bayley Scales of Infant and Toddler 
Development 3rd edition (Bayley III; cut off < -1SD; n=240) had pooled sensitivity 33% (95% CI 
20-48%) and specificity 83% (95% CI 78-88%)31, 38.  
 
Associations between early MRI findings and motor outcome or CP were more frequently reported 
than diagnostic accuracy. Five studies employed an overall score of brain injury/integrity, of which 
four found that poorer MRI scores were associated with adverse motor outcomes27, 38, 40, 46. A white 
matter injury (WMI) severity score47 was associated with adverse motor outcomes in three studies31, 
34, 40 but not in two other studies42, 43. Greater WMI volumes in frontal, parietal and temporal, but 
not occipital lobes were associated with adverse motor outcomes 34. White matter injury located in 
the frontal lobe was most predictive of adverse motor outcome34. Smaller total WM volume was 
associated with adverse motor outcomes36. Punctate WM lesions were not associated with motor 
outcome21, 26, although an association between the appearance of punctate lesions and presence of 
CP was reported39. A greater degree of signal intensity change in the periventricular WM was not 
associated with adverse motor outcomes, in infants with otherwise normal MRI or cranial 
ultrasound scans45. 
 
Intraventricular hemorrhage (IVH) was associated with poorer motor outcomes 40, 43. Two studies, 
one of which had only IVH grade I and II in their cohort31, found no associations with adverse 
motor outcomes31, 42. Ventriculomegaly (VM) at TEA following early IVH was associated with 
poorer motor outcomes26. Increasing severity of VM on early MRI was associated with poorer 
motor outcome in one study40, but another study found no associations26, possibly because they 
examined VM independently of IVH. 
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Cerebellar hemorrhage (CBH) demonstrated no associations with motor outcomes31, 40, 43. Smaller 
cerebellar volume was associated with adverse motor outcomes when both the early and term MRI 
data were pooled36. A cerebellar score which included cerebellar injury and transcerebellar diameter 
was associated with adverse motor outcome38. Presence of periventricular hemorrhagic infarction 
(PVHI) was associated with adverse motor outcomes41. Parietal PVHI resulted in a diagnosis of CP 
in 50% of cases. Temporal PVHI was responsible for poorer motor outcomes than frontal PVHI30. 
In a retrospective study of infants with periventricular leukomalacia (PVL) compared to sex 
matched, healthy preterm controls, 23 out of 33 with PVL developed CP compared with none from 
the control group23.  
 
Smaller cortical GM volume was associated with poorer motor outcomes with early and term MRI 
data combined36. Using only early MRI data, deep GM, but not cortical GM, was associated with 
poorer motor outcomes38. Smaller deep GM volume was also associated with adverse motor 
outcomes when early and term MRI data were pooled36. 
 
In a study of infants with PVL23, those who progressed to severe CP (Gross motor function 
classification system GMFCS III-V) had smaller thalamic volumes compared to no or mild CP 
(GMFCS I-II)23. A study investigating length and cross-sectional area of the corpus callosum (CC) 
found no association of length, total area, anterior or middle third area of the CC with motor 
outcomes35. A smaller area of the posterior third of the CC was associated with adverse motor 
outcomes35.  
 
Growth rates of cerebral volume, cortical surface area, total brain volume25, and volume change of 
the hippocampus33 between early and TEA MRI demonstrated no associations with motor 
outcomes. A scaling exponent of cortical surface area relative to cerebral volume was not associated 
with motor outcomes22, however total cerebral volume was smaller in infants who progressed to 
poorer motor outcomes when early and term MRI data were combined36. 
 
Diffusion MRI studies  
Sixteen studies from nine distinct cohorts acquired early diffusion MRI data20, 23, 24, 29-33, 35, 37, 39, 41, 
43, 44, 48, 49. Sensitivity and specificity of diffusion MRI findings to determine later motor outcomes 
and/or CP in individual studies are presented in Table 3. Diffusion biomarkers, regions evaluated 
and associations with motor outcomes are presented in Supplementary Table 3. Three diffusion 
MRI studies reported diagnostic accuracy of their methods although the data were not suitable to be 
combined in a meta-analysis20, 29, 48. Asymmetry of the PLIC on visual inspection of diffusion 
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images, detected cases of hemiplegic CP with sensitivity 86% and specificity 100%29. An 
asymmetry index of FA >0.05 between left and right PLIC, identified cases of hemiplegic CP with 
sensitivity 100% and specificity 88%29. An asymmetry index of RD between left and right PLIC, 
detected later hemiplegic CP with sensitivity 71% and specificity 94%29. A second study combined 
MRI connectome network features with structural MRI brain injury grade and clinical data of GA at 
birth, PMA at MRI and gender and reported a sensitivity of 66% and specificity of 79% to 
determine adverse motor outcomes20. Importantly, the same group subsequently reported that 
connectome network features alone were not predictive of motor outcomes48, suggesting that the 
variables of brain injury and perinatal data were responsible for the diagnostic accuracy of the 
initial overall model. The new study proposed a convolutional neural network framework 
(BrainNetCNN) which generated a predicted motor outcome score for an individual infant based on 
their diffusion MRI data48. They reported a mean absolute error between actual and predicted 
Bayley III motor composite score of 11%, and standard deviation of 8%48. 
 
Eight diffusion MRI studies reported associations between early MRI and motor outcomes24, 31-33, 35, 
37, 44, 49. In WM tracts (CC genu and splenium, PLIC, optic radiation), lower FA was associated with 
poorer motor outcomes31, 35, 37. A small study (n=12) reported a slower change in FA between early 
and term MRI in infants with adverse motor outcomes37. Conversely, in a larger study (n=157), no 
associations were found with FA change between early and term MRI and later motor outcomes31. 
A single study evaluating microstructure of the cingulum found no associations between FA, MD, 
AD or RD and motor outcomes44. Poorer motor outcomes were associated with a difference in slope 
of FA between left and right inferior temporal lobes, where FA increases more slowly on left 
relative to the right49. No associations between FA and motor outcomes were found in superior WM 
structures (anterior, central or posterior)31. A slower increase in FA between early and term MRI in 
basal nuclei (thalamus, caudate and lentiform nuclei) was associated with poorer motor outcomes31. 
A single study of diffusion imaging in the hippocampus found no associations with weekly change 
in MD, AD, RD between early and term MRI and motor outcomes33.  
 
A whole brain voxel-based analysis, found a greater extent of abnormalities on MD, AD and RD in 
infants with poorer motor outcome compared to infants with normal motor outcomes24. Tract-based 
spatial statistics applied to MRI acquired at PMA of 30-33 weeks found that infants with poorer 
motor outcomes had higher AD and RD in the CC, internal and external capsule32. The same study 
evaluated subsets of infants scanned at 27-29 and 34-36 weeks PMA and found no associations 
between FA, AD and RD and later motor outcomes32.  
 
Chapter 2 
12 
fMRI and MRS studies 
One study performed fMRI for the purpose of identifying target regions for tractography44. An 
MRS study investigating N-acetylaspartate (NAA)/choline in the basal nuclei, WM tracts and 
superior WM found that slower increases in NAA/choline between early and term MRI were 
associated with poorer motor outcomes31. A second MRS study evaluated differences in 
NAA/choline and three other markers of metabolism between infants born appropriate weight for 
GA compared with infants who were small for GA. They found no differences between the groups 
in either their metabolic markers or motor outcomes50. 
 
Quality of included studies 
The risk of bias and concerns regarding applicability of findings from individual studies were 
evaluated using the QUADAS-2 tool (results and scoring parameters are included as Supplementary 
Material B). Sources of potential risk of bias and applicability concerns were predominantly related 
to participant selection. Inadequate reporting of blinding of personnel involved in MRI analysis 
limited the ability to judge the risk of bias conferred from the index test. Few concerns regarding 
applicability were identified for the index test. As sufficient motor data or diagnoses of CP were 
part of the inclusion criteria for this systematic review, no concerns regarding applicability were 
identified for the reference standard. A potential risk of bias may exist for the reference standard, as 
almost half of the studies failed to report whether outcomes were assessed by personnel blinded to 
MRI findings. The majority of studies were judged as having a low risk of bias from flow and 
timing. 
 
DISCUSSION 
Early MRI demonstrates reasonable sensitivity and specificity to determine motor outcomes and CP 
in infants born preterm. Diagnostic accuracy for an outcome of CP was stronger than for adverse 
motor outcomes. In determining motor outcome, specificity was higher than sensitivity indicating 
that a normal MRI accurately identified infants who progressed to a normal motor outcome, 
whereas infants with an abnormal early MRI demonstrated variable motor outcomes. For 
determination of a later diagnosis of CP, sensitivity was higher than specificity. Global MRI scores 
accurately determined motor outcomes more strongly than WM MRI scores.  
 
The studies included in meta-analyses of global MRI scores to determine motor outcomes and CP 
demonstrate a high risk of bias due to non-consecutively recruited samples featuring an over 
representation of infants with brain injury or an outcome of CP27, 37, 46. These weighted samples may 
have led to an overestimation of the diagnostic accuracy of MRI, and the results therefore need to 
Chapter 2 
13 
be interpreted with caution51. The studies included in meta-analysis of WM to determine motor 
outcome were found to be at low risk of bias in all domains, as judged with the QUADAS-2 tool31, 
38. 
 
Early MRI findings were also associated with motor outcomes and CP. Poorer motor outcomes 
were associated with worse structural MRI global, deep gray matter and cerebellar scores, location, 
severity and volume of white matter injury, presence of intraventricular haemorrhage, 
ventriculomegaly, periventricular hemorrhagic infarction or periventricular leukomalacia, smaller 
thalamic volumes, and smaller area of the posterior third of the corpus callosum. Diffusion MRI 
showed lower fractional anisotropy and higher axial and radial diffusivity in the corpus callosum, 
PLIC, and a slower increase in FA between early and term MRI in the basal nuclei were associated 
with poorer motor outcomes.  
 
Specificity was higher than sensitivity in most studies with diagnostic accuracy data of MRI to 
detect later motor outcomes. This indicates that early MRI performs well at ruling out future 
adverse motor outcomes. Lower sensitivity however, means that not all infants with abnormal MRI 
progress to adverse motor outcomes. This is consistent with studies of MRI at TEA3, 10, 52. For 
determination of a later diagnosis of CP, sensitivity was more frequently higher than specificity, 
indicating that most infants who progress to CP were identified by abnormalities on MRI. The 
inverse relationships between sensitivity and specificity for an outcome of CP compared with motor 
outcomes may in part be the result of variability in motor outcomes for preterm infants without 
CP53. The choice of cut points in the MRI scores for sensitivity and specificity calculations may 
also contribute to this difference. If MRI scores are dichotomized as ‘any injury vs no injury’, 
sensitivity tends to be high and specificity relatively low, while if ‘normal/mild injury vs 
moderate/severe MRI scores’ are used, sensitivity drops and specificity increases.  
 
White matter abnormalities on early MRI had lower sensitivity and specificity than global measures 
of MRI abnormalities in determination of motor outcomes in this review. Key differences between 
the studies included in the meta-analyses need to be taken into consideration when interpreting this 
finding. Firstly, the sample size of the WM score meta-analysis was 240 participants compared to 
43 in the global score meta-analysis. Secondly, the studies with a global MRI score used the BSID-
II outcome, while the WM score studies used the Bayley III. This makes it difficult to determine if 
the MRI scoring system utilized was better at determination of outcome, or whether the BSID-II 
identifies a different group of children to those identified by the Bayley III. There is some concern 
that the Bayley III underestimates motor dysfunction in infants born preterm54, leading to a tentative 
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use of  <-1SD as the cut off in analyses, rather than the more widespread use of <-2SD with other 
validated tools. 
 
If WM scores have less diagnostic accuracy than global scores of early MRI, then it is an important 
difference to findings with TEA MRI10. A systematic review found term MRI WMA had greater 
predictive accuracy for motor outcomes and CP compared with other brain abnormality findings10. 
Global scores include evaluation of WM; further investigation of other components of global 
scoring may provide insight into specific abnormalities that have greater diagnostic accuracy than 
WM abnormalities on early MRI.  
 
The use of diffusion MRI is gaining momentum in preterm infant studies11. Age and maturation 
relationships between diffusion biomarkers and PMA at MRI have been demonstrated55, 56, as well 
as changes between early and term MRI57, 58. Relatively few studies have demonstrated whether 
these maturational differences equate to clinically meaningful differences in outcomes. This review 
found poorer motor outcomes were associated with lower FA and lower AD and RD in the corpus 
callosum and PLIC on early MRI31, 35, 37, and a slower increase in FA between early and term MRI 
in the PLIC37, optic radiation37 and basal nuclei31. Further research is required to determine if these 
findings are reproducible in other cohorts of preterm infants. Reporting of diagnostic accuracy is 
required to determine if these diffusion MRI biomarkers provide useful prognostic information 
which could be used to support clinical patient management. 
 
Only five of the 30 studies in this review reported diagnostic accuracy; the majority reported 
associations between early MRI findings and motor outcomes and/or CP. This finding is consistent 
with a systematic review of MRI at TEA in preterm infants11. Statistical analyses in preterm study 
populations are challenged by small numbers in a cohort progressing to adverse motor outcomes or 
CP – a phenomenon called class imbalance in the data59. In these situations, the few infants with CP 
or adverse motor outcomes may be responsible for associations, and if removed, the association 
often no longer remains significant. This explains why a study may find significant associations 
between an MRI finding and motor outcome, but then have relatively poor sensitivity and 
specificity for determining motor outcome or CP. The clinical relevance is that diagnostic accuracy 
needs to be considered when using evidence of associations between MRI and outcomes to inform 
clinical practice. 
 
A number of studies which reported no associations between MRI findings and motor outcomes had 
excluded infants with specified structural brain lesions which could be the reason no relationship 
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with motor outcomes was found22, 25, 26, 41, 45. Studies which excluded participants with structural 
brain lesions may be excluding the very cases that their analyses are trying to identify. The rate of 
CP and adverse motor outcomes are declining in preterm populations60-62, increasing the challenge 
of identification of the few cases that do progress to adverse outcomes.  
 
A variety of different brain structures were examined by the 30 studies included in this review. Few 
studies examined exactly the same structures or used exactly the same scoring methods, and those 
that did reported contradictory findings in some cases. White matter injury and IVH were two areas 
where some studies reported associations with motor outcome and others found no associations. 
This could be a sample size issue of inadequately powered studies either over- or underestimating 
associations with outcomes63. Or it could be related to sampling bias as some studies excluded 
infants with large structural brain lesions. Publication bias may also play a part as it is well known 
that negative findings are under-reported in the literature64, 65. Either way, adequately powered 
studies with rigorous methodology and representative sampling are required to replicate these early 
MRI findings and determine their true reproducibility.  
 
While some meta-analyses were performed in this review, data of only a small number of studies 
could be combined; consequently the pooled results of sensitivity and specificity should be 
interpreted with caution. Heterogeneity of MRI scoring systems, variations of dichotomized scoring 
categories and differences in motor outcome measures utilized, limited the extent of meta-analyses 
that were able to be undertaken. No studies used exactly the same MRI scoring method and 
outcome measure and so studies were grouped broadly by whether they used an overall measure of 
injury or looked at WM only.  
 
Few of the included studies were unselected, sequentially recruited samples of preterm infants, 
representative of preterm infant populations. Most studies were in tertiary centers with access to 
MRI and are likely to represent higher risk populations.  Recruitment rates of eligible infants varied 
considerably between studies with some as low as 17%37 and others as high as 86%26. Some studies 
reported high levels of recruitment, but only a proportion of the infants underwent imaging49. Some 
studies grouped data by first/second MRI rather than early/term MRI21, 30, 31. Diffusion studies 
frequently excluded a large number of scans due to movement artefact24, 41, 44, 49. 
 
Follow-up rates varied markedly between studies, a well-documented source of potential bias66. 
Some studies used presence of follow up data as part of their inclusion criteria and therefore 100% 
of the cohort had outcomes reported. Other studies had less than 50% follow-up so that even if the 
Chapter 2 
16 
cohort recruited was representative, analyses with outcomes were performed for a ‘selected’ 
subgroup42, 44. Despite these limitations, the studies included in this review provide important 
information on the consequences of early brain injury and development.  
 
Clinical implications  
Structural MRI has the greatest amount of evidence available and is the most clinically accessible of 
the modalities featured in this review. Valid and reliable scoring systems exist for early structural 
MRI38, 40 which can be adopted into clinical practice. Evidence for diffusion MRI is emerging, but 
the complexity of analysis and interpretation precludes it from application to routine clinical 
settings at this time. The evidence from this review suggests that early MRI may play an important 
role in early identification of infants at risk of CP and adverse motor outcomes, and continued 
research of early MRI is warranted. MRI findings at any age need to be interpreted in context with 
other clinical findings. 
 
Research implications 
Future research of early MRI should include reporting of diagnostic accuracy in addition to 
associations between MRI findings and outcomes. Replication of published relationships between 
early MRI and motor outcomes is required to determine reproducibility of MRI scoring and analysis 
methods. Optimization of cut points may improve diagnostic accuracy of existing scoring systems. 
Receiver operating characteristic (ROC) curve and area under the curve (AUC) analyses could be 
employed to optimize cut-points. Examination of relationships with, and diagnostic accuracy for, 
longer term outcomes is required to understand the full range of implications of early brain injury 
and the value of early MRI in providing prognostic information. One potential benefit of early MRI 
is to select infants who may benefit from early interventions which could be commenced while the 
infant is still in the neonatal intensive care unit. Animal studies of very early neuroprotective 
therapies such as hypothermia, erythropoietin, melatonin, creatine and others are showing promise. 
The ability to identify infants who may benefit from these therapies is critical. Early MRI is 
resource intensive; measures such as clinical assessment findings or readily available bedside 
cranial ultrasound need to be examined for correlations with early brain injury on MRI. Diagnostic 
accuracy of MRI at TEA is augmented by the addition of clinical measures of motor or neurological 
function 4, 67, 68. Evaluation of combinations of early clinical measures and early MRI to determine 
outcomes is warranted.  
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Strengths and Limitations  
This is the first systematic review of diagnostic accuracy of early MRI to determine later adverse 
motor outcomes or a diagnosis of CP. It is also the first systematic review of early MRI to present 
meta-analyses of early MRI data to determine later outcomes in infants born preterm. Both 
diagnostic accuracy and results of associations between early MRI and later adverse motor 
outcomes or CP are synthesized and reported in this review, providing a comprehensive overview 
of the current reported evidence for early MRI to determine motor outcomes and CP in infants born 
preterm. The following limitations require consideration: only studies published in English were 
included in this review, potentially excluding some relevant studies published in other languages; 
some of the included studies pooled their early and term MRI data with no way to determine if the 
associations with outcome were driven by findings on the term MRI; heterogeneity of the included 
studies, in terms of participants, methods and outcomes, resulted in a limited ability to pool data. 
 
Prediction of outcomes is highly desirable for both families and clinicians involved in the care of 
preterm infants, but statistical tests to determine positive and negative predictive values are greatly 
affected by the prevalence of adverse outcomes and CP in the study populations17. This greatly 
limits the ability to generalize the results beyond the population studied. Due to the heterogeneity of 
included studies in this review, and in particular the range of prevalence of adverse motor outcomes 
and CP in the study populations, no pooling of results would have been possible with positive or 
negative predictive values. Sensitivity and specificity were selected to evaluate diagnostic accuracy 
in this review as they are reporting the properties of the tests, rather than being impacted by the 
properties of the sample. 
 
Conclusion 
Identifying early markers of later adverse motor outcomes or CP remains a necessary and important 
challenge for researchers and clinicians. Early MRI has reasonable sensitivity and specificity to 
determine later motor outcomes and/or a diagnosis of CP in infants born preterm. The evidence for 
structural MRI with qualitative scoring of brain macrostructure is promising and clinically 
accessible. Evaluation of brain microstructure with diffusion MRI is emerging. Further research is 
required to refine scoring systems to optimize diagnostic and predictive accuracy, and to improve 
clinical utility. Reporting of diagnostic accuracy is critical to enable interpretation of relationships 
between early MRI findings and later motor outcomes and/or CP. 
 
Acknowledgements: Thank you to Dr Jurgen Fripp for provision of images for Figure 1. 
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Figure 1: Examples of MRI acquisition types at approximately 32 weeks postmenstrual age:  
a) structural MRI evaluated qualitatively for evidence of injury; b) diffusion MRI, from which 
quantitative measures of brain microstructure and development can be extracted (fractional 
anisotropy, mean diffusivity, axial diffusivity and radial diffusivity); c-e) population 32 week 
equivalent atlas that can be used for subject labelling (from which diffusion MRI measures can be 
extracted). 
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Figure 2: Results of meta-analyses. Pooled sensitivity and specificity of a) global MRI score to 
predict CP, b) global MRI score to predict motor outcome of < -2SD on the BSID-II, and c) MRI 
WM score to predict motor outcome on the Bayley III. Abbreviations: BSID-II Bayley Scales of 
infant and toddler development 2nd edition; Bayley III Bayley scales of infant and toddler 
development 3rd edition; CP cerebral palsy; ES pooled estimate; WM white matter. 
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Online Figure 1: Flowchart of included studies 
 
Articles identified by initial electronic search (1453) 
Titles and abstracts screened (813) 
 
Duplicates removed (640) 
Records excluded (793): 
Article type (189) 
Language (2) 
Animal study (27) 
Study population (101) 
Preterm n<10 (13) 
No early MRI (407) 
No outcome data (47) 
Normative cohort (7) 
Total included (30) 
Hand searches (5) 
 
Articles identified by electronic 
search automatic updates (93) 
Full text articles assessed 
for eligibility (114) 
 
Eligible studies (20) 
Met criteria (5) 
 
Excluded (88) 
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Table 1: Population demographics of studies included in this systematic review (Studies presented in alphabetical order; by initial then subsequent 
publications on the same or partially overlapping cohort) 
 
Study Study 
design 
No. with early 
MRI (no. of 
useable scans) 
Gestation at birth weeks 
Median [IQR] or Meana (SD), 
range 
Birth weight grams 
Median [IQR] or Meana (SD), 
range 
Sex 
Male (%) 
PMA at early MRI weeks 
Median [IQR] or Meana (SD), 
range 
Chau 201331 P 177b 27.6 [25.9-29.7], 24-32 1020 [800-1285] 82 (52%) 32.1 [30.5-33.9], 27.1-46.3 
Booth 201624  P 55(46) con. 28.3a n.s. 30 (55%) 31.3 
79 (73) exp. 27.9a n.s. 38 (48%) 32.4 
Brown 201520 P 115 b (168c) 24-32 n.s. n.s. 27-45 
Duerden 201532 P 153 27.7 [26-29.7]d, 24-32 1022 [820-1281]d 78 (51%)d 32 [30.4-33.7] 
Duerden 201633 P 138 27.7 [26-29.9], 24-32 n.s. 70 (51%) 32.3 [30.7-34] 
Guo 201734 P 124 No WMI  27.9 [26-30] n.s. 69 (56%) 32.4 [30.6-34.1] 
58 WMI  28.6 [26.3-29.8] n.s. 26 (45%) 32 [30.6-33] 
Kawahara 201648 P 115b (168c) 24-32 n.s. n.s. 27-45 
Malavolti 201635 P  193b 27.5 [25.8-29.5], 24.2-32 1000 [800-1270], 459-1870 n.s. 32 [30.4-34.1], 27.1-45 
Zwicker 201636 P 136 27.4 [25.8-29.8], 24-32 n.s. 71 (52%) 32.3 [30.8-34] 
Cornette 200221 R 50 b 30 [3.5e], 25-36 1280 [739 e], 580-3675 n.s. n.s. 
 15/50 b with PL 31[3.1e], 27-36 1320 [929 e], 580–3960 10 (67%) 35[3.1e], 29-39.7g 
Drobyshevsky 2007 37 P 24 (21) 28.7 (0.4f)g, 24.1-30.9g 1244, 640-1716 n.s. 30.4 (0.41f)g, 25.9-32.9g 
Dyet 200626 P 119 27.6, 23-29.9 880, 370-1606 67 (56%) 2 [1-5]h 
Kapellou 200622 P 119 (274c) 26.9 n.s. n.s. 2 [1-4]h 
Atkinson 200827  P 26  28.1 (2.7) n.s. n.s. <36  
Rathbone 201125 P 82b (217c) 27.7, 23.4-29.9 950, 500-1610 43(52%) 30.6, 24.1-44 
George 201738 P 83 28.4 [26.6-29.3], 23.6 – 30.6 1068 (312), 494 – 1886  49(59%)  32.2 (1.3), 29.3–35.2 
Kersbergen 201439 R 112 28.2a, 24.4-33.4 1158a, 515-2100 56 (50%) 31.2a, 26.6-34.7 
Kersbergen 201523 R M 33b with PVL  30.1, 24.7-35.4 1621a, 705-2780 24 (73%) 33.7a, 29.3-38 
31 con.  27.9, 25.6-31 1083a, 565-1630 19 (61%) 31.3a, 30.3-34.7 
Miller 200540 P 89  28, 24-34 n.s.i 47 (53%) 32 [31-33] 
Pavaine 201641 P 105 (85) 28.9a, 24.7-32.9 n.s. 46 (54%) 30.4a, 26.3-34.9 
Young 201642 P 105 28.6, 24.4-32.9 1142 (228)j 30 (58%)j Within 2 weeks of birth 
Chapter 2 
22 
Roelants Van Rijn 
200128 
n.s. 12 normal CUS 29.6 (1.9) 1230 (465) n.s. 32.2 (0.6) 
8 IVH+PI 28.9 (2.3), 26.5-32.5 1359 (530), 875-2520 31.5 (1.3) 
7 cystic PVL 29.6 (2.5), 27.2-34 1266 (575), 855-2410 31.4 (2.7) 
Roelants Van Rijn 
200450 
P 26 AGA 29.2 (2.3) 1200 (425) n.s. 32.1, 31.1-33.7 
14b SGA 30.1 (2.7)d 675 (150)d 32.9, 31.6-33.3 
Rogers 201649 P 78 (50) 26.6 (1.8) 941 (246) 33 (42%) 30.4 (2.4) 
Roze 201529 R 23 28.9, 25.7-34.6 1200, 650-1950 9 (39%) 31.3, 29.3-36.4 
Soltirovska Salamon 
201430 
R 21b Frontal PVHI  30.3a, 28-34.4 1527a, 910-2965 11 (52%) Approx. 30  
13b Temporal 
PVHI  
30.3a, 26.6-33.4 1205a, 990-2450 5 (38%) Approx. 30  
Tam 201643 P M 60 28.2a, 24-32 n.s. 37 (62%) 31.5 (2.3) 
Cui 201644 P 21 brain injury  29.1 (1.9) 1278 (290) 13 (62%) 32.4 (1.6) 
23 con. 29.1 (1.5) 1241 (273) 13 (57%) 32.2 (1.5) 
Van Wezel-Meijler 
199945 
P 42 30.9 (1.6) n.s. n.s. 33.2 (1.4)g 
Sie 200546 P 46kb 31.1 (5.6), 27-41.8 1600 (490), 840-4440 35 (76%) 20 (12), 3-53h 
Key: AGA appropriate for gestational age; CUS cranial ultrasound; IQR interquartile range; IVH+PI intraventricular hemorrhage with parenchymal involvement; M 
multicenter; N no; no. number; n.s. not specified; P prospective; PL punctate lesions; PVHI periventricular hemorrhagic infarction; PVL periventricular leukomalacia; R 
retrospective; SD standard deviation; SGA small for gestational age; WMI white matter injury; Y yes; con. control group; exp. experimental group; a mean; b sample 
includes some MRI performed at >36 weeks PMA; c represents useable scans from both early and term MRI; d includes data of some infants with only a term MRI; e 
standard deviation; f standard error; g reported as postconceptional age; h postnatal days; i multiple group median [IQR] reported; j data of n=52/105 with 2 year outcome 
data available; k sample includes 8/46 born>36 weeks GA.  
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 Table 2: Results of meta-analyses conducted in this systematic review.  
 
MRI score Outcome Number of studies Total number of 
participants 
Sensitivity (95%CI) Specificity (95%CI) 
sMRI global score CP 327, 37, 46 68 100 (86-100) 89 (54-100) 
sMRI global score <-2SD BSID-II 237, 46 43 89 (44-100) 96 (85-100) 
sMRI WM score  <-1SD Bayley III 231, 38 240 33 (20-48) 83 (78-88) 
Key: Data are percentages; point estimate and 95% confidence interval. Bayley III Bayley Scales of Infant and Toddler Development 3rd Edition; BSID II 
Bayley Scales of Infant and Toddler Development 2nd Edition; CP cerebral palsy; sMRI structural MRI; WM white matter. 
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Table 3: Sensitivity and specificity in individual studies of abnormal early MRI to determine adverse motor outcomes or CP. Presented as reported, or 
calculated from 2x2 tables of dichotomous MRI and outcome data where sufficient raw data was available. 
Study Definition of abnormal MRI 
Cut off for motor 
outcome n 
Determination of later 
adverse motor outcomes 
Determination of a later 
diagnosis of CP 
Sensitivity Specificity Sensitivity Specificity 
Atkinson 200827 sMRI global mod/severe injury Griffiths DQ <-2SD 24 100 (48-100) 55 (32-77) 100 (59-100) 61 (36-83) 
Chau 201331 sMRI WMI mod/severe <-1SD Bayley III 157 33 (17-53) 86 (79-91) n.a. n.a. 
Brown 201520 dMRI connectome: 3x10 network 
measures + IVH/WMI grade + 
clinical data (GA at birth, PMA at 
MRI, gender) & LSIa 
<-1SD Bayley III 
168 
scans 
66 79 n.a. n.a. 
Drobyshevsky 200737 sMRI global mild-severe <-2SD BSID-II 12 67 (9-99) 89 (52-100) 100 (16-100) 90 (56-100) 
George 201738 sMRI score mod/severeb: 
WM 
<-1SD Bayley III 
83 
33 (12-62) 78 (66-87) 
n.a. n.a. 
Cortical GM 0 (0-22) 81 (70-89) 
Deep GM 40 (16-68) 94 (86-98) 
Cerebellum 13 (2-40) 93 (84-98) 
Global 33 (12-62) 87 (76-94) 
sMRI score mod/severeb: 
WM 
NSMDA mild-
profound dysfunction 
43 (10-82) 78 (67-86) 
Cortical GM 0 (0-41) 83 (73-91) 
Deep GM 43 (10-82) 91 (82-96) 
Cerebellum 29 (4-71) 93 (85-98) 
Global 43 (10-82) 86 (76-93) 
Miller 200540 sMRI WMI mod/severe Abnormal 
neurodevelopmental 
outcomec 
80 58 (28-85) 75 (63-85) n.a. n.a. 
Roze 201529 dMRI Visual asymmetry of PLIC   
23 n.a. n.a. 
86 (42-99) 100 (76-100) 
Asymmetry index FA >0.05 100 (56-100) 88 (60-98) 
Asymmetry index RD 71 (30-95) 94 (68-100) 
Sie 200546 sMRI global score 5-6 
BSID II <-2sd 31 
100 (29-100) 96 (82-100) 100 (40-100) 100 (87-100) 
sMRI motor score 3-4 100 (29-100) 96 (82-100) 100 (40-100) 100 (87-100) 
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sMRI visual score 3-4 
100 (29-100) 
100 (88-
100) 
75 (19-99) 100 (87-100) 
Soltirovska Salamon 
201430 
sMRI T as opposed to F PVHI unfavorable outcomed 
31 60 (32-84) 94 (70-100) 100 (3-100) 70 (51-85) 
Key: Data are percentages; point estimate and 95% confidence interval. Bayley III Bayley Scales of Infant and Toddler Development 3rd Edition; BSID II 
Bayley Scales of Infant and Toddler Development 2nd Edition; CP cerebral palsy; dMRI diffusion MRI; DQ developmental quotient; FA fractional anisotropy; 
F frontal PVHI; LSI local synthetic instances (statistical method to address class imbalance in data); GA gestational age; n.a. not assessed; NSMDA 
Neurosensory Motor Developmental Assessment; PLIC posterior limb of the internal capsule; PMA postmenstrual age; PVHI periventricular hemorrhagic 
infarction; RD radial diffusivity; sMRI structural MRI; T temporal PVHI; WMI white matter injury; mod moderate;  a early and Term MRI data included in 
analysis; b composite scoring system including brain injury and 2 dimensional measurements of brain volume; c defined as BSID II mental development index 
<70 and/or neuromotor score of 3-540; d combination of Griffiths DQ & Neurological examination. 
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Supplementary Table 1: Motor outcomes and cerebral palsy in the studies included in this systematic review 
Study no.  Age at Outcome 
months; Median 
[IQR] or Meana 
(SD), range 
Measure Group scores 
Median [IQR] 
or Meana (SD), 
range 
Normal Mild Moderate Severe Cp/ No CP CP 
type 
(severity/ 
GMFCS) 
Chau 201331 157 18.7 [18.3-19.2] Bayley III 107[100-110]b 
91 [88-94]c 
79 [76-82]d 
61 [58-67]e 
76 (48%)b 
51 (32%)c 
  
 
17 (11%)d 
 
 
 
13 (8%)e 
n.a.  
Booth 201624  46 con. 18 Bayley III  46 (100%)g    n.a.  
73f exp. 13 (18%)b 
37 (51%)c 
 14 (19%)d 9 (12%)e n.a.  
Brown 201520 168f 18 Bayley III  146 (87%)g 22 (13%)h n.a.  
Duerden 201532 150 18.7 [18.3-19.5] Bayley III 99 [89-105]i 
100 [92-107]j 
93 [84-104]k 
   
n.a.  
PDMS-2  96 [90-101]i 
96 [92-98]j 
92 [84-97]k 
84% g 16%h 
Duerden 201633 117 18.7 [18.3-19.2] Bayley III 97 [88-107]     n.a.  
Guo 201734 124l 18.6 [18.3-19.2]l 
Bayley III 
100 [91-107]l     0/124  
30m 18.6 [18.3-19.2]m 99 [88-108]m 
    2/56  17n 18.6 [18.4-20.8]n 100 [88-103]n 
11o 19 [18.3-19.8]o 82 [75-87]o 
Kawahara 201648 168f 18 Bayley III  146 (87%)g 22 (13%)h n.a.  
Malavolti 201635 167 18 Bayley III 95a [88-107], 
49-124 
84 (50%)b 
53 (32%)c 
30 (18%)h n.a.  
Zwicker 201636 127 18 PDMS-2 96 [86-98]     n.a.  
Cornette 200221 15p 19.6 (3.75), 14-26 Neuro      4 PL+ other 
lesion /8 
PL only 
2 PL + 
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other lesion 
Drobyshevsky 200737 12 18-24 BSID II 50-103q   6g  3d 3e 2/10  
Dyet 200626 68 23.9, 19.5-34.4 Griffiths motor 95 (21)       
Neuro      4/64 1r 2s1rs 
(3t 1u) 
Kapellou 200622 63 23.83 Griffiths 59-155q     n.a.  
Atkinson 200827  25 
 
22.4 (3.4) Griffiths DQ 87 (21) 17g  3d 5e   
Neuro     7/18  
Rathbone 201125 62 24 Griffiths DQ 97.11(18.06) 
    n.a.  
70 6.1, 5.9-6.5 years MABC 12.81 (7.63) 
George 201738 
83 12.13 (0.3) 
Bayley III 96.96 (14.27) 68 (82%)g 15 (18%)h 
n.a.  
NSMDA 179.53 (18.81) 76 (92%)v 7 (8%)w 
Kersbergen 201439 17 
25, 22.6-31.3 
Griffiths DQ 99 (14)     
9/103  
65 Bayley III 108 (12)     
Kersbergen 201523 
61  Neuro      23 y/38 
(4t 2u 10z 
5† 2‡) 
Miller 200540 
86 
18.2 [13.1-19.2] Composite 
BSID-II 
Neuromotor  ⃰
0 [0-1] ⃰ 51 (59%)#   
n.a.  18.2 [13.3-21.4] 1 [0-2] ⃰  22 (26%)¨  
18.3 [17.4-21.5] 2 [1-3] ⃰   13 (15%)§ 
Pavaine 201641 
22¤ 
24 Bayley III 
94.7 (11.9), 
76-121¤ 
    n.a.  15¥ 
89.3 (11.2),  
64-107¥ 
4« 
95.8 (12.7), 
79-110« 
Young 201642 52 24 Bayley III 93.4 (13.7)     n.a.  
Roelants Van Rijn 
200128 
12ǂ 9-15 
Neuro 
     0/12  
8ǃ  
18 
     5/3 3r 2» 
7 Δ       3/1 (3 died) 2s 1» 
Roelants Van Rijn 
200450 
26 Ω 
24 Griffiths DQ 
104 (10) 25 (96%)g 1 (4%)h 
n.a.  
14 ϟ 99 (9) 13 (93%)g 1 (7%)h 
Rogers 201649 65 24 Bayley III 84.6 (10.6) 9 (14%)Ϫ 35 (52%)Ϫ 17 (26%)Ϫ 5 (8%)Ϫ n.a.  
Roze 201529 23 29, 15-67 Neuro      7/16 7r 
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Soltirovska Salamon 
201430 
21F 
39, 26-48 
composite   ‘favorable’ 15 ‘unfavorable’ 6 
  Griffiths DQ 92a 16 (76%)g 5 (24%)h 
Griffiths motor  19 (90%) 2 (10%)   
Neuro      0/21  
11T 
composite  ‘favorable’ 1 ‘unfavorable’ 9 
  Griffiths DQ 91a 6 (60%)g 4 (40%)h 
Griffiths motor  7 (70%) 3 (30%) 
neuro    1/9 1r(1t) 
Tam 201643 45 32.8 (3.6) Bayley III 98.1 (14.3)     n.a.  
Cui 201644 13 12 Bayley III      n.a.  
Van Wezel-Meijler 
199945 
42 12 (0.3), 11.5-13 BSID-II 101 (15), 68-138     n.a.  
Sie 200546 
31◊ 18 
Dutch BSID II  27 (87%)g  1 (3%)d 3 (10%)e   
Neuro      4/27 1r 2s 1» 
Key: Bayley III Bayley Scales of Infant and Toddler Development 3rd Edition motor composite score; BSID II Bayley Scales of Infant and Toddler Development 2nd 
Edition psychomotor development index; composite combination of assessments used to define outcome categories; con. control group; CP cerebral palsy; DQ 
developmental quotient; exp. experimental group; F frontal PVHI; IQR interquartile range; GMFCS Gross Motor Function Classification System; MABC Movement 
Assessment Battery for Children; n.a. not assessed; Neuro neurological examination to determine presence/absence of CP; NSMDA Neurosensory Motor Developmental 
Assessment; PDMS-2 Peabody Developmental Motor Scales 2nd edition; PL punctate lesion; SD standard deviation; T temporal PVHI; a mean; b outcome score>100; c 
outcome score 85-100; d outcome score 70-85; e outcome score <70; f number represents useable scans; g outcome score>85; h outcome score <85; i PMA at MRI 27-29 
weeks;  j PMA at MRI 30-33 weeks; k PMA at MRI 34-36 weeks; l no white matter injury (WMI); m mild WMI; n moderate WMI; o severe WMI; p represents 15/50 with 
punctate lesions; q approximate range extracted from a figure; r hemiplegia; s diplegia; t GMFCS level I; u GMFCS level II; v normal or minimal dysfunction; w mild to 
profound dysfunction; y all infants who developed CP were in the group with cystic periventricular leukomalacia; z GMFCS level III; † GMFCS level IV; ‡ GMFCS level V;  
⃰ neuromotor score40; #mental development index (MDI)>85 and normal neurologic exam; ¨ MDI 70-84 and/or motor tone/reflex abnormalities (neuromotor score 1 to 2); § 
MDI<70 and/or functional motor deficits (neuromotor score 3-5); ¤ no brain injury; ¥ mild/moderate brain injury; « severe brain injury; » quadriplegia; ǂ no abnormalities on 
cranial ultrasound; ǃ intraventricular hemorrhage with parenchymal involvement; Δ periventricular leukomalacia; Ω appropriate for gestational age; ϟ small for gestational 
age; Ϫ outcome score categories normal (≥95), mild (≥80 & <95), moderate (≥65 and <80), severe (<65); ◊ subsample born <36 GA and MRI<36 weeks PMA 
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Supplementary Table 2: Structural MRI findings in studies included in this systematic review 
Study No.  Field 
Strength 
Analysis MRI Findings 
No injury Mild Moderate Severe Poorer motor outcome is associated with 
Chau 201331 157a 1.5T WMI 109(69%) 20(13%) 18(12%) 10 (6%)  Severe WMI 
IVH 85(54%) 71(43%)b 0 0 No associations  
CBH 132 (84%) 25(16%) No associations 
PVHI 153 (97%) 4(3%) n.a. 
Booth 201624  46 con. 1.5T 
WMI 
46 (100%) 0 0 0 
n.a. 
73 exp. 44 (60%) 9 (12%) 14 (19%) 6 (8%) 
Duerden 201532 157 
scansa 
1.5T WMI 132 scans (84%) 25 scans (16%) 
n.a. 
IVH 85 scans 
(54%) 
68 scans 
(43%)b 
4 scans (3%)c 
CBH 139 scans 
(89%) 
18 scans (11%) 
Duerden 201633 138 1.5T IVH 81 (59%) 57 (41%)b 0 0 n.a. 
CBH 118 (86%) 20 (14%) n.a. 
Hippocampus 
Vol. 
    
No association with hippocampal growth from early 
to TEA MRId 
Guo 201734 182 1.5T WMI 124 (68%) 58 (32%) Severe WMI 
WMI vol.   Greater WMI volumes 
WMI location 
  
i) greater WMI volumes in frontal, parietal, & 
temporal but not occipital lobes 
ii) Frontal lobe WMI most predictive of adverse 
motor outcome 
IVH 105 (58%) 72 (40%)b 5 (3%)c n.a. 
CBH 160 (88%) 21 (12%) n.a. 
VM 143 (79%) 39 (21%) n.a. 
Malavolti 
201635 
193a 1.5T WMI 133 (69%) 48 (25%) 12 (6%) n.a. 
IVH 100 (52%) 85 (44%)b 0 8 (4%)e n.a. 
CC area 
    
i) Smaller area of posterior third of CCd 
ii) No association with total area of CC or 
anterior or middle third aread 
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CC length     No associations 
Zwicker 201636 136 1.5T WMI 95 (70%) 41 (30%) n.a. 
IVH 70 (51%) 66 (49%) n.a. 
CBH 114 (84%) 22 (16%) n.a. 
Cerebral, WM, 
cortical GM, deep 
GM, cerebellar 
vol. 
    
Smaller cerebral, WM, cortical GM, deep GM, & 
cerebellar volumesd 
Cornette 200221 15af 1.5T PL  
 
8/15 PL only ; 7/15 PL + other 
major lesion 
Additional lesions & not punctate lesions alone 
Drobyshevsky 
200737 
21 n.s. IVH 12 (57%) 6 (29%)b  2 (10%)g 1 (5%)e n.a. 
VM 12 (57%) 9 (43%) n.a. 
PVL 20 (95%) 1(5%) n.a. 
Dyet 200626 119 1.0 or 
1.5T 
IVH 95 (80%) 24 (20%) i. Normal early MRI scans (infants with PVHI, 
CBH, BG & thalamus abnormalities excluded 
from analysis) 
ii. No association with number of abnormalities 
iii. No association with VM or PL 
iv. IVH + subsequent VM 
v. PVHI, CBH, BG & thalamus abnormalities 
relationships with motor outcome not assessed 
CBH 111 (93%) 8 (7%) 
PVHI 117 (98%) 2 (2%) 
PL 106 (89%) 13 (11%) 
VM 83 (70%) 36 (30%) 
BG & thalamus 112 (94%) 7 (6%) 
Kapellou 200622 113 1.0 or 
1.5T 
Scaling exponent 
of cortical surface 
area relative to 
Cerebral vol. 
    No associations 
Atkinson 200827  26 1.0T Total brain injury 
scoreh 
8 8 10 Worse MRI scoresi 
Rathbone 
201125 
82 1 T Growth rates:       
cerebral vol.     No associationsd 
cortical surface 
area 
    No associationsd 
total brain vol.     No associationsd 
George 201738 83 3T IVH 79 (95%) 4 (5%) n.a. 
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PVL 81 (98%) 2 (2%) n.a. 
MRI scoresj: WM     No associations 
Cortical GM     No associations 
Deep GM     worse deep GM total score  
Cerebellum     worse cerebellar total score  
Global score     worse global total score 
Kersbergen 
201439 
112 1.5 or 3T IVH 
56 (50%) 22 (20%)b 12 (11%)g 
22 
(20%)e 
n.a. 
CBH 105 (94%) 7 (6%) n.a. 
Cystic PVL 111 (99%) 1 (1%) n.a. 
PVHI 87 (78%) 25 (22%) n.a. 
PWML no., 
appearance, 
location 
21 (19%) 91 (81%) 
No association with PWML appearance & lesion 
load (no.)  
CP outcome associated with appearance of PWML 
Kersbergen 
201523 
64 1.5 or 3T Thalamic vol.     
Smaller thalamic volumes (severe CP GMFCS III-V 
compared to no/mild CP)d 
thalamic vol. 
corrected for 
Total brain vol. 
    
Miller 200540 86 1.5T Global 54 (63%) 32 (37%) Mod/severe abnormalities on MRI 
WMI 39 (49%) 17(21%) 21(26%) 3(4%) Increasing severity of WMI 
IVH 56 (65%) 24 (28%)b 6 (7%)c Increasing severity of IVH 
CBH 77 (90%) 9 (10%) No associations 
VM 62 (72%) 7 (8%) 7 (8%) Increasing severity of VM 
Pavaine 201641 85 1.5T Global brain 
injury 
41 (48%) 34 (40%) 
10 
(12%) 
No associations  
IVH 58 (68%) 15 (18%)b 12 (14%)g  n.a. 
PVHI 82 (96%) 3 (4%) Presence of PVHI 
PWML 52 (61%) 24 (28%)k 2 (2%)l 7 (8%)m n.a. 
Young 201642 52n n.s. WMI 35 (67%) 13 (25%) 4 (8%) No associations 
IVH 33 (63%) 7 (14%)b 12 (23%)c No associations 
Roelants Van 
Rijn 200128 
27 1.5T IVH 17 (63%) 10 (37%) n.a. 
PVL 20 (74%) 7 (26%) n.a. 
Soltirovska 21a 1.5 or 3T Frontal PVHI      Temporal rather than frontal PVHI 
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Salamon 201430 13a Temporal PVHI      
Tam 201643 60 1.5T WMI 44 (73%) 7 (12%) 9 (15%) No associations 
IVH 44 (73%) 9 (15%)b 7 (12%)c Grade 3-4 IVH 
CBH 54 (90%) 6 (10%) No associations 
Cui 201644 21o 3T WMI 7 (33%) 8 (38%) 3 (14%) 3 (14%) n.a. 
IVH  5 (24%) 10 (48%) 2 (9%) 4 (19%) n.a. 
Van Wezel-
Meijler 199945 
42 1.5T Periventricular 
WM SI 
19 (45%)  
23 
(55%) 
No associations 
Sie 200546 31p 1.5T MRI scores: 
Generalq 
5 (16%) 16 (52%) 9 (29%) 1(3%) Worse general scores 
Motor 17 (55%) 10 (32%) 2 (7%) 2 (7%) Worse motor scores 
Visual 15 (48%) 13 (42%) 2 (7%) 1 (3%) Worse visual scores 
Key: BG basal ganglia; CBH cerebellar hemorrhage; CC corpus callosum; con. control group; CP cerebral palsy; exp. experimental group; GM gray 
matter; IVH intraventricular hemorrhage; n.a. not assessed; PL punctate lesion; PVHI periventricular hemorrhagic infarction; PWML punctate white 
matter lesion; SI signal intensity; VM ventriculomegaly; WM white matter; WMI white matter injury; vol. volume; a sample includes some early MRI 
performed at >36 weeks PMA; b IVH grade 1/269; c IVH grade 3/469; d early and Term MRI data included in analysis; e grade 4 IVH69; f represents 15/50 with 
punctate lesions; g IVH grade 369; h MRI score is a combination of early and TEA MRI findings; i calculated from raw data available in publication; j scoring 
system including brain injury and 2 dimensional measurements of brain volume; k isolated PWML; l linearly arranged PWML; m confluent PWML; n 
MRI data of 52/105 with outcome data available; o brain injury group only (control group had no structural abnormalities); p subsample born <36 GA and 
MRI<36 weeks PMA; q general score classifications normal (1), mild (2&3), moderate (4&5), severe (6).  
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Supplementary Table 3: Diffusion MRI findings in studies included in this systematic review 
Study Number Biomarker Region Poorer motor outcome is associated with 
Chau 201331 157a FA WM tracts (CC genu & 
splenium,  PLIC, OR) 
lower FA (when cohort grouped by motor outcome); 
no association with FA change between early & 
termb  
Basal nuclei (thalamus, 
caudate, lentiform nuclei) 
slower FA increase between early & termb  
Superior WM (anterior, 
central, posterior) 
no associations 
Booth 201624  91 scansac (80 normal 
& 11 abnormal 
outcomed) 
extent of FA/MD/AD/RD 
abnormalities measured by 
STEAM 
abnormalities identified for 
each individual 
greater extent of abnormalities on MD, AD, RD 
(trend towards greater extent of abnormalities on FA) 
Brown 201520 115a (168 scans) Connectome: 3x10 network 
measures + IVH/WMI grade + 
clinical data (GA at birth, PMA at 
MRI, gender) 
Whole brain network See Table 5 for sensitivity & specificity 
Duerden 201532 22 @ 27-29w PMA 
93 @ 30-33w PMA 
32 @ 34-36w PMA 
 
FA, AD, RD whole brain; CC 27-29 weeks: no associations; 
30-33 weeks: poorer fine motor; lower AD, RD in 
CC, IC, EC to cerebral peduncles; no association 
with FA; no association with gross and total motor 
scores 
34-36 weeks: no associations 
Duerden 201633 117 MD, AD, RD  hippocampus no associations with weekly change in MD, AD, RD 
between early and term MRIb 
Kawahara 201648 115a (168 scans)  Connectome: streamline number Whole brain network Prediction of motor outcome: absolute error between 
actual and predicted Bayley III motor composite 
score: mean 11% (standard deviation 8%) 
Malavolti 201635 167a FA CC genu & splenium lower FAb 
Drobyshevsky 200737 12 FA, MD 21 regions distributed over 
brain; of note: PLIC 
lower FA (30 weeks); 
slower FA change between early & termb 
occipital WM slower FA change between early & termb 
Kersbergen 201439 27  ADC – visual evidence of whole brain n.a. 
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restricted diffusion in PWML 
Kersbergen 201523 29 FA, MD, AD, RD CST, PLIC n.a. 
Pavaine 201641 85 FA, MD, AD, RD PLIC, OR not reported 
Rogers 201649 38 FA, MD, AD, RD 
slopes of FA & MD using serial 
scans 
ALIC, PLIC, OR, CC, 
cingulum bundle, centrum 
semiovale, frontal lobe in 
the forceps minor & 
subcortical WM of superior 
temporal lobe, inferior 
temporal lobe & 
orbitofrontal region. 
Difference in slope of FA between left & right 
inferior temporal lobe, where FA increases more 
slowly on left relative to the rightb 
 
Roze 201529 23 with PVHI asymmetry of FA, MD, AD, RD; 
visual asymmetry 
PLIC See Table 5 for sensitivity & specificity 
Soltirovska Salamon 
201430 
5 with temporal PVHI 
 
Visual inspection OR n.a. 
Tam 201643 45 FA, MD, AD, RD Whole brain 
PLIC, OR 
n.a. 
Cui 201644 13 FA, MD, RD, AD  cingulum no associations 
Key: AD axial diffusivity; ADC apparent diffusion coefficient; CC corpus callosum; CST cortico-spinal tract; EC external capsule; FA fractional anisotropy; GM gray 
matter; IC internal capsule; IVH intraventricular hemorrhage; MD mean diffusivity; n.a. not assessed; OR optic radiation; PLIC posterior limb of the internal capsule; 
PMA postmenstrual age; PVHI periventricular hemorrhagic infarction; PWML punctate white matter lesions; RD radial diffusivity; STEAM Statistical Template 
Estimation for Abnormality Mapping; WM white matter; WMI white matter injury; a  sample includes some early MRI performed at >36 weeks PMA; b early and term 
MRI data included in analysis; c experimental group only; d n=22 infants with ‘borderline outcome’ excluded from analysis.   
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Supplementary Material A - Detailed systematic review search strategy 
 
Pubmed (447) 
preterm OR “premature infant” OR “infant, premature"[MeSH Terms] 
mri OR mr[tiab] OR “magnetic resonance imaging” OR "magnetic resonance imaging"[MeSH 
Terms] OR “magnetic resonance”  OR dti[tiab] OR diffusion 
motor[tiab] OR "Motor Activity"[Mesh] OR neuromotor OR bayley OR aims OR nsmda OR mabc 
OR Griffith[tiab] OR Griffiths[tiab] OR "cerebral palsy"[MeSH Terms] OR "cerebral palsy" OR 
cp[tiab] 
 
Scopus (192) 
premature infant OR preterm OR prematurity 
mri OR mr OR “magnetic resonance imaging” OR “magnetic resonance”  OR dti OR diffusion 
motor OR 'motor activity' OR neuromotor OR bayley OR aims OR nsmda OR mabc OR griffith*  
OR peabody OR "cerebral palsy" OR cp 
 
Cinahl (117) 
preterm OR “premature infant” OR MH "Infant, Premature" 
mri OR TI mr OR AB mr OR “magnetic resonance imaging” OR MH "Magnetic Resonance 
Imaging+"  OR “magnetic resonance”  OR TI dti OR AB dti OR diffusion 
TI motor OR AB motor OR MH "Motor Skills+" OR MH "Motor Skills Disorders" OR neuromotor 
OR bayley OR aims OR nsmda OR mabc OR Griffith* OR Peabody OR MH "Cerebral Palsy"  OR 
"cerebral palsy" OR TI cp OR AB cp 
 
Embase (666) 
'prematurity'/exp OR “premature infant” OR preterm 
mri OR mr:ti,ab OR “magnetic resonance imaging” OR 'nuclear magnetic resonance imaging'/exp 
OR “magnetic resonance” OR dti:ti,ab OR diffusion 
motor:ti:ab OR 'motor activity'/exp  OR neuromotor OR bayley OR aims OR nsmda OR mabc OR 
Griffith* OR Peabody OR "cerebral palsy" OR 'cerebral palsy'/exp 
 
Cochrane (31) 
premature infant OR preterm OR prematurity 
mri OR mr OR “magnetic resonance imaging” OR “magnetic resonance” OR dti OR diffusion 
motor OR 'motor activity' OR neuromotor OR bayley OR aims OR nsmda OR mabc OR Griffith* 
OR Peabody OR "cerebral palsy" 
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Supplementary Material B: Assessment of the risk of bias and concerns regarding applicability, evaluated using the QUADAS-2 tool19 for studies 
included in this systematic review 
 
Study 
Risk of bias Applicability concerns 
Patient selection Index test (MRI) Reference 
standard (motor 
outcome) 
Flow and timing Patient 
selection 
Index test Reference 
standard 
Could selection of 
study participants 
have introduced 
bias? Was a 
consecutive or 
random sample 
enrolled? Did study 
avoid inappropriate 
exclusions? 
Could conduct or 
interpretation of MRI 
have introduced bias? 
Blinded scoring of 
MRI? Were 
sensitivity & 
specificity cut point 
criteria pre-specified? 
Could outcome 
assessment, its 
conduct, or its 
interpretation have 
introduced bias? 
Were outcome 
assessors blind to 
MRI findings? 
Could patient flow 
have introduced 
bias? Did all 
participants receive 
the same outcome 
assessment?  Were 
all patients included 
in analysis? 
Are there 
concerns that 
individual 
study 
participants 
do not match 
review 
question? 
Are there 
concerns that 
the MRI, its 
conduct, or 
interpretation 
differ from 
the review 
question? 
Are there 
concerns that the 
target condition 
as defined by the 
reference 
standard does not 
match the review 
question? 
Chau 201331 +  + + + —  + + 
Booth 201624  —  + + + — + + 
Brown 201520 ?  ?  ? + —  —  + 
Duerden 201532 +  +  +  + + + + 
Duerden 201633 +  ?  +  + + + + 
Guo 201734 +  + + + + + + 
Kawahara 201648 —  ?  ? + —  + + 
Malavolti 201635 +  + +  + —  —  + 
Zwicker 201636 +  + + + + —  + 
Cornette 200221 — + — + —  + + 
Drobyshevsky 2007 
37 
—  + + —  —  + + 
Dyet 200626 + ? + —  + + + 
Kapellou 200622 + ?  + —  — + + 
Atkinson 200827  —  ?  + + — + + 
Rathbone 201125 + ?  ?  —  —  + + 
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George 201738 + + + + + + + 
Kersbergen 201439 — ?  ?  —  —  + + 
Kersbergen 201523 —  + ?  + — + + 
Miller 200540 +  + ?  + + + + 
Pavaine 201641 —  ?  ?  —  + + + 
Young 201642 —  ?  ?  + + + + 
Roelants Van Rijn 
200128 
—  + ?  + + + + 
Roelants Van Rijn 
200450 
—  ?  ?  + —  + + 
Rogers 201649 +  + + + + + + 
Roze 201529 —  + ?  + — + + 
Soltirovska 
Salamon 201430 
— ?  ?  + —  + + 
Tam 201643 + + + —  + + + 
Cui 201644 ?  ?  ?  —  + —  + 
Van Wezel-Meijler 
199945 
—  + + + + + + 
Sie 200546 —  ?  ?  —  +  + + 
+ low risk; — high risk; ? unclear risk 
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Supplementary Material B continued: QUADAS-2 methodological evaluation of included 
studies19  
Domain 1: Participant selection 
A. Risk of bias 
Was a consecutive or random sample of participants enrolled? 
YES: if the articles clearly stated that a consecutive or random samples was enrolled;  
NO: if it was clear that this was not the case (e.g. if a study included participants with MRI for 
clinical reasons' (convenience sample), MRI only performed if abnormalities detected on CUS;  
UNCLEAR: in other cases where it was not clear if consecutive or random samples were enrolled. 
 
Did the study avoid inappropriate exclusions? 
Inappropriate exclusions included: large number of scans excluded due to movement artefact 
(dMRI). Acceptable exclusions included: congenital abnormality/malformation, chromosomal 
abnormality, congenital infections, medical instability as reason for no MRI, geographical 
boundaries, language, large lesion such as PVL/PVHI (due to very low prevalence, and clear risk of 
outcome already established).  
YES: if inappropriate exclusions were not found in the included study,  
NO: if reasons for inappropriate exclusion were found.  
UNCLEAR: if there was no description of the inclusion and exclusion criteria and inappropriate 
exclusion could not be ascertained. 
 
Could the selection of participants have introduced bias? 
LOW RISK: if all questions were scored "YES", or a maximum of one question with unclear. 
HIGH RISK: if at least one question was scored as "NO". 
UNCLEAR RISK: if at least two questions were scored as "UNCLEAR" and one as "NO". 
 
B. Concerns regarding applicability 
Was there concern that the included participants did not match the review question? 
LOW CONCERN: if all included participants were preterm born with MRI before 36 weeks PMA. 
If sufficient data were reported so that data from only preterm born infants with MRI<36 weeks 
could be calculated and reported in SR. If motor outcomes and CP were appropriately represented 
in the cohort. 
HIGH CONCERN: if sample included participants that were born >36 weeks GA or with PMA at 
MRI>36 weeks. Or if sample had an over-representation of brain injury or adverse outcomes/CP. 
UNCLEAR CONCERN: if it is unclear whether the study fulfilled either the criteria for low 
concern or for high concern.
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Domain 2: Index test 
A. Risk of bias 
Were the MRI results interpreted without knowledge of the results of the motor outcome? 
Were sensitivity & specificity cut point criteria pre-specified? 
YES: if people performing the MRI scoring were blinded to the results outcome assessments, or if 
the MRI scoring/analysis method was objective;  
NO: if people performing the MRI scoring had knowledge of the results of outcome assessments;  
UNCLEAR: if the study did not explicitly describe how the MRI was conducted, scored or 
interpreted.  
 
Could the conduct or interpretation of the MRI have introduced bias? 
LOW RISK: if the MRI scoring was performed blinded to the results of the outcome assessment. 
HIGH RISK: if there was prior knowledge of the results of the outcome assessment. 
UNCLEAR RISK: if there was no clear description of blinding of MRI scoring/analysis. 
 
B. Concerns regarding applicability 
Was there concern that the index test (MRI acquisition and scoring), its conduct, or 
interpretation differed from the review question? 
LOW CONCERN: if the MRI scoring system was designed for use in preterm infants with the 
intention of identifying abnormalities which might be related to later motor outcomes, and if only 
early MRI data was used in analysis. Only exception here was if analysis method was examining 
change between early and term MRI. 
HIGH CONCERN: if the MRI scoring system was not designed for use in preterm infants with the 
intention of identifying abnormalities which might be related to later motor outcomes, or if early 
and term MRI data were pooled for analysis. 
UNCLEAR CONCERN: if it was unclear whether the study fulfilled criteria for "low concern" or 
"high concern" or if the study provided limited information regarding the conduct and interpretation 
of the MRI. 
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Domain 3: Reference standard 
A. Risk of bias 
Describe the reference standard and how it was conducted and interpreted 
Was the reference standard likely to correctly classify the target condition? 
YES: if the outcome assessment was a validated assessment tool with quantitative data of motor 
outcome, or a structured neurological assessment to determine the presence/absence of cerebral 
palsy;  
NO: if the test used for outcome was not validated;  
UNCLEAR: if there was no description of the outcome assessment used. 
 
Were the outcome assessment results interpreted without knowledge of the results of the MRI 
findings? 
YES: if people performing and scoring the outcome assessments were blinded to the results of the 
early MRI;  
NO: if people performing and scoring the outcome assessments had knowledge of the MRI results;  
UNCLEAR: if the study did not explicitly describe how the outcome assessment was conducted 
and interpreted. 
 
Could the reference standard, its conduct, or its interpretation have introduced bias? 
LOW RISK: if the reference standard (outcome assessment) used was performed and evaluated 
without knowledge of the results of the index test (MRI). 
HIGH RISK: if the reference standard (outcome assessment) was evaluated with the knowledge of 
the results of the index test (MRI). 
UNCLEAR RISK: if there was no clear description of the reference standard used, how it was 
performed and interpreted in relation to the results of the index test. 
 
B. Concerns regarding applicability 
Was there concern that the target condition as defined by the reference standard did not 
match the review question? 
LOW CONCERN: if motor outcomes or CP were described. 
HIGH CONCERN: not applicable, as studies were only included in this systematic review if they 
contained quantitative motor outcome data or data of diagnosis of CP in study sample. 
UNCLEAR CONCERN: if it was unclear whether the study fulfilled either the criteria for "low 
concern" or for "high concern". 
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Domain 4: Flow and timing 
A. Risk of bias 
Did all participants receive the same outcome assessment?  Were all patients included in 
analysis (i.e. follow up rate)? Was there an appropriate interval between index test(s) and 
reference standard? Was motor outcome evaluated at ≥12 months CA? (not applicable as 
studies were only included if motor outcomes were assessed at ≥12 months corrected age) 
 
YES: if ≥80% of study participants underwent outcome assessment and were included in analyses;  
NO: if<80% of study participants underwent outcome assessment and were included in analyses;  
UNCLEAR: if there was no description of how and when the samples for both the index text and 
the reference standard were collected. 
 
Could the participant flow have introduced bias? 
LOW CONCERN: if the answer to the above question was "YES" which means that >80% of 
participants enrolled in the study were subjected to the same reference standard and index test, and 
were included in the final analysis. 
HIGH CONCERN: if above question was answered “NO". 
UNCLEAR CONCERN: if it was unclear whether the study fulfilled either the criteria for "low 
concern" or for "high concern".
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2.3 Summary of Chapter 2 
This systematic review comprehensively evaluated the current literature on the ability of early MRI 
to determine motor outcomes in infants born preterm. Thirty articles were evaluated, 25 of which 
presented data of structural MRI and 16 of which presented diffusion MRI. The evidence suggests 
that early structural MRI has reasonable sensitivity and specificity to determine adverse motor 
outcomes and CP, while evidence for diffusion MRI is emerging. At this stage, structural MRI, 
evaluated qualitatively for evidence of injury or growth impairment is clinically accessible, while 
diffusion MRI and analysis remains restricted to research facilities. 
 
Further evidence is required for early MRI, in particular with regards to diffusion imaging, which 
offers promise to further our understanding of preterm infant brain microstructural development. 
This motivated the design and development of the PPREMO study. A prospective cohort study 
design is the most robust study design methodology for observational studies, and so was the study 
design selected. The study aimed to recruit an unselected, consecutive cohort to ensure a 
representative sample of infants born <31 weeks GA. A number of studies in the systematic review 
performed a second MRI at TEA, and evaluated differences in measures between the early and term 
MRI in relation to outcome. Therefore, the PPREMO study was designed with both an early and 
term MRI. For MRI biomarkers at early or term MRI to be of clinical use, relationships with 
concurrent clinical measures obtained at the same time points, and then follow up with validated 
tools was imperative.  
 
As a result, the study was designed with an MRI at 30-32 weeks PMA (‘Early MRI’) and at 40-42 
weeks PMA (‘Term MRI’) and concurrent clinical assessment of motor, neurological, 
neurobehavioural and visual performance. Follow up at 3 months CA included gross motor and 
visual assessment.  Neurodevelopmental outcome and presence/absence of CP was determined at 12 
months CA. The following chapter presents the study protocol. 
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Chapter 3: Study Protocol 
3.1 Introduction to Chapter 3 
Chapter 3 consists of the study protocol titled, “PPREMO: a prospective cohort study of preterm 
infant brain structure and function to predict neurodevelopmental outcome”. This protocol paper 
delivers a detailed literature review, rationale and methods for the broader PPREMO study, the 
study initiated and established by this doctoral student, and within which this thesis is embedded. 
This thesis addresses the first three primary aims specified in the protocol paper, documenting the 
relationships between structural and diffusion MRI and clinical measures of motor, neurological 
and neurobehavioural function at Early and Term MRI, and then examining the ability of these 
measures of brain structure and function to predict motor and neurodevelopmental outcomes to 12 
months CA. The remaining primary and secondary aims involve EEG and assessment of nutritional 
intake and their relationships with MRI and/or clinical measures. These elements are part of the 
broader PPREMO study, the analysis and interpretation of which form the basis of other student 
projects, or post-doctoral work. While EEG and infant nutrition are detailed in the protocol paper 
introduction and methods, they are beyond the scope of this thesis. 
3.2 Paper 2:  
This article was published in BMC Pediatrics in September 2015 (journal impact factor 1.813). It is 
reproduced with acknowledgement, under the terms of the Creative Commons Attribution 4.0 
International License (http://creativecommons.org/licenses/by/4.0/). 
 
George JM, Boyd RN, Colditz PB, et al. PPREMO: a prospective cohort study of preterm infant 
brain structure and function to predict neurodevelopmental outcome. BMC Pediatr 2015; 15: 123. 
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PPREMO: A prospective cohort study of preterm infant brain structure and function to 
predict neurodevelopmental outcome 
George JM, Boyd RN, Colditz PB, Rose SE, Pannek K, Fripp J, Lingwood B, Lai M, Kong A, 
Ware RS, Coulthard A, Finn C, Bandaranayake S 
 
Abstract  
Background More than 50 percent of all infants born very preterm will experience significant 
motor and cognitive impairment. Provision of early intervention is dependent upon accurate, early 
identification of infants at risk of adverse outcomes. Magnetic resonance imaging at term equivalent 
age combined with General Movements assessment at 12 weeks corrected age is currently the most 
accurate method for early prediction of cerebral palsy at 12 months corrected age. To date no 
studies have compared the use of earlier magnetic resonance imaging combined with neuromotor 
and neurobehavioural assessments (at 30 weeks postmenstrual age) to predict later motor and 
neurodevelopmental outcomes including cerebral palsy (at 12-24 months corrected age). This study 
aims to investigate i) the relationship between earlier brain imaging and 
neuromotor/neurobehavioural assessments at 30 and 40 weeks postmenstrual age, and ii) their 
ability to predict motor and neurodevelopmental outcomes at 3 and 12 months corrected age. 
Methods/Design This prospective cohort study will recruit 80 preterm infants born ≤30 week’s 
gestation and a reference group of 20 healthy term born infants from the Royal Brisbane & 
Women’s Hospital in Brisbane, Australia. Infants will undergo brain magnetic resonance imaging at 
approximately 30 and 40 weeks postmenstrual age to develop our understanding of very early brain 
structure at 30 weeks and maturation that occurs between 30 and 40 weeks postmenstrual age. A 
combination of neurological (Hammersmith Neonatal Neurologic Examination), neuromotor 
(General Movements, Test of Infant Motor Performance), neurobehavioural (NICU Network 
Neurobehavioural Scale, Premie-Neuro) and visual assessments will be performed at 30 and 40 
weeks postmenstrual age to improve our understanding of the relationship between brain structure 
and function. These data will be compared to motor assessments at 12 weeks corrected age and 
motor and neurodevelopmental outcomes at 12 months corrected age (neurological assessment by 
paediatrician, Bayley scales of Infant and Toddler Development, Alberta Infant Motor Scale, 
Neurosensory Motor Developmental Assessment) to differentiate atypical development (including 
cerebral palsy and/or motor delay).  
Discussion Earlier identification of those very preterm infants at risk of adverse 
neurodevelopmental and motor outcomes provides an additional period for intervention to optimise 
outcomes. 
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Infants born very preterm (≤32 weeks gestational age; GA) are at a high risk of experiencing 
significant motor difficulties with 10-15% developing cerebral palsy (CP)1, a further 40-50% having 
minor motor and behavioural difficulties2, 3 and 30-60% experiencing cognitive  difficulties at school 
age4. At least  25% of infants follow a trajectory of  typical development with no evident sequelae of 
their difficult neonatal course5. Interventions are becoming available which aim to improve outcomes 
for infants born very preterm, necessitating the development of tools which can firstly identify those 
infants at risk of adverse outcomes as early as possible, and secondly provide accurate quantitative 
measurement of changes that are the result of an intervention. Currently, brain Magnetic Resonance 
Imaging (MRI)  at term equivalent age (TEA) combined with the General Movements assessment 
(GMs) at 3 months corrected age (CA), show the greatest predictive accuracy of motor and 
neurodevelopmental outcomes and CP at 1, 2 and 5 years CA6-10. 
In preterm infants imaged at TEA, structural MRI (T1 and T2 weighted images) analysed qualitatively 
for evidence of white and gray matter abnormalities predict motor and cognitive outcome8, 11, motor 
distribution of CP12, 13, severity of motor involvement in CP14 and neurobehavioural development15. 
White matter injury has been identified as the predominant injury in the preterm infant brain, with 
lesions such as periventricular leukomalacia (PVL) and intra-ventricular haemorrhage (IVH) well 
described and linked to poorer outcomes and CP8, 16. More recently, recognition of the intercurrent and 
subsequent developmental disturbances in both white and gray matter as a result of the primary lesion, 
support the description of preterm brain injury as an ‘encephalopathy of prematurity’17. Qualitative 
classification of gray and white matter macrostructure from structural MRI  has improved prediction of 
outcomes, but the need for quantitative microstructural information has lead to investigation of 
diffusion MRI in this population18, 19. 
Diffusion MRI measures the random motion of water molecules, which is hindered and restricted by 
the presence of cell membranes, the cytoskeleton, and macromolecules in the brain20. A number of 
quantitative metrics can be obtained from diffusion MRI to characterise the tissue, including  fractional 
anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) derived 
using the diffusion tensor model (i.e. Diffusion Tensor Imaging, DTI)21. These measures of the degree 
of restriction of diffusion (FA) and speed of diffusion (MD) change during brain development due to 
increasing fibre organisation, membrane proliferation, and myelination22. Diffusion MRI also provides 
estimates for the direction of the underlying white matter tracts, and, using tractography, enables the 
delineation of those pathways as they course through the brain. 
White matter damage of prematurity is associated with increased values of MD and decreased values 
of FA22, 23. A significant correlation exists between values of FA in the corticospinal tracts and 
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postmenstrual age (PMA)24 and between MD and later motor impairment25. Higher MD values at term 
are associated with poorer neurodevelopmental outcomes at 2 years in preterm infants26. Diffusion 
MRI has been reported to be an independent predictor of psychomotor delay25 and to predict CP with a 
sensitivity of 80% (95% Confidence Interval [CI] 28-100) and a specificity of 66% (95% CI 53-78)25. 
Associations between FA values and cognitive outcomes have been reported27. The use of MRI 
tractography to predict neurodevelopmental outcomes is not yet well established28. 
Potential limitations of diffusion imaging such as complex crossing fibre microstructure, reliability and 
reproducibility, are being addressed through novel diffusion MRI acquisition and analysis techniques29. 
Customized for preterm babies, they include novel pre-processing, the use of 60-direction High 
Angular Resolution Diffusion Imaging (HARDI), high b values and fibre orientation distribution 
analysis30. These deal with the identified need for greater accuracy of tractography and improved 
quantitative markers31. 
Imaging technology advances are now able to be coupled with earlier imaging, with the advent of MRI 
compatible incubators. Safety and feasibility have been established for MRI in the neonatal period after 
birth and before TEA, with the potential to provide further insights into this period of rapid brain 
development32-37. At the stage very preterm infants enter the extra-uterine environment, between the 
end of the second and beginning of the third trimesters, cortical neurogenesis and migration are 
complete, axonal and dendritic branching continue vigorously, and synaptogenesis is commencing38, 39. 
From this stage until TEA  is reached, white matter increases by 5 times the original volume, cortical 
gray matter volume increases 4 times and cortical folding both commences and is essentially 
completed15, 40. Brain development is rapid, vulnerable to injury but also adaptive to environmental 
inputs that guide and consolidate developing brain connections in a process termed neuroplasticity41. 
An area of specific interest in early imaging is the cortical subplate42. This structure consists of neurons 
formed in deep gray matter neurogenic sites such as the thalamus, and arrive to lie below the cortical 
neurons that migrated earlier from the subventricular zone43. At 30 weeks gestation, the subplate 
reaches its peak thickness, many times thicker than the cortex, and by term has almost completely 
regressed44. This major wave of growth and death establishes the long range projections between the 
deep gray matter and the cortex, and the short- and long- range cortico-cortical connections that are 
fundamental to integration of motor and cognitive functions45. This information on brain structure and 
structural connectivity from earlier neuroimaging increases the potential of understanding the trajectory 
of  structural brain development.  
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Electroencephalography (EEG) is a useful method of measuring cortical function for diagnosis and 
predicting later outcomes. Relationships between EEG and structural and functional connectivity have 
been shown throughout development in both adults and infants46-50. Electroencephalography signals 
represent cortical electrical activity measured on the scalp and can be collected non-invasively with 
relative ease and low cost. Electroencephalography has strong predictive capacity for outcome in the 
term infant with hypoxic ischaemic encephalopathy51. Increasing use in the preterm population, 
particularly in configurations using a limited number of electrodes, are evidenced with the first reports 
of its utility in predicting outcome52, 53.  Multi-channel EEG, typically 10-20 channels in the newborn, 
is well established in clinical practice and provides information about normal and abnormal 
functionality of the developing brain54. Deeper insights are possible with further analysis of 
multichannel EEG55-58.  The power and the frequency of oscillations in the  cortex can be assessed 
using power spectral density analysis59.  
Electroencephalography is able to define the electrical activity of the neonatal brain structural network 
that is visualised in diffusion imaging30, 60, 61. The electrical activity of these networks is characterised 
by two alternating modes observed in the amplitudes of EEG signals: a mode associated with the self-
organising, locally generated spontaneous electrical activity transients (SATs) and a mode representing 
the low-amplitude intervals between SATs62, 63. This bimodality gradually attenuates from mid 
gestation and activity becomes continous by term63. 
In parallel to neuroimaging and neurophysiological modalities, several clinical assessments of 
neuromotor, neurobehaviour and neurological function are proposed for use in the preterm period  and 
early infancy64. Two systematic reviews on the clinimetric properties of such measures found Prechtl’s 
General Movements Assessment to have the greatest predictive accuracy of an outcome of CP64, 65. 
This neuromotor assessment evaluates spontaneous infant movement from preterm birth until 5 months 
CA66. A systematic review examining the accuracy of tests to predict CP included a meta-analysis of 
GMs and reported a pooled sensitivity and specificity of 98% (95% CI 74-100%) and 91% (95% CI 
83-93%) respectively10.  It is important to note that GMs at 3 months CA also predict severity of CP67, 
cognition68, minor neurological dysfunction69 and behavioral and psychiatric outcome70. 
Neurobehaviour refers to an infant’s ability to self-regulate, orient, be responsive to stimuli and sustain 
attention71. Neurobehavioural assessment in the preterm period reveals changes between birth and 
TEA, and differences between preterm and term infants assessed at TEA72, 73. Poorer neurobehavioural 
performance at TEA is associated with white matter abmormality on structural MRI, a range of adverse 
perinatal variables and predicts neurodevelopmental outcomes and CP at 18 months CA72, 74, 75. 
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Components of the NICU Neonatal Neurobehavioural Scale, namely a low handling score, low 
movement score and high lethargy score are significantly related to an outcome of CP75. 
Neurological examination of infants offers reasonable prediction of outcomes, with sensitivity and 
specificity increasing as the infant progresses from the preterm period, through TEA and into the first 
year of life10, 76. Prediction of CP and motor outcome in the preterm period is relatively poor due to the 
presence of early transient abnormal signs with later good outcomes causing false positives and the 
converse resulting in false negatives10, 77. When neurological examination is performed before term age 
in preterm infants, the sensitivity for an outcome of CP is 57-86% and specificity 45-83%78, 79. At term, 
neurological assessment has a sensitivity of 88% and specificity of 46% to predict structural MRI 
abnormalities80 and 68-79% and 63-70% to predict CP78, 81. In the post term period sensitivity and 
specificity range from 68-96% and 52-97% respectively78, 81. 
Perinatal factors, including growth and nutrition, have been identified as risk factors of adverse 
outcomes. Poor growth during the first weeks after preterm birth is a significant predictor of poor 
neurodevelopmental outcome82-84. Increased nutrient intake leads to better growth85-87, and presumably 
better brain development, although this relationship is not proven.  There is a need for clear evidence of 
the relationship between early nutrient intake and brain development in preterm infants, so that 
improved nutrient regimens can be designed.  
Individual modalities of MRI, EEG, clinical measures, perinatal risk factors and nutrition have been 
evaluated in relation to later outcomes for preterm infants as described above. Combinations of 
modalities have been evaluated and often demonstrate improved prediction of outcomes over 
individual modalities alone6, 7, 10, 88, 89. The relationships between modalities at TEA are emerging, but 
to our knowledge, few studies to date have examined the relationships between early clinical measures, 
perinatal risk factors and nutrition, and very early imaging at 30 weeks PMA7, 15, 72, 73, 80, 90-92. This 
study aims to contribute to the understanding of brain structure-function relationships in the very early 
phase of the developmental trajectory, improving the ability to identify infants at risk of adverse 
outcomes, facilitating innovation of interventions and developing quantitative biomarkers of brain 
development. 
Broad aim: This prospective cohort study of infants born ≤30 weeks will investigate the 
relationship between brain structure (structural and diffusion MRI), brain function (neurological, 
neuromotor, neurobehaviour, vision and EEG), perinatal risk factors and nutrition of very preterm 
infants in the preterm period (30-32 weeks) and at TEA; then examine the ability of these early 
measures to predict motor and neurodevelopmental outcomes at 3 and 12 months CA.  
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Primary aims: In a prospective cohort study of infants born at ≤30 weeks, and a term reference 
group, this study aims: 
1. To examine the relationship between brain structure on structural and diffusion MRI, brain 
function on clinical measures of neurological, neuromotor and neurobehavioural performance, 
and perinatal risk factors at 30 and 40 weeks PMA. 
2. To determine whether brain structure and function at 30 weeks PMA predicts outcomes of brain 
structure and function at 40 weeks PMA, 3 months CA and 12 months CA. 
3. To evaluate the ability of structural and diffusion MRI and functional measures at 30 and 40 
weeks PMA age to predict motor outcome at 3 months CA and motor, neurodevelopmental 
outcome and CP at 12 months CA. 
4. To evaluate the ability of perinatal variables and social risk (socio-economic status; SES) to 
predict severity of motor outcome and CP at 12 months CA. 
 
Secondary Aims: 
1. To examine the development of motor, sensory, visual and auditory connectivity between 30 
week and 40 week MRIs in infants born preterm with and without brain lesions. 
2. To examine the correlation between brain function on dense array EEG, and motor and visual 
outcomes at 40 weeks PMA. 
3. To evaluate the ability of dense array EEG at 40 weeks PMA to predict visual outcome at 3 
months CA and cognitive outcome at 12 months CA. 
4. To examine the correlation between data fusion of brain functions on dense array EEG and 
brain structure on diffusion MRI, and motor and visual outcomes at 40 weeks PMA. 
5. To evaluate the ability of data fusion of brain functions on dense array EEG and brain structure 
on diffusion MRI, to predict visual outcome at 3 months CA and cognitive outcome at 12 
months CA. 
6. To examine the relationship between preterm macronutrient intake from birth to 34 weeks and 
brain development at 40 weeks post menstrual age, and determine if nutritional intake is more 
predictive of brain development than other maternal and neonatal risk factors. 
 
Hypotheses 
The specific hypotheses to be tested include the following. In infants born very preterm: 
1. A strong correlation exists between MRI, clinical measures and perinatal variables at 30 weeks 
PMA. 
2. Brain structure and function at 30 weeks PMA predicts outcomes at 40 weeks PMA, 3 months 
CA and 12 months CA.  
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3. Brain structure and function at 40 weeks PMA predicts neurodevelopmental outcome at 3 and 
12 months CA.  
4. A strong correlation exists between EEG, clinical measures and perinatal variables at 40 weeks 
PMA, and 3 months and 12 months CA. 
 
Methods and analyses 
Design 
A prospective observational cohort study of infants born very preterm with a comparison group of 
infants born at term. 
Ethical considerations 
Ethical permission to conduct the study has been obtained from the Human Research Ethics 
Committees at The Royal Brisbane & Women’s Hospital (HREC/12/QRBW/245), and The 
University of Queensland (2012001060). The trial has been registered with the Australian New 
Zealand Clinical Trials Registry (ACTRN12613000280707). Participation in the study is voluntary, 
written informed consent for participation in the study is obtained from a parent or guardian, and 
families may withdraw from the study at any time without explanation.  
Study sample and recruitment 
Preterm sample 
This study aims to recruit 80 preterm infants from the Neonatal Intensive Care Unit (NICU) at the 
Royal Brisbane and Women’s Hospital (RBWH). A research nurse will screen infant admissions for 
eligibility, and determine the appropriate stage to approach the family based on medical stability 
and approval from the treating neonatologist. Eligible families will be approached and if they 
express an interest in the study, they will be provided with detailed information and an explanation 
of the study. Parents will be given the opportunity to ask questions and discuss involvement with 
their treating clinician prior to making their decision. Informed written consent will be obtained 
from parents or guardians interested in participating and their infant will be formally enrolled. 
Inclusion criteria 
Infants born at ≤30 week’s gestation, who live within 200km of the hospital to allow for follow up 
hospital appointments and home visits, and have English speaking families as there is insufficient 
funding for translators, are eligible for this study. 
Exclusion criteria 
Infants diagnosed with any congenital or chromosomal abnormality that could adversely impact 
neurodevelopmental outcome, and/or any contraindications to MRI, are ineligible for this study. 
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Term reference sample 
Twenty term born babies will be recruited from either the postnatal ward of the RBWH, or as 
interested volunteers by word of mouth. 
Eligibility criteria 
Infants are eligible to participate in the reference sample if they are born between 38 and 41 weeks 
gestation following an uncomplicated pregnancy and delivery, have a birth weight above the 10th 
percentile, and are not admitted to neonatal intensive or special care units following their birth. 
Sample Size  
There are no data currently available to assess the relationship between MRI and clinical measures 
at 30 weeks PMA to predict motor outcome at 3 months CA and motor/neurodevelopmental 
outcome or CP at 12 months CA. Sample size calculations are based on a study investigating the 
ability of MRI at TEA, and the GMs assessment, to predict motor outcomes and CP at 12 months 
CA 6. In a prospective cohort of infants born <30 weeks GA and in a total sample size of n=86, 
MRI was classified as normal (n=22), or with mild (n=54), moderate (n=6) or severe (n=4) white 
matter abnormality (WMA) 93. Infants with normal or mild WMA were grouped (n=76), and infants 
with moderate and severe WMA were grouped (n=10) 6. We assume the same ratio (7.6 MRI 
normal or with mild/moderate WMA: 1 MRI with moderate/severe WMA) will be observed in this 
study. Of the n=10 infants in the prior study that had moderate/severe WMA, n=5 (50%) developed 
CP 6. If we assume that 5% of infants with MRI normal or with mild/moderate WMA develop CP, 
then the study requires 69 infants to be recruited (8 with MRI with moderate/severe WMA and 61 
with MRI normal or with mild/moderate WMA) in order to be able to reject the null hypothesis that 
the proportion of infants with CP in the two groups are equal with power=90%. The Type I error 
probability associated with this test of this null hypothesis is 0.05. In order to explore WMA earlier, 
at 30 weeks PMA, and its ability to predict CP at 12 months CA, an increase in the projected 
numbers will be required, and a further 15-20% added to account for attrition. Consequently, the 
aim is to recruit a total sample size of 80 infants with full data sets. 
Perinatal data collection   
An extensive record of the pregnancy, birth history, and neonatal course will be collected from the 
medical discharge summary. This will allow detailed description of the characteristics of the 
sample, allow comparison to outcomes establishing predictor variables, and to adjust for 
confounders.  
A number of prenatal variables have been shown to impact short and long-term outcomes. 
Prolonged rupture of membranes, defined as spontaneous rupture of membranes ≥24 hours before 
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delivery is the most significant risk factor of a poor outcome among pregnancy history94, 95. 
Maternal antenatal corticosteroid administration reduces the risk of neonatal death and respiratory 
distress (complete course defined as more than 1 dose of steroids given, and 1st dose at more than 
24 hours and less than 8 days before birth)94-96. Evidence also exists for antenatal steroids protecting 
against cerebral haemorrhage97. The neuroprotective effect of magnesium sulphate administration 
reduces the risk of an outcome of CP (relative risk 0.68, 95% confidence interval 0.54 to 0.87)98. 
Assisted conception is associated with adverse neurodevelopmental outcomes independent of 
prematurity, multiple pregnancy and gender for infants born between 22-26 weeks gestation99. 
Multiple birth status will be examined as the widely held view that singletons experience better 
outcomes than multiples has recently been challenged. In a population based study of n=1473 born 
<29 weeks gestation, infants from multiple gestation pregnancies demonstrated comparable 
neurodevelopmental outcomes to singletons100. 
Birth history variables collected will include GA at birth, gender and birthweight. The risk of CP 
and adverse neurodevelopmental outcomes increases with decreasing GA at birth101, and multiple 
studies report poorer outcomes for male infants94, 102-104. Intra uterine growth retardation (IUGR) 
can result in decreased cortical volume, poorer outcomes and increased risk of neonatal 
complications105, 106, and babies that are small for gestational age (SGA) are at a higher risk of 
death, adverse neonatal outcomes and neurodevelopmental impairment107. Growth restriction in this 
study will be defined as a birth weight <10th percentile based on the Olsen growth curves. 
Information will be gathered over each infant’s neonatal course from birth until discharge from 
hospital. Cranial ultrasound findings, specifically findings of PVL and IVH graded according to the 
criteria of Papile et al, 1978 will be documented, with higher grades predictive of adverse outcomes 
and CP108. Necrotising enterocolitis (NEC) is associated with poorer growth, cognitive and motor 
outcomes, and is considered proven if the infant warranted treatment which included nil by mouth 
and antibiotics95, 109. Late onset sepsis is a significant risk factor, diagnosed by isolation of an 
organism from at least one blood culture and a decision to give antibiotics with therapeutic intent, 
from 48hrs after birth94, 95. Culture proven sepsis is independently associated with an outcome of 
CP110. Postnatal corticosteroid use demonstrates an independent effect on poor outcome, in 
particular with behavioural outcomes and CP94, 111, 112. Bronchopulmonary dysplasia or chronic 
neonatal lung disease are independent risk factors for adverse neurodevelopmental outcomes due to 
recurrent episodes of hypoxia111, 113-117. Chronic neonatal lung disease is defined as babies born <32 
weeks GA requiring any respiratory support or supplemental oxygen for a chronic pulmonary 
disorder at 36 weeks PMA95. Postmenstrual age at NICU discharge will be documented, as poorer 
behavioural outcomes are associated with longer length of hospital stay118.  
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For each infant from birth until 34 weeks PMA, the daily intake of all nutrient-containing solutions 
will be recorded. Intake of protein, lipid, carbohydrate and energy for each day will be calculated by 
multiplying intake volumes for each solution administered by the nutrient concentration obtained 
from manufacturer’s specifications or, for breast milk, published data119.  
Socio-demographic information such as maternal and paternal education and occupation will be 
collected using a baseline parent questionnaire (see Additional file 1). Social and environmental 
factors may impact infant development, and low socio-economic status and parenting factors have 
been shown to adversely influence outcomes120. Social risk will be  assessed using a score 
measuring six aspects of social status including: family structure, education of primary caregiver, 
occupation of primary income earner, employment status of primary income earner, language 
spoken at home and maternal age116, 121, 122. Each item will be scored between 0 and 2 for a total 
score of 12, with scores of 2 and above being considered high social risk in line with other research 
in this population121, 122. Higher social risk has been strongly associated with later behaviour 
problems, and independently predicts a lack of early intervention services122, 123. A recent 
systematic review found evidence that lower socio-economic status results in an additional risk of 
CP, over and above the risks conferred by prematurity or lower birthweight124. 
Procedures 
Study procedures are depicted in Figure 1. Participants will be recruited, consented and enrolled as 
described above. Between 30-32 weeks PMA, when medically stable, infants will undergo an MRI. 
In the event an MRI cannot be undertaken due to medical instability, MRI’s will be conducted when 
the infant becomes medically stable and up to a maximum age of 36 weeks PMA. This will ensure 
that less fragile infants are not over-represented in the sample. The following day, infants will 
undergo clinical assessment by an assessor blinded to GA at birth, CUS and MRI findings and any 
unrelated medical information, and a video recording of their spontaneous movements will be 
captured. As there is no established gold standard neurological or neurobehavioural assessments for 
use at this time point, a combination of the NICU Neonatal Neurobehavioural Scale (NNNS), 
Hammersmith Neonatal Neurological Examination (HNNE), and the Premie-Neuro will be used125. 
These assessments will be combined to minimise handling and modified to remove items unsuitable 
for administration at this age. The assessment time will be 10-15 minutes, conducted before a 
scheduled feed and cares to ensure optimum comfort and alertness. Infant cues, physiological signs 
of stress or distress, oxygen saturations and heart rate will be monitored throughout, and the 
assessment paused or discontinued where necessary. The assessment will be video recorded for 
independent scoring and testing of inter- and intra-rater reliability. 
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At TEA the family will be invited to return for their infant to undergo a second MRI and an EEG. 
The following day an assessor blinded to GA at birth and CUS and MRI findings will visit the 
family at home to undertake the clinical assessments. A video of the infant’s spontaneous 
movement will be recorded for later scoring of the GMs assessment, a brief assessment of visual 
function will be undertaken and 3 motor and neurobehavioural assessments will be administered, 
combined to remove duplicate items. The NNNS assessment, which is highly structured, will be 
completed first, followed by the few additional items of the HNNE and the Test of Infant Motor 
Performance (TIMP). Total assessment time will be approximately 1 hour, however, the assessment 
will be conducted at the infant’s pace, and breaks for feeds or sleep will be undertaken as 
appropriate. 
At 3 months CA, during a home visit, a GMs video of the infant’s spontaneous movement will be 
taken, and a visual assessment and the TIMP will be completed. The total assessment time will be 
approximately 40 minutes. 
At 12 months CA, families will be invited back to the RBWH for follow up assessment of their 
child’s motor and neurodevelopmental outcome. In a telephone call prior to the appointment a 
research nurse will gather up to date information on the child’s current medical team, medical 
history since discharge, any diagnoses made and details of any interventions they have received. A 
paediatrician blinded to medical history will assess for signs of neurological abnormality and the 
presence of features of CP. A physiotherapist blinded to background history will conduct 
neurodevelopmental and motor assessments. As no single measure has been shown to provide 
conclusive data on attainment and quality of motor skills in this population, a combination of the 
Bayley Scales of Infant and Toddler Development III (Bayley III), the Neurosensory Motor 
Developmental Assessment (NSMDA) and the Alberta Infant Motor Scale (AIMS) will be 
performed126. The total assessment time will be 1-1.5 hours. 
Measures 
MRI Methods 
Image Acquisition: Brain MRI will be performed using a 3T (Siemens Tim Trio, Erlangen, 
Germany) and an MR compatible incubator with dedicated neonatal head coil (LMT Lammers 
Medical Technology, Lubeck, Germany). Noise from the MRI will be attenuated using Natus Mini 
Muffs (Natus Medical Inc., San Carlos, CA). The preterm group will have an MRI at 30-32 and 
again at 40-42 weeks PMA. The term group will have an MRI at 40-42 weeks PMA. All infants 
will be monitored with pulse oximetry and electrocardiographic monitoring. Infants will be fed, 
fitted with ear protection to minimize noise exposure, carefully wrapped and placed in the incubator 
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in the scanner without sedation or anaesthesia. The total scanning duration will be approximately 
45-60 minutes for each baby. Where possible, images impacted by significant motion artefacts will 
be rescanned. The MR protocol will include T1, T2 TSE, T1w MPRage, T2w HASTE and 3 echo 
T2 map, Arterial Spin Labelling (ASL), 30 direction diffusion weighted imaging (DWI), and 64 
direction DWI sequences. Additional file 2 outlines the MRI protocol parameters. A 
neuroradiologist will review clinical sequences and classify white and gray matter injury93, 127. 
Quantitative T2 will be measured using a T2 image series acquired with echo times of 27, 122 and 
189 ms and repetition time 10580 ms; 47 axial contiguous slices of 2.0 mm thickness will be 
acquired with a 144 × 180 mm field of view, a flip angle of 150°, and a 153 × 256 matrix 
(reconstructed to 204 × 256), resulting in voxel sizes of 0.70 × 0.70 x 2.0 mm3. T1-weighted 
magnetization prepared rapid-acquisition gradient echo volumes in the sagittal plane will be 
acquired with an echo time of 3.21 ms and repetition time 2100 ms; 96 sagittal slices of 1.3 mm 
thickness will be acquired with a 160 mm field of view, a flip angle of 9°, and a 128 × 128 matrix, 
resulting in voxel sizes of 1.25 × 1.25 × 1.3 mm3. 
Diffusion images will be acquired using single-shot echo planar multi-direction diffusion-weighted 
sequence, employing dual bipolar diffusion gradient and double spin. This will include the 
acquisition of a 30 direction DWI protocol (b=1000 s/mm2) and a 64 direction HARDI protocol (b = 
2000 s/mm2). The images will be acquired per location, consisting of one low (b=0s/mm2) and the 
rest high (b=1000 or 2000s/mm2) diffusion-weighted images, in which the encoding gradients are 
uniformly distributed in space. Imaging parameters of the diffusion sequence will be: field of view 
224 x 224 mm, matrix 128×128, repetition time 9500 ms, echo time 130 ms and flip angle of 90°. A 
field map for diffusion data is acquired using two 2D gradient recalled echo images (TE1/TE2 
4.9/7.4ms) to assist in correction for residual distortions due to susceptibility inhomogeneity’s 
(acquisition time 1m). These sequences allow exploration of brain microstructure and function, 
specifically: (i) regional and global cortical surface and thickness, (ii) white matter organisation, (iii) 
structural connectivity of relevant areas and (iv) pre-myelination (T2). 
Arterial spin labelling MRI provides a non-invasive technique to measure cerebral blood flow (CBF), 
although its feasibility and value in neonates is largely unknown. As the neonate’s brain rapidly 
grows, it is anticipated that an associated increase in CBF would occur to supply the nutrients and 
energy needed for the added brain weight128. Arterial spin labelling MRI will be performed using a 
PICORE Q2TIPS sequence with echo-planar imaging. Imaging parameters of the ASL scan will be: 
field of view 256 mm, matrix 64×64, repetition time 3427.5 ms, echo time 21 ms, inversion time of 
arterial spins (TI1) 700 ms, saturation stop time 1600 ms, total transit time of the spins (TI2) 1800 
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ms, tag thickness 100 mm, tag to proximal slice gap 25 mm, 17 axial slices, slice thickness 5 mm, 
time lag between slices 22.5 ms, and Bandwidth Per Pixel Phase Encoding time of 23.343 ms. 
Image Analysis: MRI data will be analyzed using advanced image processing techniques as below.  
a) Structural Analysis: 
T2 relaxation maps will be obtained from three T2-weighted images by first aligning all T2- 
weighted images to the T2-weighted image with the shortest echo time (TE=27ms) using rigid-body 
registration, followed by voxel-wise estimation of T2 employing a nonlinear least-squares fit. The 
T2w MR will be segmented using the MILXView neuroimaging platform with the UNC neonate 
atlas and ALBERT atlas used to provide initial priors and anatomical labelling129-131. Statistical 
analysis will use Regions-of-Interest and voxel based analysis techniques. Summary measures of T2 
will be calculated within pathways delineated using tractography.  
b) Diffusion Analysis: 
An extensive pre-processing and quality control procedure will be used to detect and correct image 
artefacts caused by involuntary head movement, cardiac pulsation, and image distortions30. Fractional 
anisotropy (FA) and mean diffusivity (MD) will be estimated from corrected diffusion data using a 
diffusion tensor model. Constrained spherical deconvolution implemented in MRtrix will be 
employed to estimate fibre orientation distribution (FOD)132. Whole-brain voxel based analysis of FA 
and MD will be performed using tract-based spatial statistics optimised for neonates133. Whole-brain 
voxel-based analysis of fibre orientation distributions will be conducted using Apparent Fibre 
Density (AFD)31. Probabilistic tractography will be performed using MRtrix. White matter pathways 
will be delineated using the multi-regions-of-interest approach. A number of pathways, including 
cortico-spinal tract, corpus callosum, superior longitudinal fasciculus and thalamic radiations, will be 
extracted. Summary measures of FA, MD, AFD and T2 within pathways will be calculated. 
c) Arterial Spin Labelling analysis: 
An extensive pre-processing and quality control procedure will be used to detect and correct image 
artefacts caused by motion, random thermal and physiological noise, EPI distortion, spatial-temporal 
denoising, correction for temporal decay and partial voluming of the signal. The CBF maps will then 
be calculated in absolute units ( ), with the first equilibrium magnetization of arterial blood 
estimated using the calibration image (first acquired image), and GM and WM maps rescaled. 
Statistical analysis will use Regions-of-Interest and voxel based analysis techniques.  
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EEG  
Dense array EEG (dEEG) will be collected using either; i) a NicOne EEG amplifier (Cardinal 
Healthcare, USA) with a sampling rate of 256 Hz from 32 channels using an appropriately sized 
EEG cap (Waveguard, ANT-Neuro, Germany) with electrode positioning according to the 
international 10-20 standard, or ii) a 64-electrode high-density sensor net (HydroCel Geodesic 
Sensor Net, Electrical Geodesics Inc.). Each electrode is enclosed in a saline sponge, in a geodesic 
tension structure comprised of elastic threads. EEG signals are transmitted from the sensor net 
electrodes to an amplifier (Electrical Geodesics Inc.) digitised and recorded via NetStation software 
(Electrical Geodesics Inc.). 
For the EEG data i) directional relationships between channels, ii) frequency-specific amplitude 
fluctuations, and iii) time-varying behaviour through directional connectivity analysis and phase 
synchrony among channels will be examined. Electroencephalography power will be estimated in 
the frequency bands delta/theta (2–7 Hz), alpha (8–13 Hz), beta (14–32 Hz) to examine changes in 
the power and frequency of oscillations over the sensorimotor cortex as an index of corticospinal 
linkage and maturation59. 
The electric resting state network (eRSN) analysis will follow a multi-step procedure comprising i) 
pre-processing of EEG signals, ii) extracting band amplitude fluctuation envelopes at the frequency 
band of interest, and iii) evaluating their network characteristics within two modes of activity. 
Relationships between eRSN characteristics and outcome will be sought using approaches including 
pair-wise relationships such as mutual information measures, with testing using surrogate signals as 
well as different statistical testings at individual and group levels. 
Clinical measures 
General Movements Assessment (GMs): The GMs is a predictive and discriminative tool that 
involves observation of an infant’s spontaneous motor activity66. It can be used from preterm birth 
until 20 weeks CA and is carried out by videoing the infant in supine, in a calm alert state with no 
external stimulation. Scoring is completed from the recording with 3 full movement sequences 
required for pattern recognition (approximately 5 minutes)66. In the early preterm stage this may 
require up to an hour of video in order to select sequences of active movement, but at TEA and 12 
weeks CA it may only take a few minutes. Movements are classified as normal or abnormal (poor 
repertoire, cramped synchronised or chaotic) in the writhing period from preterm up to 6 weeks post 
term. During the fidgety period from 9-20 weeks post term, fidgety movements are classified as 
present, abnormal or absent66. Infants in this study will have an assessment of their GMs in the 
preterm period (30 - 32 weeks PMA), one assessment at TEA, and one at 10-12 weeks CA. The 
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GMs have been found to have the greatest predictive accuracy of motor outcome in two systematic 
reviews on the clinimetric properties of neuromotor and neurobehavioural assessment tools for use 
in preterm infants in the preterm period and first year of life64, 65. A systematic review examining 
the accuracy of tests to predict cerebral palsy included a meta-analysis of GMs. The pooled 
sensitivity and specificity were 98% (95% CI 73-100%) and 91% (95% CI 83-95%) respectively10. 
General Movements in the fidgety period display greater sensitivity and specificity than those in the 
writhing period6, 7, 134 and have also shown an ability to predict functional severity of CP as 
classified by GMFCS67. Additionally, GMs predict cognition68, 135, 136, minor neurological 
dysfunction and developmental coordination disorder69, 137, as well as behavioral and psychiatric 
outcomes70, 138.  
The NICU Network Neurobehavioural Scale (NNNS): The NNNS is a discriminative 
neurobehavioural assessment initially designed for use in prenatally substance exposed infants as 
part of the Maternal Lifestyle Study (MLS)139. Its application for use in other high-risk infant 
populations including very preterm infants is now well established64, 75, 125. Neurobehavioural 
functioning is determined through evaluation of neurological and motor performance, orientation to 
auditory and visual stimuli, state regulation, self-soothing competence and stress signs. Forty-five 
items are administrated in a structured format comprising state-dependent ‘packages’, with a further 
21 summary items scored. The stress/abstinence scale encompasses an additional 51 observed 
items. Summary scores are calculated to enable statistical analysis, and they include orientation, 
habituation, hypertonicity, hypotonicity, excitability, arousal, lethargy, nonoptimal reflexes, 
asymmetric reflexes, stress, self-regulation quality of movement and handling140. Training and 
certification is required to administer and score the assessment. 
Normative data on the NNNS are available in 2 studies, with samples of 125 and 344 healthy term 
infants respectively, assessed within 48 hours of birth141, 142. Data of preterm infants assessed using 
the NNNS at 1 month CA are available though it is important to note that the cohort is selected 
from the MLS sample and therefore includes infants with high social risk and drug-exposure143. 
Preterm infants display poorer neurobehaviour at TEA when compared to term controls on the 
NNNS73, 144. Significant disturbances were found in motor behaviour, tone, poorer self-regulation 
capacities, higher excitability scores144, poorer orientation, lower tolerance of handling and more 
stress in preterm infants compared with term born infants73. These alterations in neurobehaviour 
correlated with cerebral abnormalities in white and gray matter on qualitative structural MRI72. 
Predictive validity of the NNNS has been established with neurobehaviour at term predicting motor 
and cognitive outcomes at 18 months, motor outcomes at 24 months and cognitive outcomes at 4.5 
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years75, 145, 146. Test-retest reliability has been established with preterm infants with correlations 
ranging from .30 to .44 across three time points tested (34, 40 and 44 weeks PMA)147.  
Hammersmith Neonatal Neurological Examination (HNNE): The HNNE was developed for the 
assessment of term and preterm infants at risk of developmental delay148-150. It is a discriminative 
and predictive test that assesses posture and tone, reflexes, movements and neurobehavioural 
responses. It is criterion and norm referenced, with normative data from a sample of 224 healthy 
low-risk term infants assessed between 6 and 48 hours after birth149. Raw scores are converted into 
a continuous score derived through optimality scoring with final scores ranging between 0-34, and 
scores <30.5 considered to be suboptimal150. Preterm infants have been found to have poorer scores 
on the HNNE compared with term born infants when assessed at TEA. In a sample of 157 infants 
born at <33 weeks GA mean optimality scores were 26.4151. Discriminative validity was 
demonstrated in a normative study of a sample of 380 preterm infants (GA at birth 25-35 weeks) 
with a normal outcome and a sample of 85 infants who developed CP examined at TEA. Preterm 
infants with later outcome of CP had a greater number of suboptimal items scored compared to 
those preterm infants who had a normal outcome152. Concurrent validity has been demonstrated in 2 
studies (n=168 and n=66), where poorer scores on the HNNE related to increasing severity of 
cerebral abnormality on structural MRI72, 80. A systematic review examining the predictive validity 
of the HNNE to predict an outcome of CP report a sensitivity range of 57-86% and specificity range 
of 45-83% when performed before term age (<37 weeks PMA)78, 79. This increases to a sensitivity 
range of 68-96% and specificity range of 52-97% when assessed in the post term period78, 81. 
Percentage agreement has been shown to be good between raters after training (>96%)153, however 
few reliability statistics are available. The infants in the present study will have the HNNE 
assessment at 30 weeks gestation, and TEA. 
Premie-Neuro: The Premie-Neuro is a neurological and neurobehavioural assessment tool 
developed by Ellison and Daily154. It consists of 3 subscales of 8 items each: neurologic, movement 
and responsiveness. Although limited published data are available for this relatively new tool, it was 
selected for this study for the following reasons: i) scoring of neurologic and movement subscales 
can be completed in even the sickest and most fragile of infants as they require minimal handling, 
ii) significant overlap with the HNNE and NNNS means the assessment can be scored with the 
addition of only 2 items overall, iii) scores are based on expected findings at differing gestational 
age154. Validity has been established for discriminating between preterm infants at high and low risk 
for neurodevelopmental delay, although interrater reliability was low and test–retest reliability was 
fair to moderate155. It will be scored from the combined assessment performed at 30 weeks PMA for 
infants in this study. 
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Neonatal Visual Assessment: The neonatal assessment of visual functions provides useful 
information on various aspects of early neonatal visual function, including ocular motility, fixation, 
following, acuity and attention at distance. The battery is easy to perform, does not require long 
training, and can be performed reliably from 32 weeks PMA156. It has been demonstrated to 
contribute to prediction of neurodevelopmental outcome in preterm babies157-159. The overall 
sensitivity and specificity of Neonatal Visual Assessment to predict 12 month CA visual scores 
were 90% and 63% respectively in 121 preterm infants158. In this study, infants will be assessed at 
TEA and 12 weeks CA. 
Test of Infant Motor Performance (TIMP): The TIMP is a discriminative and evaluative test of 
functional motor behaviour used to assess infants between the ages of 34 weeks PMA and 4 months 
CA160, 161. The test assesses the postural and selective control of movement needed for functional 
motor performance in early infancy and is norm referenced. Observational and elicited items are 
administered in a standardised procedure and the test takes 20-40 minutes to administer. At 12 
weeks CA, the TIMP has been shown to predict 12 month motor performance with sensitivity 92% 
and specificity 76%162 and preschool motor performance (mean age 4.75 years) with sensitivity 
72% and specificity 91%163. In this study, the TIMP will be performed at TEA and at 12 weeks CA 
by an assessor trained by the test author. 
Neurodevelopmental and motor outcome at 12 months 
Medical Assessment: A paediatrician experienced in infant development and diagnosis of CP will 
independently assess infants in this study at 12 months CA. The purpose of this assessment is to 
discriminate which infants are developing typically from those who are not, and to confirm 
diagnoses of CP or not CP164. It is acknowledged that 12 months CA is early to confirm a diagnosis 
of CP, especially in less severe cases. For this reason a structured neurological examination of 
posture, reflexes, muscle tone and movement will be conducted with participants classified as 
‘normal’ (entirely normal neurological examination), ‘unspecified signs’ (e.g. hypotonia, 
asymmetric reflexes) or ‘abnormal’ (definite neurological abnormality, likely CP). In cases where 
CP can be confirmed, motor type and distribution will be recorded as per the SCPE guidelines165, 
and functional severity established through classification with the Gross Motor Function 
Classification System (GMFCS)166. The assessment will be videoed and a second blinded assessor 
will perform this classification for reliability purposes. 
Bayley Scales of Infant and Toddler Development III (Bayley III): The Bayley III is a discriminative 
tool designed to assess cognitive, language and motor development, and social-emotional and adaptive 
behaviour167. It is currently the most widely used assessment tool for overall neurodevelopment in follow up 
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studies of preterm infants between 1 and 3 years CA. It is a norm-referenced test with normative data for the 
cognitive, language and motor subscales taken from a sample of 1700 American infants and children167. 
Normative data for the adaptive behaviour scale was obtained independently in a sample of 1350 infants and 
children167. Normed scores of the Bayley III have a mean of 100 and a SD of 15, where higher scores reflect 
better development. Bayley III Motor Composite score correlates with the second edition of the Peabody 
Developmental Motor Skills (r =0.57)167. Reliability has been established with the average reliability 
coefficients for the composite scale scores range from .91 (Cognitive) to .93 (Language)167. In a systematic 
review of the predictive value of the Bayley III on development of very preterm infants, mental development 
index scores were strongly predictive of later cognitive functioning (14 studies with a total sample n=1330 
children), r=0.61 (95% CI: 0.57-0.64)168. Motor scale scores were only moderately predictive of later motor 
function (across 5 studies with a total sample of n=555 children), r=0.34 (95%CI: 0.26-0.42). For this reason, 
a further two assessments which are primarily motor assessments, and have stronger psychometric properties 
will be used, the NSMDA and the AIMS65. The Bayley III involves interaction between the infant and the 
examiner in a standardised series of play tasks, and takes 45-60 minutes to administer at 12 months CA. 
Neurosensory Motor Developmental Assessment (NSMDA): The NSMDA is a discriminative and 
predictive, criterion-referenced test of gross and fine motor development65, 169. It examines gross 
and fine motor performance, neurological status, posture, balance and response to sensory input. 
The examiner observes and administers items and the test takes 10-30 minutes to complete. The 
results give a total score and a functional classification of motor development as normal, or with 
mild, moderate or severe problems of posture, movement and co-ordination. Assessment at 4 
months predicts outcomes at 24 months with a sensitivity of 80% and a specificity of 56%170. Studies 
looking at the longer term predictive validity of the NSMDA, found assessment at 12 months had 
strong associations with motor and cognitive scores at 4 years171, and NSMDA assessment at 8 
months to have an 80% sensitivity of motor outcomes at 11-13 years in extremely low birth weight 
infants with no apparent neurological deficit or CP172. The NSDMA will be used to classify each 
infant’s development as normal or as having mild, moderate, severe or profound motor dysfunction 
at 12 months CA. 
Alberta Infant Motor Scale (AIMS): The AIMS is a discriminative, norm-referenced tool that tests 
gross motor skills through the components of weight bearing, posture and antigravity movements162, 
173. The test involves observation of the infant in prone, supine, sitting and standing and is able to be 
completed in this study purely through observation during the Bayley III and NSMDA assessments 
with no additional handling. Normative data are based on a population of 2200 term infants from 0-
18 months in Alberta, Canada174, and when recently compared with a contemporary sample of 650 
Canadian infants, found to still be relevant. Normative data for preterm infants has also been 
published with a sample of 800 infants born at <32 weeks from the Netherlands175. Raw scores are 
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obtained with centile ranks and age equivalent growth scores available for term and preterm infants. 
The AIMS has high inter-rater reliability (ICC= .98 to .99)176, 177, and intra-rater reliability (ICC= 
.97-.99)177. Concurrent validity with the Bayley II at 12 months CA in a cohort of preterm infants 
has been established (r= .90)177. Although the AIMS was not designed as a predictive tool, it has 
moderate to excellent predictive validity. In a sample of 164 preterm infants assessed at 8 months 
CA, the AIMS predicted motor outcomes at 18 months CA with a sensitivity 86.4% and specificity 
93%178. The suitability of using the AIMS as a discriminative and predictive tool at 12 months CA 
in preterm infants has been supported by a clinimetric review of neuromotor measures for preterm 
infants in the first year of life65. The AIMS will be used to classify each infant’s development as 
normal or suspicious/abnormal at 12 months CA in this study.   
Blinding 
The researchers involved in MRI and EEG analysis (KP, JF, SER, MML, and AHTK) will be 
blinded to GA at birth, CUS findings and clinical assessment findings. The researchers carrying out 
the clinical assessments and scoring (JMG, PBC) will be blinded to gestational age at birth, MRI 
and CUS findings. Outcome assessments at 12 months CA will be performed and scored by 
assessors blinded to infant perinatal history, MRI and early clinical assessment findings. 
Adverse events 
There are no known health or safety risks related to any aspect of the described study. There are no 
known risks for MRI and no sedation will be used. The principal researchers RNB, PBC and SER 
will review any adverse event or unintended effect detected. 
Data analysis and statistical considerations 
When models involve brain structure and function data from one time point (either 30-32 or 40-42 
weeks), standard regression models will be constructed; when models use data from both 30-32 and 
40-42 weeks, mixed-effects models that take into account within-infant correlation will be used. 
Models will be constructed using standard principles; first univariable analyses will be used to 
identify variables significant at the p<0.15 level and these variables then entered into multivariable 
models one-by–one, in decreasing order of significance. At each step the current model will be 
compared to previous models using the likelihood ratio test. Linear regression will be used for 
continuous outcomes (e.g. diffusion MRI measures of FA and MD); logistic regression for binary 
outcomes (e.g. disability/no disability); and multinomial logistic regression for categorical 
outcomes with > 2 categories (e.g. NSMDA categories of normal/suspect/abnormal). Results will be 
presented as effect estimates and 95% confidence intervals. The sensitivity and specificity of the 
predictive assessment model will be determined based on diagnosis of disability using standard 
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definitions. Perinatal, clinical, demographic and social characteristics will be included as 
covariables when appropriate. Analyses will be supervised by RSW, a senior biostatistician at The 
University of Queensland. 
Discussion 
To our knowledge, this protocol describes the first study examining the clinical correlates of early 
advanced brain imaging and clinical measures at 30 weeks PMA to predict motor and 
neurodevelopmental outcomes at 3 and 12 months CA. The results of this study will i) establish the 
relationships between early clinical measures, EEG, perinatal variables and nutrition and early 
advanced neuroimaging at 30 weeks PMA, ii) establish which components of brain structure and 
function most accurately predict neurodevelopmental, motor outcomes and CP at 3 and 12 months 
CA, iii) accurately identify infants at risk of adverse outcomes at an earlier stage, introducing an 
additional window of opportunity for intervention, iv) contribute to understanding brain 
development between 30 and 40 weeks PMA, v) and develop robust quantitative biomarkers of 
brain maturation, which can then be used in the research of interventions in this population. 
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3.3 Summary of Chapter 3 
This chapter presented the rationale, aims and methodology of the prospective cohort study within 
which this thesis is embedded. The literature review for the protocol paper was completed in 2014, 
and a substantial amount of new data has been published since then. Brain imaging of preterm 
infants in the neonatal period and up to TEA has gathered momentum over the last few years. This 
is evidenced by the number of peer-reviewed publications of MRI in preterm infants increasing 
exponentially from 27 in the year 2005 to 62 in 2010, 111 in 2015 and 135 in 2016 (data from 
pubmed). Chapter 2 of this thesis has summarised and presented the literature pertinent to this thesis 
up to March 2017, ensuring that all relevant published literature has been incorporated.  
 
It must also be noted that academic discussions in recent years have drawn attention to, and 
cautioned against the use of the terms ‘predict/s’ in the context of MRI and the relationship with 
neurodevelopmental outcomes24. In addition, systematic reviews published since this protocol paper 
have shown sensitivity of MRI at TEA to predict CP ranging from 67-100%25. False positives are 
also noted at advanced NICU centres publishing optimally studied cohorts. For these reasons, while 
this thesis set out to evaluate the ability of MRI to predict CP, we have been careful not to overstate, 
and instead refer to MRI as ‘determining/detecting’ cases of adverse motor outcomes and CP, or 
‘demonstrating predictive value for’ adverse motor outcomes and/or CP. 
 
This thesis fits within the broader PPREMO study. Aims of this thesis as outlined in Chapter 1 are 
encompassed by overarching primary aims 1-3 from the protocol paper, but are more detailed and 
tailored to this thesis. The perinatal data related to primary aim 4 has been collected, and is used in 
this thesis for the purposes of describing the cohort and for use in multivariable regression models 
where required. Secondary aims focussing on EEG and nutritional intake are part of the broader 
PPREMO study. 
 
3.3.1 Implementation of the PPREMO study 
Recruitment commenced in February 2013 and was completed in April 2016. Final 12-month 
outcome data was collected in May 2017. The published study protocol asserted an aim to recruit a 
total sample size of 80 infants with full data sets. Various factors impacted the number of infants 
with full datasets, such as attrition or motion artefacts making diffusion MR images unusable for 
analysis. For these reasons, a total of 146 preterm infants were recruited. Of these, 119 infants 
underwent Early MRI and concurrent clinical assessments, 109 returned at term and 105 of these 
had a term MRI. Three month follow up was conducted for 107 infants and 104 had 12-month 
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outcome assessments completed. The PPREMO study also recruited a reference sample of 19 term 
born infants with MRI and clinical data, and had data sharing agreements with another 2 studies 
which provided a further 19 datasets. The total term reference sample had data from 38 infants. 
 
The first step to understand the Early MRI data was to examine the structural MRI data. A validated 
scoring system for structural images was required. On examination of the literature it was found 
that the most comprehensive scoring system for use in very preterm infants at TEA was that by 
Kidokoro et al26. The Kidokoro scoring system combines evaluation of brain injury, with regional 
measures designed to capture the effect of secondary brain growth. It also evaluates deep GM and 
the cerebellum, and has been validated for use from 36-42 weeks PMA. Scoring systems for use 
earlier than TEA in preterm infants were available10, 11, however they evaluated WM and cortical 
GM only. The decision was made to validate the Kidokoro scoring method for Early MRI (29-35) 
weeks.  
 
The progression of the study and order of data analyses and preparation of publications which are 
included in this thesis are illustrated in Figure 1. The order in which these analyses were undertaken 
impacted the sample sizes available for each paper. Sample size calculations for the PPREMO study 
indicated that 80 infants with Early MRI and 12 month outcomes would provide adequate power for 
statistical analysis. As all structural MR images were able to be scored with the Kidokoro method, 
once the threshold of 80 datasets was reached, the validation paper was initiated. Subsequently, 
once the full cohort had been recruited and Early and Term MRI data collected, the relationships 
between Early structural MRI and concurrent clinical measures were evaluated. Once the final 
participant 12-month data had been collected, evaluation of diffusion MRI data was undertaken. 
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Study Progression 
Paper 3: Validation of structural MRI 
scoring system at 29-35 weeks PMA 
(Chapter 4) 
From the first n=110 recruited: 
N=83 with Early MRI & 12 month data  
N=77 with Term MRI & 12 month data 
N=38 term reference sample infants 
Paper 4: Concurrent clinical correlates of 
Early and Term structural MRI scores 
(Chapter 5). From n=146 recruited: 
N=119 with Early MRI and clinical measures  
N=102 with Term MRI and clinical measures 
Chapter 6: Relationships between Early and 
Term diffusion MRI and 12 month 
outcomes. From n=146 recruited: 
N=48 with useable Early diffusion MRI & 
12 month data  
N=65 with useable Term diffusion MRI & 
12 month data 
N=18 term reference sample infants with 
useable diffusion MRI 
Figure 1: Study progression and preparation of publications 
119 with Early MRI  
105 with Term MRI  
7 medically unstable  
1 died  
7 MRI equipment failures  
7 MRI slots unavailable  
2 MRI-incompatible 
surgical clip  
2 failed MRIs- movement  
1 withdrew  
8 failed to return for MRI 
1 declined 2nd MRI 
1 hospitalized remotely at TEA 
2 MRI equipment failures 
2 withdrew 
  
104 with 12 month outcomes  
146 recruited 
Preparation of publications 
Chapter 4 
87 
Chapter 4: Validation of an MRI brain injury and growth scoring system in 
very preterm infants scanned at 29-35 weeks postmenstrual age 
4.1 Introduction to Chapter 4 
The need for validated structural MRI scoring systems for use in the early period was believed to be 
an important first step in understanding the Early MRI data. The benefit to clinicians is that such 
tools are clinically accessible, relatively quick and easy to administer, and with validation with later 
outcomes, might provide diagnostic and prognostic information. From a research perspective, most 
studies involving advanced diffusion imaging at TEA utilise qualitative MRI scoring systems to 
describe their cohort, define inclusion and exclusion criteria or to correlate their advanced metrics 
with known structural abnormalities found on structural images. Diffusion studies of Early MRI 
require validated tools for analysis of structural images for the same purposes. An additional benefit 
is that all MRIs in the present cohort could be classified using a structural scoring system whereas 
advanced imaging excludes up to 40% of participant MRIs due to movement artefact or limitations 
with tissue segmentation. 
4.2 Paper 3:  
This article was published in the American Journal of Neuroradiology in May 2017 (journal impact 
factor 3.124). It is reproduced with acknowledgement, under the terms of the Creative Commons 
Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). 
 
George JM, Fiori S, Fripp J, Pannek K, Bursle J, Moldrich RX, Guzzetta A, Coulthard A, Ware RS, 
Rose SE, Colditz PB, Boyd RN. Validation of an MRI Brain Injury and Growth Scoring System in 
Very Preterm Infants Scanned at 29- to 35-Week Postmenstrual Age. AJNR Am J Neuroradiol 
2017: May 18. doi: 0.3174/ajnr.A5191 [Epub ahead of print]. 
Chapter 4 
88 
Validation of an MRI Brain Injury and Growth Scoring System in Very Preterm Infants 
Scanned at 29- to 35-Week Postmenstrual Age 
George JM, Fiori S, Fripp J, Pannek K, Bursle J, Moldrich RX, Guzzetta A, Coulthard A, Ware RS, 
Rose SE, Colditz PB, Boyd RN 
 
Abstract  
Background and Purpose The diagnostic and prognostic potential of brain MRI prior to term-
equivalent age (TEA) is limited until valid MRI scoring systems are available. This study aimed to 
validate an MRI scoring system of brain injury and impaired growth for use at 29 to 35 weeks 
postmenstrual age in infants born <31weeks gestational age. 
Materials and Methods Eighty-three infants in a prospective cohort study underwent Early 3T 
MRI between 29 and 35weeks postmenstrual age (mean 32+2 ±1+3weeks; 49 males, born at median 
gestation of 28+4weeks; range, 23+6-30+6weeks; mean birthweight, 1068 ±312 g). Seventy-seven 
infants had a second MRI at term-equivalent age (mean, 40+6 ±1+3weeks). Structural images were 
scored using a modified scoring system which generated WM, cortical gray matter, deep gray 
matter, cerebellar and global scores. Outcome at 12 months corrected age (mean, 12 months 4 days 
±1+ 2weeks) consisted of the Bayley Scales of Infant and Toddler Development, 3rd ed. (Bayley III), 
and the Neuro-Sensory Motor Developmental Assessment. 
Results Early MRI global, WM, and deep gray matter scores were negatively associated with 
Bayley III motor (regression coefficient for global score ß=-1.31; 95%CI=-2.39, -0.23; p=0.02), 
cognitive (ß=-1.52; 95%CI=-2.39, -0.65; p<0.01) and the Neuro-Sensory Motor Developmental 
Assessment outcomes (ß=-1.73; 95%CI=-3.19, -0.28; p=0.02). Early MRI cerebellar scores were 
negatively associated with the Neuro-Sensory Motor Developmental Assessment (ß = -5.99; 95% 
CI, -11.82, -0.16; p = 0.04. Results were reconfirmed at term-equivalent age MRI. 
Conclusion This clinically accessible MRI scoring system is valid for use at 29 to 35weeks 
postmenstrual age in infants born very preterm. It enables identification of infants at risk of adverse 
outcomes prior to the current standard of term-equivalent age. 
 
Abbreviations:  
c-, corrected; CGM, cortical gray matter; DGM, deep gray matter 
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Preterm infants are at risk of brain injury and impaired brain growth and consequently poorer 
outcomes in infancy and childhood1-6. Scoring of structural MRI to classify brain injury and growth 
has been validated for use at term-equivalent age (TEA) in infants born preterm1, 7. Initial systems 
were qualitative, focusing on classification of the severity of WM and cortical gray matter (CGM) 
injuries7-9. The degree of WM abnormality demonstrated significant associations with concurrent 
motor, neurological, and neurobehavioural performance10-13, and increasing WM abnormality was 
associated with poorer motor and cognitive outcomes1, 2, 5, 7, 14-16.  
 
Scoring systems of MRI at TEA were further developed to include quantitative biometrics to 
measure the impact of secondary brain maturation and growth following preterm brain injury17. 
These brain metrics correlated with brain volumes and differentiated preterm and term-born infants 
at TEA MRI17. At TEA, transcerebellar diameter was associated with fidgety general movements at 
3 months corrected age (CA)18, poorer cognitive outcomes at 12 months CA19, and poorer motor 
and cognitive outcomes at 2 years CA20. Reduced deep gray matter area at TEA was associated with 
poorer motor and cognitive outcomes19 and an increased interhemispheric distance independently 
predicted poorer cognitive development at 2 years CA3. Reduced biparietal width at TEA predicted 
both motor and cognitive outcomes at 2 years CA in infants born very preterm3, 21. 
 
Term-equivalent age MRI scoring systems have been further developed to include evaluation of 
deep gray matter (DGM) structures and the cerebellum22. At TEA, global brain abnormality scores 
were significantly associated with motor outcomes at 2 years CA23 and cognitive outcomes at 7 
years24, 25. Deep gray matter scores were significantly associated with poorer attention and 
processing speeds, memory and learning24, 25.  
 
With safe earlier MRI now possible using MR compatible incubators, valid scoring systems for use 
earlier than TEA are required. The aim of this study was to validate an MRI scoring system 
previously developed for very preterm infants at TEA in a cohort of infants born <31 weeks 
gestational age with MRI between 29 and 35 weeks PMA22. The study aimed to establish predictive 
validity for motor and cognitive outcomes at 12 months CA. Secondary aims were to examine inter- 
and intrarater reproducibility and to examine relationships between global brain abnormality 
categories and known perinatal risk factors. It was hypothesized that the scoring system would be 
valid and reliable for use at this earlier time point but with more infants classified with brain 
abnormalities, due to immaturity rather than injury.  
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Methods  
Study Design and Participants 
This prospective cohort study of infants born <31 weeks’ gestational age (GA) was conducted at the 
Royal Brisbane and Women’s Hospital, Brisbane, Australia between February 2013 and April 2015. 
Preterm infants were eligible if they had no congenital abnormality, and their parents/carers were 
English speaking who lived within a 200km radius of the hospital26. A reference sample of healthy 
term-born babies was simultaneously recruited to generate reference values and cut points for the 
regional brain measurements that form part of the scoring system. Inclusion criteria for term born 
infants were a GA at birth of 38-41 weeks, birthweight above the 10th percentile, an uncomplicated 
pregnancy, delivery and postpartum period, and normal neurological examination findings26. Ethics 
approval was obtained from the Royal Brisbane and Women’s Hospital Human Research Ethics 
Committee (HREC/12/QRBW/245) and The University of Queensland (2012001060), and the trial 
was registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12613000280707).  
 
MRI Acquisition  
Brain MRI was performed during sleep without sedation between 30-32 weeks PMA or when the 
infant was medically stable (range 29-35 weeks PMA, ‘Early MRI’) and again at TEA (40-42 
weeks PMA, ‘Term MRI’). Infants were scanned using a 3T MRI, Siemens Tim Trio (Erlangen, 
Germany), utilizing an MR compatible incubator with its dedicated neonatal head coil (Nomag 
incubator; LMT Lammers Medical Technology, Lübeck, Germany). Coronal, axial, and sagittal T2-
weighted HASTE (TR/TE 2000/90ms, flip angle 150°, field of view 200x160mm, matrix 320x256, 
section thickness 4mm), axial T1 TSE (TR/TE 1490/90ms, flip angle 150°, field of view 
200x160mm, matrix 256x180, section thickness 2mm), and an axial multi-echo T2 TSE 
(TR/TE1/TE2/TE3 10580/27/122/189ms, flip angle 150°, field of view 144x180mm, matrix 
204x256, section thickness 2mm) were acquired. 
 
MRI scoring  
A standardized MRI scoring system according to Kidokoro et al was used to score all MRIs22. An 
independent neurologist with training in radiology and experienced in neonatal MRI scoring (SF) 
performed the scoring. The scorer had no knowledge of any clinical characteristics of the infants 
except PMA at the time of scanning. Scoring was confirmed by a senior neuroradiologist (AC). 
Modifications to scoring cut points were made using the term reference data means and standard 
deviations27, 28. Scoring items and parameters are detailed in On-line Table 1, a scoring proforma is 
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included in On-line Table 2, and On-line Figs 1-18 provide examples of lesion types and regional 
measurements.  
 
Cerebral WM abnormality was rated on 6 components, with a maximum total score of 15: cystic 
degeneration, focal signal abnormalities, delayed myelination, thinning of the corpus callosum, 
dilated lateral ventricles, and reduction of WM volume22. Myelination of the corpus callosum and 
posterior limb of the internal capsule was expected by 36 weeks PMA, so all infants were given a 
score of 2 for this item on Early MRI. The CGM was rated on 3 components with a maximum total 
score of 8: signal abnormality, delayed gyration, and dilated extracerebral CSF space. Cerebellar 
and DGM abnormality were rated on signal abnormality and volume reduction with maximum total 
scores of 6 for each22. A total of WM, CGM, DGM and cerebellar scores yielded a global brain 
abnormality score (0-35)22. Each of the WM, CGM, DGM, cerebellum and global scores could be 
further categorized into no, mild, moderate or severe brain abnormality categories22. The WM total 
scores were categorized as none (0-2), mild (3-4), moderate (5-6) or severe (≥7) WM abnormality. 
Cortical GM, DGM and cerebellar categories used the following total scores; none (0), mild (1), 
moderate (2) and severe (≥3). Total global scores were classified as normal (0-3), mild (4-7), 
moderate (8-11) or severe (≥12) brain abnormalities.  
 
Six regional measurements form part of the scoring: thickness of the corpus callosum (genu, body 
and splenium), ventricular diameter, biparietal width, interhemispheric distance, DGM area and 
transcerebellar diameter. These measurements change with PMA at time of MRI as a result of head 
and brain growth. To address this change and to minimize the risk of confounding, the relationship 
of each of these measures with PMA at MRI was examined to derive a correction method for PMA 
at MRI. The PMA was determined based on the obstetric estimate measure of gestation at 
delivery29. In the preterm group, Early and Term MRI data were pooled for each of the regional 
measures, and cases with focal brain lesions were removed to ensure that any linear relationship 
found was the result of age and not confounded by brain injury. For each measure that demonstrated 
a linear relationship with PMA at MRI, the regression coefficient (slope) was utilized to generate an 
equation for correction, written as: corrected value=measured value + regression coefficient x (40 - 
PMA at MRI). The correction was then applied to the full cohort. On-line Figs 8-10 and 15 provide 
instructions for conducting regional measurements, correcting the raw values and scoring. 
 
The regional measurements were also obtained for the term reference sample and examination of 
the relationship with PMA at MRI was performed separately to that of the preterm group. When 
linear relationships were found, measurements were corrected as per the equation above. Following 
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correction of the term reference sample regional scores, means and standard deviations were 
calculated, and these were used to create cut points for scoring each of the respective regional 
measurements.  
 
Inter-rater reproducibility of MRI scoring was tested on a separate sample with 20 MRI scans from 
each time point scored by a second blinded rater, a pediatric radiologist (JB).  Intra-rater 
reproducibility was tested with 20 MRI scans from each time point rescored 1 month apart (SF).  
 
Neurodevelopmental Outcome at 12 months CA  
All infants underwent neurodevelopmental assessment at 12 months CA by an experienced 
physiotherapist blinded to MRI findings and medical history. The Bayley Scales of Infant and 
Toddler Development, 3rd ed. (Bayley III), was performed, and composite scores for motor and 
cognitive performance were generated30. The Neuro-Sensory Motor Developmental Assessment 
(NSMDA) evaluates neurological and sensory motor function in addition to gross and fine motor 
performance, with total scores and functional classifications used31, 32. The NSMDA at 12 months 
CA has good predictive validity for motor and cognitive outcomes and cerebral palsy at 4 years CA 
for very preterm infants33, 34 and 24-month motor and functional outcomes for infants with cerebral 
palsy35.  
 
Statistical Analysis 
Sample size calculations were based on qualitative evaluation of MR images at TEA predicting 12 
month outcomes4, with 69 infants required to reject the null hypothesis with 90% power (at 
p<0.05).  A sample of 80 infants was recruited to account for attrition and the earlier PMA at MRI 
(29-35 weeks PMA). 
 
The association between each of the 6 regional measurements and PMA at MRI was analyzed by 
using mixed effects regression models for the preterm sample data, and separately for the term 
reference sample data with linear regression. When a linear relationship was found, data were 
centered around the mean and the relationship was examined to determine if it was quadratic. 
Correction equations were then applied to the raw regional measures. Term reference sample mean 
and standard deviation data were used to generate scoring cut points for each of the regional 
measures. Paired t-tests were used to determine statistically significant differences between Early 
and Term MRI item scores in the preterm group. 
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The association between a) Early MRI scores and 12 month outcomes, and b) Term MRI scores and 
12 month outcomes, were evaluated with univariable and multivariable linear regression. 
Multivariable regression included potential confounders of sex, social risk and, for NSMDA only, 
CA at assessment. 
 
To examine the predictive validity of both Early and Term MRI, sensitivity, specificity and 
accuracy (percentage of cases correctly classified) were calculated. Dichotomized MRI and 
outcome data were used to construct 2x2 tables. MRI category scores were dichotomized into 
normal/mild or moderate/severe categories for each of the subscales and global scores. Bayley 
motor and cognitive composite scores were dichotomized (by <-1 SD) and the NSMDA functional 
classification scores as normal/minimal vs mild/moderate/severe/profound.  
 
Inter- and intra-rater reliability was evaluated by using intra-class correlation coefficients (ICCs) 
(type 3,1). Agreement was evaluated using the percentage level of accuracy, in which the definition 
for accuracy was exact score ±1 for the subscale scores and exact score ±2 for the global scores.  
 
When investigating perinatal risk factors, differences across global brain abnormality score 
categories were determined using Mann-Whitney U tests (dichotomous perinatal risk factors) and 
Kruskal Wallis 1-way ANOVAs (continuous perinatal risk factors). Analysis was performed using 
the Stata statistical package, version 14 (StataCorp, College Station, TX, USA). 
 
Results  
Participants 
Of 214 eligible preterm infants, 110 consented to the study, of whom 83 had Early MRI and 12 
month outcomes available and were included in this analysis (16 no Early MRI: 5 medically 
unstable, 1 death, 4 cancellations due to MRI equipment failure, 3 with no MRI slots, 1 withdrawn, 
2 with movement artefacts; 11 failed to return for 12 month follow up). Of these, 77/83 had a 
second MRI at Term. Thirty-eight term born infants were included in the reference sample. 
Demographic data and MRI scores are summarized in Tables 1-3; 12 month outcomes are 
summarized in Table 4. There were minimal differences between those participants with both Early 
and Term MRI, and those with only Early MRI, except that all 6 participants who did not undergo 
their Term MRI were classified with a higher social risk36, 37. Given the established relationship 
between higher social risk and poorer neurodevelopmental outcome and an increased risk of 
cerebral palsy, and to address this difference in our cohort between Early and Term MRI, all 
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multivariable analyses included social risk as a potential confounder38, 39. All term reference sample 
infants had a normal global brain abnormality category score. 
 
Associations between regional brain measurements and PMA at MRI 
All preterm regional measures except the body of the corpus callosum demonstrated linear 
relationships with PMA at MRI (p<0.01). In the term reference sample, linear relationships were 
found only for transcerebellar diameter and corpus callosum genu. Results of regression analyses 
and corrected regional measures for the Early, Term and term reference sample MRIs are presented 
in On-line Tables 3 and 4.  
 
Findings in each scoring domain at Early and Term MRI  
Results for scoring items are presented in On-line Table 1. Incidence of WM cystic lesions, CGM 
signal abnormality, and WM volume reduction as measured by corrected biparietal width remained 
stable between Early and Term MRI. A proportion of signal abnormalities in the WM and DGM 
resolved between Early and Term MRI. A propensity to score worse at Term compared with Early 
MRI was evidenced for each of the following: ventricular dilatation, interhemispheric distance, 
volume reduction of DGM and cerebellum, and thinning of the corpus callosum. More infants had 
delayed gyral maturation at Early MRI compared with Term MRI. 
 
Predictive validity of Early MRI 
Results of univariable and multivariable regression analyses between Early MRI scores and 
neurodevelopmental outcomes are presented in Fig1 (first row); sensitivity, specificity and accuracy 
in Table 5. Global, WM and DGM scores on Early MRI were associated with Bayley III motor 
outcome multivariably (global score: β=-1.31; 95%CI=-2.39; -0.23; p=0.02). Early MRI WM, 
DGM and global scores were associated with Bayley III cognitive outcome (global β=-1.52; 
95%CI=-2.39; -0.65; p<0.01). Early MRI WM, DGM, cerebellar and global scores were associated 
with outcome on the NSMDA (global β=-1.73; 95%CI=-3.19; -0.28; p=0.02).  The sensitivity of 
Early MRI global scores to predict motor, cognitive, and NSMDA outcomes ranged from 33-50% 
specificity ranged from 86-87%, with the percentage of accurately classified cases ranging from 77-
83%.  
 
Predictive validity of term MRI 
Univariable and multivariable regression analyses between Term MRI scores and 
neurodevelopmental outcomes are presented in Figure 1 (second row). Sensitivity, specificity and 
accuracy are presented in Table 5. At Term MRI, WM, DGM, cerebellar, and global scores were 
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associated with Bayley III motor and cognitive and NSMDA scores. Global scores were associated 
with Bayley III motor outcome (β =-1.71; 95%CI=-2.63; -0.79; p<0.01), cognitive outcome (β =-
1.32; 95%CI=-2.10; -0.53; p<0.01), and NSMDA (β =-2.36; 95%CI=-3.62; -1.10; p<0.01). The 
sensitivity of Term MRI global scores to predict motor, cognitive and NSMDA outcomes ranged 
from 14-33% specificity ranged from 90-92% with the percentage of accurately classified cases 
ranging from 77-87%.  
 
Inter- and intrarater reproducibility  
Reliability and agreement results are presented in On-line Table 5. At Early MRI, intrarater 
reliability ranged from 0.82-0.97 (ICC), and agreement, from 90-100%. Interrater reliability was 
low for CGM (ICC=0.08), but excellent for the other subscales (ICC=0.76-0.86) and the global total 
(ICC=0.89). Interrater agreement ranged from 70-95%. At Term MRI, intrarater reliability ICCs 
ranged from 0.74-0.96, with global score ICC of 0.97. Intrarater agreement ranged from 90-100%. 
Interrater reliability once again showed lower reliability for CGM (ICC=0.66); however the other 
subscale ICCs ranged from 0.86-0.93, and the global score ICC was 0.93. Interrater agreement 
ranged from 80-100%. 
 
Perinatal risk factors  
Perinatal risk factors were associated with increasing severity of MRI global brain abnormality 
category scores (On-line Table 6). Early MRI was associated with gestational age at birth, birth 
weight, patent ductus arteriosus, retinopathy of prematurity, postnatal corticosteroids, ventilation, 
and oxygen therapy. Term MRI was associated with gestational age at birth, birth weight, higher 
social risk, retinopathy of prematurity, ventilation, oxygen requirement at 36 weeks PMA and 
requirement for home oxygen.  
 
Discussion  
This clinically accessible scoring system of structural brain MRI for use at 29-35 weeks PMA for 
infants born at <31 weeks gestational age is valid. Early MRI WM, DGM and global brain 
abnormality scores were associated with Bayley III motor and cognitive scores and outcome on the 
NSMDA at 12 months CA. Early cerebellar scores were also associated with NSMDA outcome. 
These associations were reconfirmed at Term MRI. In addition, Term MRI cerebellar scores were 
associated with Bayley III motor and cognitive outcomes. 
 
Early MRI was more strongly associated with cognitive than motor outcomes. The scoring system 
upon which this study was based has been used in 2 studies examining the relationships between 
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TEA MRI and cognitive outcomes at 7 years24, 25. Our results support previous findings at TEA and 
suggest that the brain changes associated with adverse cognitive outcomes are already present as 
early as 29-35 weeks PMA7.  
 
Of all MRI subscale scores, at Early and Term MRI, DGM demonstrated the strongest relationship 
with outcome. This finding supports inclusion of DGM evaluation in qualitative and semi-
quantitative scoring systems in this population. Cerebellar scores on Early MRI were associated 
with NSMDA scores but not the Bayley III motor score. This finding is interesting because the 
Bayley III motor scale focuses on motor achievement, while the NSMDA evaluates quality of 
motor performance, including balance and postural reactions, functions known to be modulated by 
the cerebellum. The NSMDA also includes assessment of muscle tone, reflexes and sensory motor 
function, and at 12 months CA has been shown to predict motor and cognitive outcomes and 
cerebral palsy at 4 years in preterm infants33, 34.  
 
The specificity of the scoring system is reasonable, indicating that those infants whose global 
scoring category is moderate or severe have a high probability of poor motor and cognitive 
outcomes at 12 months CA. The sensitivity is relatively low, so not all infants who progress to poor 
motor and cognitive outcomes will be identified by this scoring system at Early or Term MRI; 
however, it also means that the risk of false positives is low. Parents indicate a desire for 
prognostication and early identification of outcomes40, and a low false positive rate is preferable to 
prolonged distress caused by a false positive result where parents spend years waiting for an 
adverse outcome that does not occur41, 42. A combination of TEA MRI findings and 3 months CA 
general movements assessment demonstrates improved predictive validity over TEA MRI alone43-
45, so evaluation of the relationships between this Early MRI scoring system and concurrent clinical 
measures and the combination of Early MRI and clinical measures to predict later outcomes is 
warranted. 
 
Our results indicate that Term MRI scores demonstrate stronger associations with 12 month 
outcomes than Early MRI scores. Term MRI associations described here are stronger than those 
found by another group using the original scoring system23, suggesting that the modified scoring cut 
points, based on term born reference sample data, may be an improvement over the original scale27. 
It must be noted that their outcome was at 2 years CA rather than 12 months CA in the present 
study. Stronger associations of Term MRI with outcomes may be due to small focal lesions evident 
on Early MRI having resolved by Term MRI, or volume reduction becoming more apparent. Both 
of these require further exploration. Term MRI scores presented here show a lower incidence of 
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myelination delay compared with the cohort upon which the scale was originally based. In the 
present study, the T1 sequence was performed at the end of the MRI when infants were often 
beginning to wake up; therefore, it had a higher incidence of motion artefacts. For this reason, T2-
weighted images were used to score myelination delay with their improved contrast, and this may 
have resulted in an overestimation of myelination compared to the earlier study22. 
 
Conclusion  
This study presents a clinically accessible MRI scoring system of brain injury and growth for use 
from 29-35 weeks PMA in infants born at <31 weeks GA that has good reproducibility and 
significant associations with motor and cognitive outcomes at 12 months CA. The tool is suitable 
for use in research and for assisting clinical patient management.  
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Table 1: Characteristics of preterm sample and term reference sample included in this validation 
study 
 
 
Full preterm 
sample with Early 
MRI n=83 
Preterm sample 
with additional 
Term MRI n=77 
Term 
Reference 
Sample 
n=38 
Birth and Maternal Data n(%), Median[IQR] or Mean(SD), range 
Gestational age at birth (weeks) 28+4[26+6-29+3], 23+6 
– 30+6 
28+5[26+6-29+3], 23+6 
– 30+6 
39+6[39-40+3], 
38+2 – 41+3 
Birth weight (g) 1068(312), 494 – 
1886 
1076(322), 494 – 
1886 
3509(317), 
2932 – 4330 
Birth head circumference (cm) 25.62(2.38), 20.5-
30.5 n=80 
25.64(2.43), 20.5-
30.5 n=75 
34.71(1.12), 
32.5 – 37 n=31 
Males 49(59%) 46(60%) 19(50%) 
Multiple births 24(29%) 21(27%) 0(0%) 
Premature rupture of membranes 19(23%) 18(23%) 4(12%) n=33 
Caesarian section 60(72%) 56(73%) 9(27%) n=33 
Chorioamnionitis 14(17%) 13(17%)  
Antenatal steroids 62(75%) 57(74%)  
Magnesium sulphate 43(65%) n=66 41(65%) n=63  
Higher social risk 40(48%) 34(44%) 5(16%) n=31 
Key: Early MRI, 29-35 weeks PMA; Term MRI, 40-42 weeks PMA; PMA postmenstrual age 
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Table 2: Characteristics of preterm sample and term reference sample included in this validation 
study 
 
Acquired medical factors 
From birth to Early 
MRI n=83 
From birth to Term 
MRI n=77 
Term 
Reference 
Sample n=38 
Patent ductus arteriosus 39(47%) 36(47%)  
IVH  17(20%) 16(21%)  
IVH grade 3 or 4 4(5%) 4(5%)  
Periventricular leukomalacia 2(2%) 2(3%)  
Hydrocephalus 2(2%) 2(3%)  
NEC diagnosed or suspected 3(4%) 2(3%)  
Confirmed sepsis 3(4%) 2(3%)  
Total parenteral nutrition (days)  11[8–14], 0–30 11[8-14], 0–30  
Postnatal corticosteroids 14(17%) 14(18%)  
Ventilation (days) 3[0–12], 0–48 2[0–12], 0–48  
CPAP (days) 15[7–25], 0–47 30[7–47], 0–81  
Oxygen therapy (hours) 12[1–125], 0–1515, 
n=69 
29[2–370], 0–3912, 
n=67 
 
36week PMA O2 requirement   23(30%)  
PMA at MRI (weeks) 32+2(1+3), 29+3 –35+2 40+6(1+3), 38+3– 46+4 41+3(1), 39+2 – 
44 
Weight at MRI (g) 1500(352), 883 –
2715 
Early MRI 
1505(359), 883-2715 
Term MRI 
3127(627), 1900–
5150 
3428(378), 
2500–4200 
n=31 
Key: Early MRI, 29-35 weeks PMA; Term MRI, 40-42 weeks PMA; PMA postmenstrual age; 
IVH Intraventricular hemorrhage; NEC necrotizing enterocolitis; CPAP continuous positive 
airway pressure. 
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Table 3: Characteristics of preterm samples and term reference sample included in this validation 
study 
 
MRI Scores  
Early MRI 
 
Term MRI 
 
Term Reference 
Sample 
 median[IQR] 
White Matter  3[2–4] 1[1–3] 0[0-0] 
Cortical gray matter 0[0-1] 0[0-1] 0[0-0] 
Deep gray matter 0[0-1] 0[0-1] 0[0-0] 
Cerebellum 0[0-0] 0[0-1] 0[0-0] 
Global Score  4[3–7] 3[1–5] 0[0-0] 
Key: Early MRI, 29-35 weeks PMA; Term MRI, 40-42 weeks PMA; PMA postmenstrual age 
 
Table 4: Bayley III and NSMDA scores at 12 months corrected age (n=83) 
 
12 month outcomes mean(SD) 
Age at assessment 12 months 4 days (1+2weeks) 
Bayley III Motor Composite 96.96(14.27) 
Bayley III Cognitive Composite 104.64(12.07) 
NSMDA total  179.53(18.81) 
12 month outcomes dichotomized number (%) 
Bayley III Motor Composite <-1SD 15(18%) 
Bayley III Cognitive Composite <-1SD 6(7%) 
NSMDA functional classification ≥2 7(8%) 
Key: NSMDA neurosensory motor developmental assessment 
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FIG 1. Associations between Early (first row) and Term (second row) MR imaging scores and neurodevelopmental outcome at 12-months corrected 
age for the preterm cohort. Solid lines represent univariable regression analyses, and dashed lines represent multivariable analyses for which sex, social 
risk and, for NSMDA only, corrected age at assessment were added.
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Table 5: Sensitivity, specificity and accuracy of Early and Term MRI scores categorized as moderate/severe to predict an outcome of <-1SD on the 
Bayley III or NSMDA functional classification of mild-profound dysfunction  
 
 
12 month neurodevelopmental outcome 
Bayley III Motor Composite score Bayley III Cognitive Composite score NSMDA 
Early MRI 
(n=83) 
Sensitivity Specificity Correctly 
classified 
Sensitivity Specificity Correctly 
classified 
Sensitivity Specificity Correctly 
classified 
WM 33(12-62) 78(66-87) 70 50(12-88) 78(67-87) 76 43(10-82) 78(67-86) 75 
CGM 0(0-22) 81(70-89) 66 0(0-46) 83(73-91) 77 0(0-41) 83(73-91) 76 
DGM 40(16-68) 94(86-98) 84 33(4-78) 90(81-95) 86 43(10-82) 91(82-96) 87 
Cerebellum 13(2-40) 93(84-98) 78 17(1-64) 92(84-97) 87 29(4-71) 93(85-98) 88 
Global Score 33(12-62) 87(76-94) 77 50(12-88) 86(76-93) 83 43(10-82) 86(76-93) 82 
Term MRI 
(n=77) 
         
WM 14(2-43) 92(82-97) 78 33(4-78) 93(84-98) 88 29(4-71) 93(84-98) 87 
CGM 21(5-51) 79(67-89) 69 0(0-46) 77(66-87) 71 29(4-71) 80(69-89) 75 
DGM 36(13-65) 86(75-93) 77 33(4-78) 83(72-91) 79 71(29-96) 87(77-94) 86 
Cerebellum 21(5-51) 92(82-97) 79 33(4-78) 92(83-97) 87 43(10-82) 93(84-98) 88 
Global Score 14(2-43) 90(80-96) 77 33(4-78) 92(83-97) 87 29(4-71) 91(82-97) 86 
Key: Sensitivity and specificity: percentage (95%CI); Correctly classified: percentage; Early MRI, 29-35 weeks PMA; Term MRI, 40-42 weeks 
PMA; CGM cortical gray matter; DGM deep gray matter 
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On-line Table 1: Scoring parameters and findings in preterm sample Early and Term MRI, and term reference sample MRI, presented as number (%) 
 
 
Score 
 Early MRI 
n=83 (t1) 
Term MRI 
n=77 (t2) 
Reference 
n=38 
Difference  
t1-t2 (p) 
Cerebral WM  
Cystic lesions 
0 None 76(92%) 73(95%) 38(100%) 0.71 
1 Focal unilateral 5(6%) 2(3%) 0  
2 Focal bilateral 1(1%) 1(1%) 0  
3 Extensive unilateral 0 0 0  
4 Extensive bilateral 1(1%) 1(1%) 0  
Focal signal abnormality 0 None 62(75%) 66(86%) 38(100%) 0.05 
1 Focal punctate 12(14%) 4(5%) 0  
2 Extensive punctate 2(2%) 2(3%) 0  
3 Linear 7(8%) 5(6%) 0  
Myelination delay 0 Myelinated PLIC & corona radiata 0 72(94%) 38(100%) <0.01 
1 Only PLIC myelinated 0 1(1%) 0  
2 Minimal myelination–no myelin in PLIC 83(100%)# 4(5%) 0  
Thinning of Corpus 
Callosum 
0 Genu, midbody, & splenium <2SD below mean 80(96%) 61(79%) 37(97%) <0.01 
1 Genu or midbody or splenium >2SD below mean 1(1%) 14(18%) 1(3%)  
2 Genu or midbody & splenium >2SD below mean 2(2%) 2(3%) 0  
Dilated lateral ventricles 0 Both sides within 2 SD of mean 69(83%) 55(71%) 36(95%) 0.24 
1 One side >2SD but <3SD above mean 6(7%) 15(19%) 2(5%)  
2 One or both sides >3SD above mean 8(10%) 7(9%) 0  
Volume reduction 0 cBPW <2SD below mean 34(41%) 31(40%) 37(97%) 0.51 
1 cBPW >2SD below but <3SD below mean 29(35%) 27(35%) 1(3%)  
2 cBPW >3SD below mean 20(24%) 19(25%) 0  
Cortical GM 
Signal abnormality 
0 None 83(100%) 77(99%) 38(100%) 0.32 
1 Focal unilateral 0 0 0  
2 Focal bilateral 0 1(1%) 0  
3 Extensive unilateral 0 0 0  
4 Extensive bilateral 0 0 0  
Gyral maturation 0 Delay <2 weeks 63(76%) 75(97%) 38(100%) <0.01 
1 2 ≤ delay < 4 weeks 13(16%) 2(3%) 0  
2 Delay ≥ 4 weeks 7(8%) 0 0  
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Increased extracerebral 
space 
0 cIHD within 2 SD of mean 68(82%) 55(71%) 37(97%) 0.06 
1 cIHD >2SD & <3SD above mean 10(12%) 7(9%) 1(3%)  
2 cIHD >3SD above mean 5(6%) 15(19%) 0  
Deep GM  
Signal abnormality 
0 None 75(90%) 75(97%) 38(100%) 0.01 
1 Focal unilateral 5(6%) 1(1%) 0  
2 Focal bilateral 3(4%) 1(1%) 0  
3 Extensive unilateral 0 0 0  
4 Extensive bilateral 0 0 0  
Volume reduction 0 cDGMA <2SD below mean 59(71%) 50(64%) 37(97%) 0.06 
1 cDGMA >2SD below & <3SD below mean 17(20%) 13(17%) 1(3%)  
2 cDGMA >3SD below mean 7(8%) 14(18%) 0  
Cerebellum  
Signal abnormality 
0 None 78(94%) 72(94%) 38(100%) 0.32 
1 Punctate unilateral 4(5%) 5(6%) 0  
2 Punctate bilateral 0 0 0  
3 Extensive unilateral 1(1%) 0 0  
4 Extensive bilateral 0 0 0  
Volume reduction 0 cTCD <2SD below mean 69(83%) 54(70%) 37(97%) 0.09 
1 cTCD >2SD below & <3SD below mean 8(10%) 16(21%) 1(3%)  
2 cTCD >3SD below mean 6(7%) 7(9%) 0  
Key: Early MRI, 29-35 weeks PMA; Term MRI, 40-42 weeks PMA; Mean and SD refer to term reference sample data; GM gray matter; cBPW 
corrected biparietal width; cDGMA corrected deep GM area; cTCD corrected transcerebellar diameter; IHD interhemispheric distance; PLIC 
posterior limb of the internal capsule; VD ventricular diameter; # all Early MRIs scored 2 for myelination delay to represent ‘unmyelinated PLIC 
and corona radiata’. p<0.05 represents a significant difference between Early and Term MRI scores in the preterm sample. 
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 On-line Table 2: Structural MRI scoring system for use from 29-46 weeks postmenstrual age in preterm infants – Score Sheet 
Date: 
Patient ID: 
Postmenstrual age (PMA) at MRI:     ‘c’ denotes corrected value 
Cerebral WM Score 0 Score 1 Score 2 Score 3 Score 4 Comments 
Cystic lesions None Focal unilateral 
(On-line Fig 1) 
Focal bilateral 
(On-line Fig 2) 
Extensive 
unilateral 
(On-line Fig 
3) 
Extensive 
bilateral 
(On-line Fig 
4) 
 
Focal signal 
abnormality 
None Focal punctate 
(On-line Fig 5) 
Extensive punctate 
(On-line Fig 6) 
Linear 
(On-line Fig 
7) 
  
Myelination delay Myelinated PLIC & 
corona radiata 
Only PLIC myelinated Minimal myelination – no 
myelin in PLIC 
   
Thinning of corpus 
callosum 
 
(On-line Fig 8) 
Measure genu, midbody & splenium on a midsagittal section & correct genu & splenium for PMA at MRI using 
equations: 
cGenu = measured genu + 0.03x(40-PMA at MRI) 
cSplenium = measured splenium + 0.03x(40-PMA at MRI) 
 
cGenu >1.13mm &  
Midbody >0.7mm & 
cSplenium >1.84mm 
cGenu <1.13mm OR 
Midbody <0.7mm OR 
cSplenium <1.84mm  
(cGenu <1.13mm OR 
Midbody <0.7mm) & 
cSplenium <1.84mm 
  
Dilated lateral 
ventricles 
 
(On-line Fig 9) 
Measure left (LV) & right ventricle (RV) at level of ventricular atrium & correct for PMA at MRI using equation: 
cRV = measured RV + 0.15x(40-PMA at MRI) 
cLV = measured LV + 0.13x(40-PMA at MRI) 
cRV<9.12mm & 
cLV<8.42mm 
One or both: 
9.12mm<cRV<10.39mm 
8.42mm<cLV<9.39mm 
One or both: 
cRV>10.39mm 
cLV>9.39mm 
  
Volume reduction 
 
(On-line Fig 10) 
Measure biparietal width (BPW) at level of the basilar turn of the cochlea & correct for PMA at MRI using equation:  
Corrected BPW= measured BPW + 2.33x(40-PMA at MRI) 
cBPW >78.52mm 74.6mm <cBPW< 78.52mm  cBPW <74.6mm  
WM total =  /15 
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Cortical GM Score 0 Score 1 Score 2 Score 3 Score 4 Comments 
Signal 
abnormality 
None Focal unilateral Focal bilateral Extensive 
unilateral 
Extensive 
bilateral 
 
Gyral 
maturation 
34-36weeks PMA, marginal sulcus & paracentral gyrus present; secondary sulci in frontal lobes, superior & middle 
temporal & prerolandic, postrolandic, insula, & occipital regions present. 36-38weeks PMA, additional secondary gyri 
in transverse & inferior temporal; anterior & posterior orbital gyri established. 40weeks PMA, tertiary inferior 
temporal & inferior occipital gyri & sulci (Inder et al 2003). 
 
Delay <2 weeks  2 ≤ delay < 4 weeks Delay ≥ 4 weeks    
Increased    
extracerebral 
space 
 
(On-line Fig 10) 
Measure interhemispheric distance (IHD) between crowns of superior frontal gyri at same section as measurement for 
BPW. Correct for PMA at MRI using equation: 
cIHD = measured IHD + 0.16x(40- PMA at MRI) 
 
cIHD <3.98mm 3.98mm <cIHD< 4.69mm  cIHD >4.69mm   
Cortical GM total=   
/8 
Deep GM Score 0 Score 1 Score 2 Score 3 Score 4 Comments 
Signal 
abnormality 
None Focal unilateral  
(On-line Fig 11) 
Focal bilateral 
(On-line Fig 12) 
Extensive 
unilateral 
(On-line Fig 
13) 
Extensive 
bilateral 
(On-line Fig 
14) 
 
Volume 
reduction 
 
(On-line Fig 15) 
Measure deep gray matter area (DGMA) on a single axial section where caudate heads, lentiform nuclei, and thalami 
are maximally visible. Correct for PMA at MRI using equation: 
cDGMA = measured DGMA + 0.45x(40- PMA at MRI) 
 
cDGMA >11.1mm 10.51mm <cDGMA< 
11.1mm 
cDGMA <10.51mm  Deep GM total =   
/6 
Cerebellum Score 0 Score 1 Score 2 Score 3 Score 4 Comments 
Signal 
abnormality 
None Punctate unilateral 
(On-line Fig 16) 
Punctate bilateral 
 (On-line Fig 17) 
Extensive 
unilateral 
 (On-line Fig 
18) 
Extensive 
bilateral 
 
 
Volume 
reduction 
 
(On-line Fig 9) 
Measure transcerebellar diameter (TCD) at level of atria, maximal horizontal distance. Correct for PMA at MRI using 
equation: cTCD = measured TCD + 1.78x(40- PMA at MRI) 
 
cTCD >50.02mm 48.04mm <cTCD<50.02mm  cTCD <48.04mm  Cerebellum total =    
/6 
Global total =        /35   Global score category (0-3 normal; 4-7 mild; 8-11 moderate; 12+ severe) 
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On-line Table 3: Relationship between postmenstrual age at MRI and each regional measurement 
  
 Preterm sample n=135  
(n=71 Early MRI, n=64 Term MRI) 
Term reference sample n=38 
 Regression Coefficient 95% CI p Regression Coefficient 95% CI p 
Corpus callosum genu 0.03 0.01; 0.05 0.01 0.28 0.02; 0.53 0.03      
Corpus callosum body 0.01 -0.01; 0.02 0.33 -0.03 -0.19; 0.12 0.64      
Corpus callosum splenium 0.03 0.01; 0.04 <0.01 0.04 -0.15; 0.23 0.67     
Ventricular diameter right 0.15 0.11; 0.18 <0.01 0.35 -0.06; 0.76 0.09     
Ventricular diameter left 0.13 0.1; 0.16 <0.01 0.10 -0.22; 0.43 0.51     
Biparietal width 2.33 2.19; 2.48 <0.01 0.00 -1.32; 1.33 0.99     
Interhemispheric distance 0.16 0.12; 0.2 <0.01 0.03 -0.21; 0.27 0.78     
Deep gray matter area 0.45 0.42; 0.47 <0.01 0.11 -0.09; 0.3 0.27     
Transcerebellar diameter 1.78 1.72; 1.84 <0.01 0.99 0.33; 1.66 0.01      
Key: Early MRI, 29-35 weeks PMA; Term MRI, 40-42 weeks PMA; Preterm sample- cases with focal brain lesions were removed to 
ensure that any linear relationship found was the result of age and not confounded by brain injury. Regression analyses were conducted 
separately for the preterm and term samples. 
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On-line Table 4: Corrected means and standard deviations of the regional measurements for Early and Term MRI for the preterm group, and the term 
reference samplea.  
 Early MRI n=83 Term MRI n=77 Term reference sample n=38 
Corpus callosum genu 1.96 (0.43) 1.91 (0.67) 2.63 (0.75) 
Corpus callosum body 1.33 (0.28)b 1.40 (0.43)b 1.60 (0.45) b 
Corpus callosum splenium 2.71 (0.51) 2.61 (0.62) 2.98 (0.57) b 
Ventricular diameter right 7.43 (3.29) 7.49 (3.58) 6.48 (0.97) b 
Ventricular diameter left 7.51 (3.20) 7.70 (4) 6.58 (1.3) b 
Biparietal width 77.40 (4.47) 77.40 (5.44) 86.38 (3.93) b 
Interhemispheric distance 3.27 (0.79) 3.50 (1.33) 2.56 (0.71) b 
Deep gray matter area 11.48 (0.82) 11.44 (1.01) 12.28 (0.59) b 
Transcerebellar diameter 51.55 (2.53) 51.34 (2.73) 53.98 (1.98) 
Key: a For each measure that demonstrated a linear relationship with PMA at MRI in On-line Table 3, the regression coefficient (slope) was used to 
generate an equation for correction, written as: Corrected Value = Measured Value + Regression Coefficient x (40-PMA at MRI). A single equation 
was used to correct Early and Term MRI regional measures for the preterm group. The term reference sample data were corrected separately. 
b Uncorrected values—that is, for regional measures in which no linear relationship was found and no correction was performed. 
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On-line Table 5: Inter- and intrarater reproducibility of Early and Term MRI scores 
 Inter-rater (n=20) Intra-rater (n=20) 
Early MRI scores Reliability ICC [95% CI] % Agreement Reliability ICC [95% CI] % Agreement 
White matter 0.79 [0.47, 0.92] 70 0.97 [0.93, 0.99] 95 
CGM 0.08 [0.00, 0.63] 95 0.92 [0.80, 0.97] 100 
DGM 0.86 [0.64, 0.94] 85 0.92 [0.81, 0.97] 90 
Cerebellum 0.76 [0.40, 0.91] 95 0.82 [0.51, 0.93] 95 
Global 0.89 [0.72, 0.96] 80 0.97 [0.91, 0.99] 95 
Term MRI scores     
White matter 0.93 [0.82, 0.97] 90 0.96 [0.89, 0.98] 90 
CGM 0.66 [0.15, 0.87] 90 0.75 [0.32, 0.91] 95 
DGM 0.86 [0.66, 0.95] 90 0.96 [0.89, 0.98] 100 
Cerebellum 0.91 [0.78, 0.97] 100 0.91 [0.77, 0.97] 100 
Global 0.93 [0.82, 0.97] 80 0.97 [0.92, 0.99] 95 
Key: “% agreement” is defined as an exact agreement ±1 point for subscale scores and exact agreement ±2 points for global scores; CGM 
cortical gray matter; DGM deep gray matter. 
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On-line Table 6: Perinatal variables and grade of global brain abnormality of infants included in this validation paper  
 Global Brain Abnormality  
 Normal (Score 0-3) Mild (Score 4-7) Moderate (Score 8-11) Severe (Score ≥12) p value 
Variables 
Early MRI Term MRI Early MRI Term MRI Early MRI Term MRI Early MRI Term MRI Early 
MRI 
Term 
MRI n = 28 n = 49 n = 41 n = 20 n = 10 n = 5 n = 4 n = 3 
GA at birth (weeks) 28+6 (1+5) 28+3 (1+6) 27+6 (1+6) 28+2 (1+3) 27+3 (2+0) 25+3 (1+0) 27+0 (2+4) 27+3 (2+6) 0.04 0.03 
Birth weight (g) 1213 (266) 1145 (318) 1018 (305) 1001 (280) 913 (306) 820 (94) 974 (427) 878 (587) <0.01 0.04 
Male sex 17 (61%) 30 (61%) 24 (59%) 12 (60%) 5 (50%) 3 (60%) 3 (75%) 1 (33%) 0.85 0.64 
Multiple births 8 (29%) 12 (25%) 12 (29%) 7 (35%) 4 (40%) 2 (40%) 0 (0%) 0 (0%) 0.95 0.58 
Maternal PROM 10 (36%) 14 (29%) 7 (17%) 2 (10%) 1 (10%) 1 (20%) 1 (25%) 1 (33%) 0.07 0.23 
Chorioamnionitis 8 (29%) 9 (18%) 5 (12%) 3 (15%) 0 (0%) 0 (0%) 1 (25%) 1 (33%) 0.05 0.66 
Antenatal steroids 23 (82%) 36 (74%) 29 (71%) 17 (85%) 8 (80%) 1 (20%) 2 (50%) 3 (100%) 0.30 0.88 
Higher social risk 11 (41%) 16 (33%) 19 (46%) 12 (60%) 7 (70%) 4 (80%) 2 (50%) 2 (67%) 0.21 <0.01 
PDA 7 (25%) 21 (43%) 24 (59%) 8 (40%) 5 (50%) 5 (100%) 3 (75%) 2 (67%) 0.01 0.19 
Maternal MgSO4 16 (64%) 26 (59%) 20 (63%) 12 (75%) 6 (86%) 2 (100%) 1 (50%) 1 (100%) 0.67 0.11 
Caesarian section 20 (71%) 34 (69%) 30 (73%) 15 (75%) 7 (70%) 4 (80%) 3 (75%) 3 (100%) 0.95 0.32 
ROP 7 (25%) 14 (29%) 20 (49%) 13 (65%) 8 (80%) 4 (80%) 3 (75%) 2 (67%) <0.01 <0.01 
NEC 1 (4%) 1 (2%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (50%) 1 (33%) 0.22 0.50 
Confirmed sepsis 2 (7%) 2 (4%) 1 (2%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0.26 0.41 
TPN (days) 10 [6-13] 11 [8-14] 12 [8-15] 11 [7-14] 13 [8-14] 14 [14-19] 18 [6-28] 11 [n.d.] 0.12 0.17 
Postnatal steroids 1 (4%) 7 (14%) 7 (17%) 3 (15%) 3 (30%) 2 (40%) 3 (75%) 2 (67%) <0.01 0.11 
Ventilation (days) 2 [0-3] 2 [0-8] 3 [2-18] 3 [0-7] 3 [2-34] 30 [11-42] 31 [8-35] 20 [n.d.] 0.02 0.04 
CPAP (days) 12 [4-21] 18 [6-46] 17 [8-32] 33 [9-52] 15 [10-27] 50 [37-55] 7 [3-23] 32 [n.d.] 0.14 0.12 
Oxygen therapy 
(hours) 
5 [1-42] 46 [2-386] 51 [5-253] 6 [1-62] 1 [1-774] 512 [n.d.] 
665 [114-
1358] 
1958 [n.d.] 0.01 0.57 
BPD n.a. 11 (22%) n.a. 6 (30%) n.a. 4 (80%) n.a. 2 (67%) n.a. 0.02 
Home oxygen n.a. 5 (100%) n.a. 4 (20%) n.a. 3 (60%) n.a. 1 (33%) n.a. 0.02 
Key: Continuous measures reported as mean (SD) or median [IQR]. Categorical measures reported as frequency (percentage). BPD bronchopulmonary 
dysplasia (oxygen requirement at 36 weeks PMA); CPAP continuous positive airway pressure; NEC necrotizing enterocolitis (diagnosed or suspected); 
PDA patent ductus arteriosus; PROM premature rupture of membranes; ROP retinopathy of prematurity; TPN total parenteral nutrition. n.a., not 
applicable; n.d., not determinable due to small sample size; p value<0.05 indicates a significant association between the perinatal variable and increasing 
severity of MRI global brain abnormality category score 
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Online Figures 
 
 
ON-LINE FIG 1. Cerebral WM, cystic lesion, 
focal unilateral, score 1 (axial T2). 
 
ON-LINE FIG 2. Bilateral connatal cysts, 
classified as cerebral WM, cystic lesion, focal 
bilateral, score 2 (axial T2). 
 
 
ON-LINE FIG 3. Cerebral WM, cystic lesion, 
extensive unilateral, score 3 (axial T2). 
        
 
ON-LINE FIG 4. Cerebral WM, cystic lesion, 
extensive bilateral, score 4 (axial T2). 
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ON-LINE FIG 5. Cerebral WM, focal signal 
abnormality, focal punctate, score 1 (axial T1). 
 
ON-LINE FIG 6. Cerebral WM, focal signal 
abnormality, extensive punctate, score 2 (axial 
T1). 
 
ON-LINE FIG 7. Cerebral WM, focal signal 
abnormality, linear, score 3 (axial T2). 
 
ON-LINE FIG 8. Cerebral WM, thinning of the 
corpus callosum. Measure genu, midbody, and 
splenium on a midsaggital section (T2) and 
correct genu and splenium for PMA at MR 
imaging by using the following equations: 
cGenu = Measured Genu + 0.03 × (40-PMA at 
MRI). cSplenium = Measured Splenium +0.03 
× (40-PMA at MRI). Score 0: cGenu > 1.13 mm 
and midbody > 0.7 mm and cSplenium > 1.84 
mm. Score 1: cGenu < 1.13 mm or midbody < 
0.7 mm or cSplenium < 1.84 mm. Score 2: 
(cGenu <1.13 mm or midbody < 0.7 mm) and 
cSplenium <1.84 mm. 
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ON-LINE FIG 9. Cerebral WM, dilated lateral 
ventricles. Measure left (LV) and right ventricle 
(RV) at the level of the ventricular atrium 
(coronal T2) and correct for PMA at 
MRimaging by using the following equation: 
cRV = Measured RV + 0.15 × (40-PMA at 
MRI). cLV = Measured LV+ 0.13 × (40-PMA 
at MRI). Score 0: cRV < 9.12 mm and 
cLV<8.42 mm. Score 1: One or both: 9.12 
mm<cRV<10.39 mm; 8.42 mm< cLV < 9.39 
mm. Score 2: One or both: cRV> 10.39 mm; 
cLV> 9.39 mm. Cerebellum, volume reduction. 
Measure transcerebellar diameter (TCD) at the 
level of the atria, maximal horizontal distance 
(coronal T2), correct for PMA at MR imaging 
by using the following equation: cTCD= 
Measured TCD + 1.78×(40-PMA at MRI). 
Score 0: cTCD > 50.02 mm. Score 1: 48.04 
mm<cTCD < 50.02 mm. Score 2: cTCD< 
48.04 mm. 
 
 
 
ON-LINE FIG 10. CerebralWM,volume 
reduction. Measure biparietal width at level of 
the basilar turn of the cochlea (coronal T2) and 
correct for PMA at MR imaging by using the 
following equation: Corrected BPW= Measured 
BPW + 2.33×(40-PMA at MRI). Score 0: 
cBPW> 78.52 mm. Score 1: 74.6 mm< cBPW < 
78.52 mm. Score 2: cBPW < 74.6 mm. Cortical 
GM, increased extracerebral space (coronal T2). 
Measure the interhemispheric distance (IHD) 
between the crowns of the superior frontal gyri 
at the same section as measurement for BPW. 
Correct for PMA at MRimaging by using the 
following equation: cIHD = Measured IHD + 
0.16 × (40-PMA at MRI). Score 0: cIHD < 3.98 
mm. Score 1: 3.98 mm < cIHD < 4.69 mm. 
Score 2: cIHD> 4.69 mm. 
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ON-LINE FIG 11. Deep GM, signal 
abnormality, focal unilateral, score 1 (axial T2). 
 
ON-LINE FIG 12. Deep GM, signal 
abnormality, focal bilateral, score 2 (axial T2). 
     
ON-LINE FIG 13. Deep GM, signal 
abnormality, extensive unilateral, score 3 (axial 
T2). 
 
ON-LINE FIG 14. Deep GM, signal 
abnormality, extensive bilateral, score 4 (axial 
T2). 
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ON-LINE FIG 15. DeepGM, volume reduction. 
Measure deep gray matter area (DGMA) on a 
single axial section where the caudate heads, 
lentiform nuclei, andthalami are maximally 
visible (axial T2). Correct forPMA at MR 
imaging by using the following equation: 
cDGMA = Measured DGMA + 0.45 × (40-
PMA at MRI). Score 0: cDGMA > 11.1 mm. 
Score 1: 10.51 mm< cDGMA <11.1 mm. Score 
2: cDGMA < 10.51 mm. 
 
 
ON-LINE FIG 16. Cerebellum, signal 
abnormality, punctate unilateral, score 1 (axial 
T1). 
 
ON-LINE FIG 17. Cerebellum, signal 
abnormality, punctate bilateral, score 2 (axial 
T2). 
 
ON-LINE FIG 18. Cerebellum, signal 
abnormality, extensive unilateral, score 3 (axial 
T2). 
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4.3 Summary of Chapter 4 
This paper provides validation of a scoring system for Early structural MRI at 29-35 weeks PMA 
for infants born <31 weeks GA. Strengths of the study include the large sample with Early MRI and 
12-month motor and cognitive outcomes, which is representative of contemporaneous cohorts of 
preterm infants born <31 weeks GA. While this thesis focusses on motor outcomes, cognitive 
outcomes were included in this paper to adequately validate the scoring methodology.  
 
This study provides a number of key contributions. It is the first validated scoring system for Early 
structural MRI that includes evaluation of deep GM structures and the cerebellum. It is also the first 
validated scoring system for Early MRI that utilises regional measurements to capture the impact of 
secondary brain growth impairments following early brain injury. Associations with 12-month CA 
motor and cognitive outcomes are presented, as well as sensitivity and specificity as measures of 
diagnostic accuracy for detection of infants with later adverse motor outcomes.  
 
The present study provides detailed evaluation of the relationship between each regional brain 
measurement and PMA at time of MRI and proposes a scoring algorithm to correct for PMA at 
MRI for each measure. This is important as a method to adequately adjust for PMA at MRI in 
statistical analyses. The equations for correcting the regional measurements proposed here 
effectively standardise the PMA at MRI allowing for accurate comparison between infants. In 
addition, cut points of regional measures are based on mean and standard deviation data of the term 
reference sample, a modification to the original scale upon which this scoring system is based. A 
scoring proforma is provided to facilitate clinical and research utility of the tool. 
 
The application of this scoring system was descriptive and not interpretive. Findings were scored 
objectively without interpretation of the aetiology or likely significance of a particular finding in 
regards to outcome. The reason for this was to account for situations where the aetiology was not 
straightforward, and differences in interpretation would result in a reduction of the reliability of the 
scoring system. This makes the scoring system accessible to a wider range of clinicians, and not 
limited to only those with very extensive knowledge of radiology. Isolated findings which are 
known to be incidental findings with limited sequelae, will fall into the normal/mild range in this 
scoring system. An example of this is ON-LINE Figure 2 which shows bilateral connatal cysts, a 
common incidental finding of no clinical significance. We have amended the caption for figure 2 
to “Bilateral connatal cysts, classified as cerebral WM, cystic lesion, focal bilateral, score 2 (axial 
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T2)’, to ensure that readers do not mistake this example as cystic periventricular leukomalacia, 
which carries a much more significant risk of adverse outcomes.  
 
Limitations of the study include the relatively low sensitivity of the scoring system to predict motor 
and cognitive outcomes. The specificity of the scoring system is reasonable, indicating that a 
normal or mild MRI abnormality score determines which infants progress to a normal outcome, and 
there is a low risk of false positives. The sensitivity for Early MRI to predict cognitive outcomes 
presented here is still higher than that of the most widely used qualitative MRI scoring system at 
TEA (50% vs 41%) 6. The fundamental reality is that brain macrostructure evaluated qualitatively 
for evidence of injury and/or growth impairment, incorrectly classifies a number of infants. Some 
infants with quite severe brain lesions, especially enlarged ventricles, go on to have reasonable 
motor and cognitive outcomes, while others with qualitatively ‘normal’ brains continue on to 
display poor outcomes. This is one of the reasons that advanced diffusion MRI is gaining traction in 
an attempt to determine if brain microstructure can address this challenge and improve diagnostic 
accuracy. Interestingly, sensitivity is higher at Early MRI than Term MRI, while specificity is 
slightly higher at Term rather than Early MRI in the present study. Despite these limitations, the 
potential to identify high risk infants prior to discharge from the NICU and reduce the burden to 
families of having to return to an advanced medical centre for neuroimaging is not to be 
underestimated. It would enable planning of follow-up care and implementation of targeted, early 
interventions to optimise outcomes for these vulnerable infants and their families. If false positives 
do occur, it will result in increased follow up and care. This situation is preferable to a loss of 
follow up that may occur from families failing to return for an MRI at TEA and thereby never being 
identified at higher risk of adverse outcomes. 
 
Following validation of the scoring system for use at Early MRI (29-35 weeks PMA), the next step 
taken was to examine the relationships between MRI scores and concurrent clinical measures at 
Early and Term MRI to address Aim 3 of the thesis. 
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Chapter 5: Relationship between very early brain structure and neuromotor, 
neurological and neurobehavioral function in infants born <31 weeks 
gestational age 
5.1 Introduction to Chapter 5 
To examine the relationships between the structural MRI scores and concurrent clinical measures of 
motor, neurological and neurobehavioural performance, cross-sectional analysis was conducted 
with Early MRI and the clinical measures conducted within a week of the Early MRI. This was then 
repeated for the Term MRI and concurrent clinical assessments. The results are presented in the 
following paper. 
5.2 Paper 4:  
This manuscript has been submitted to the journal Early Human Development (journal impact factor 
1.913). 
 
George JM, Fiori S, Fripp J, Pannek K, Guzzetta A, David M, Ware RS, Rose SE, Colditz PB, 
Boyd RN. Relationship between very early brain structure and neuromotor, neurological and 
neurobehavioral function in infants born <31 weeks gestational age.  
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Relationship between very early brain structure and neuromotor, neurological and 
neurobehavioral function in infants born <31 weeks gestational age 
George JM, Fiori S, Fripp J, Pannek K, Guzzetta A, David M, Ware RS, Rose SE, Colditz PB, 
Boyd RN 
 
Abstract  
Aim This study aimed to examine associations between structural MRI and concurrent motor, 
neurological and neurobehavioural measures at 30-32 weeks postmenstrual age (PMA; ‘Early’), and 
at term equivalent age (‘Term’). 
Method In this prospective cohort study, infants underwent Early MRI (n=119; 73 male; median 
32weeks 1 day PMA) and Term MRI (n=102; 61 male; median 40 weeks 4 days PMA) at 3T. 
Structural images were scored generating white matter (WM), cortical gray matter, deep gray 
matter, cerebellar and global brain abnormality scores. Clinical measures were General Movements 
Assessment (GMs), Hammersmith Neonatal Neurological Examination (HNNE) and NICU 
Neonatal Neurobehavioral Scale (NNNS). The Premie-Neuro was administered Early and the Test 
of Infant Motor Performance (TIMP) and a visual assessment at Term.  
Results Early MRI cerebellar scores were strongly associated with neurological components of 
HNNE (reflexes), NNNS (Hypertonicity), the Premie-Neuro neurological subscale (regression 
coefficient β=-0.06; 95% confidence interval CI=-0.09, -0.04; p<0.001) and cramped-synchronized 
GMs (β=1.10; 95%CI=0.57, 1.63; p<0.001). Term MRI WM and global scores were strongly 
associated with the TIMP (WM β=-1.02; 95%CI=-1.67, -0.36; p=0.002; global β=-1.59; 95%CI=-
2.62, -0.56; p=0.001).  
Interpretation Brain structure on Early and Term MRI was associated with concurrent motor, 
neurological and neurobehavioral function in very preterm infants.  
 
What this paper adds  
Structure-function relationships exist between MRI abnormality scores and concurrent clinical 
measures at both Early and Term MRI.  
At Early MRI, cerebellar subscale scores have the strongest associations with clinical measures. 
Early MRI cerebellar scores relate to neurological and motor rather than neurobehavioural items.  
At Term MRI, the strongest associations were with motor performance on the TIMP.  
WM abnormality scores are related to motor and neurological performance at Term but not at Early 
MRI. 
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Infants born very preterm are at high risk of impaired motor, cognitive, language and behavioral 
function which are the result of early brain injury and impaired brain development. Brain imaging 
such as magnetic resonance imaging (MRI) and clinical evaluation (motor, neurological or 
neurobehavioural function) are different techniques to identify structural and functional markers of 
brain injury and development. Both methods are used to predict outcomes, target interventions and 
counsel and support families1-4. Relationships between these brain structure and function methods 
have been demonstrated at term equivalent age (TEA) in very preterm infants5-7. Although MRI is 
now more frequently acquired earlier than TEA, there is little information yet on structure-function 
relationships at this earlier stage. Availability of clinical correlates for this early structural MRI 
would support clinicians working without access to MRI, and guide selection of clinical measures 
to discriminate between infants with structural brain abnormalities and those without. 
 
At TEA, structure-function relationships have been demonstrated between qualitative structural 
MRI scoring systems and clinical measures of motor (General Movements Assessment, GMs), 
neurological (Hammersmith Neonatal Neurological Examination, HNNE) and neurobehavioural 
function (NICU Network Neurobehavioral Scale, NNNS)5-8. The MRI scoring systems utilized in 
these studies evaluate white matter (WM) and cortical gray matter (GM) for evidence of injury. 
Cerebral WM abnormalities, the predominant pattern of brain injury in very preterm infants, are 
associated with poorer neurological and neurobehavioral scores at TEA5-7. Earlier MRI studies with 
qualitative scoring of structural images demonstrate associations with later neurodevelopmental 
outcomes 9-11; however concurrent functional correlates have not yet been demonstrated. 
 
Scoring systems of structural MRI at TEA have been further developed to include evaluation of 
deep GM structures and the cerebellum, and include regional measurements to capture the effect of 
impaired brain growth12. Validated for use from 36-42 weeks postmenstrual age (PMA), the scale 
demonstrates associations with gestational age (GA) at birth, birthweight, a number of clinical risk 
factors and neonatal infection12, 13. No concurrent motor, neurological or neurobehavioural 
correlates have been published for this scoring system at TEA. This scoring system, which includes 
evaluation of deep GM and the cerebellum as well as incorporating regional measurements, has 
recently been adapted and validated for use from 29-35 weeks PMA in very preterm infants11. 
These comprehensive scoring systems of structural MRI provide new biomarkers of brain injury 
and development in preterm infants.  
 
The aim of this study was to examine the structure-function relationships between structural MRI 
brain abnormality scores and concurrent clinical measures of neuromotor, neurological and 
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neurobehavioral performance at 30-32 weeks PMA (‘Early’ MRI) and again at 40-42 weeks PMA 
(‘Term’ MRI). A secondary aim was to evaluate which clinical measures demonstrated the strongest 
association with a) Early MRI and b) Term MRI.  
 
Method  
Study Design and Participants 
This prospective cohort study enrolled infants born <31 weeks GA at the specialist tertiary neonatal 
center at the Royal Brisbane and Women’s Hospital between February 2013 and February 2016. 
Infants were eligible if their parents/carers lived within a 200 km radius of the hospital and were 
English speaking. Infants with known congenital or chromosomal abnormalities likely to affect 
their neurodevelopmental outcome were excluded. Informed parental consent was obtained for all 
participants. This study is nested within a broader study, and sample size calculations are detailed in 
the study protocol14. Ethical approval was obtained from the RBWH Human Research Ethics 
Committee (HREC/12/QRBW/245), The University of Queensland (2012001060) and the trial was 
registered with the Australian New Zealand Clinical Trials Registry (ACTRN12613000280707).  
 
MRI Acquisition  
Brain MRI was performed between 30-32 weeks PMA or when the infant was medically stable 
(‘Early’), and again at 40-42 weeks PMA (‘Term’). Infants were scanned utilizing an MR 
compatible incubator equipped with a dedicated neonatal head coil (LMT Lammers Medical 
Technology, Lübeck, Germany). MRI was performed during natural sleep without sedation, and 
with ear protection to attenuate noise. A 3T MRI Siemens Tim Trio (Erlangen, Germany) scanner 
was used. Coronal, axial, and sagittal T2-weighted HASTE (TR/TE 2000/90ms, flip angle 150°, 
field of view 200x160mm, matrix 320x256, slice thickness 4mm) were acquired as they are more 
resilient to motion artefacts . Axial T1 TSE (TR/TE 1490/90ms, flip angle 150°, field of view 
200x160mm, matrix 256x180, slice thickness 2mm) and an axial multi-echo T2 TSE 
(TR/TE1/TE2/TE3 10580/27/122/189ms, flip angle 150°, field of view 144x180mm, matrix 
204x256, slice thickness 2mm) were acquired. 
 
MRI Scoring 
A standardized MRI scoring system was used to score all MRIs by an independent neurologist with 
training in radiology (SF)11, 12. The scorer was blinded to birth and medical history, cranial 
ultrasound results and clinical assessment findings. Four subscale scores were generated; WM, 
cortical GM, deep GM, and the cerebellum, the total of which produced a global score11, 12. Cerebral 
WM scoring evaluates cystic degeneration, focal signal abnormalities, delayed myelination, 
Chapter 5 
 126 
thinning of the corpus callosum, dilated lateral ventricles, and reduction of WM volume. Cortical 
GM assesses signal abnormality, delayed gyration, and dilated extracerebral CSF space. Signal 
abnormality and volume reduction of the deep GM and cerebellum are evaluated and scored. Both 
T1 and T2 images were evaluated during scoring. T1 hyperintensities and T2 hypointensities were 
both recorded and considered as signal abnormalities. Sagittal T2 weighted images were used to 
score the corpus callosum as it is clearly visualized as low signal intensity prior to myelination. 
Inter- and intra-rater reproducibility of the scale have been demonstrated11, 12.  
 
Clinical Measures 
Clinical assessments were completed within a week of MRI. Tools were combined to reduce 
handling of the infant. At Early assessment the GMs, HNNE, NNNS and the Premie-Neuro were 
conducted and assessments were modified with items inappropriate for administration removed. At 
TEA, all assessments were completed in full (GMs, NNNS, HNNE, the Test of Infant Motor 
Performance TIMP, and a visual assessment). Clinical assessors were blinded to birth history and 
brain imaging findings. 
  
The GMs evaluates neuromotor performance through observation of spontaneous movements and 
good predictive validity has been reported. Sensitivity in the preterm period and at TEA is 75-
100%, with higher sensitivity for an outcome of cerebral palsy (CP) than general developmental 
outcomes; specificity ranges from 40-48%15, 16. Scoring was performed by advanced GMs raters JG 
and BS, with BS additionally blinded to other clinical assessment findings. Cases of non-agreement 
were reviewed until consensus was reached and advice sought from a third rater (blinded to all 
clinical and imaging information except PMA at assessment) where necessary.  
 
The HNNE is a neurological assessment evaluating posture, tone, reflexes, spontaneous 
movements, orientation and behaviour17. All items except placing were administered at the Early 
assessment. When performed in the preterm period, reported sensitivity and specificity for 
predicting an outcome of CP are 57-86% and 45-83% respectively, increasing to 68-96% and 52-
97% respectively when administered at TEA18. Inter-rater reliability between the clinical assessor 
(JG) and an observer (PC) for the HNNE total optimality score was tested with the intra-class 
correlation coefficient calculated to be 0.94 Early, and 0.99 at Term.  
 
The NNNS is a neurobehavioral assessment that evaluates an infant’s response to stimuli and 
handling, state regulation, motor performance and neurological status19. For administration at Early 
assessment, a number of items were removed which resulted in availability of summary scores in 10 
Chapter 5 
 127 
of the 13 domains of the test. The NNNS at TEA has been shown to predict motor and cognitive 
outcomes at 18 months corrected age (CA), motor outcomes at 24 months CA and cognitive 
outcomes at 4.5 years20-22. Cerebral abnormalities correlated with poorer NNNS scores at TEA5. 
The test administrators (JG and KM) are accredited on the NNNS.The Premie-Neuro (PN) is a 
neurological examination designed for use from 23-37 weeks PMA in preterm infants23. It could be 
scored from the combination of the other Early assessments with the addition of only a single item. 
The PN consists of 3 categories; neurological, movement and responsiveness, and has scoring based 
on expected performance at each week of PMA23. 
 
At TEA, a visual assessment developed by Ricci et al was used to examine visual function by 
testing ocular motility, acuity and the ability to fix and follow24. Visual function demonstrates 
predictive validity for neurodevelopmental outcomes in preterm cohorts25. The TIMP was 
introduced as a standardized assessment of gross motor development. Construct validity enabling 
discrimination between infants at high and low risk of adverse motor outcomes has been 
demonstrated26. Sensitivity for prediction of school age motor outcomes has been reported at 50%, 
and specificity of 100%27. 
 
Statistical Analysis 
Associations between each MRI subscale and global score and each concurrent clinical measure 
were evaluated using linear regression. This was performed separately for the Early and Term MRI 
data and the respective concurrent clinical data. Univariable analysis was performed, followed by 
multivariable analysis adjusting for GA at birth, sex and a measure of social risk14, 28. Results are 
presented as regression coefficients with 95% confidence intervals and the level of significance was 
set at 5%. There was no imputation for missing data and appropriateness of regression models was 
assessed using standard diagnostic tests. Analysis was performed using the Stata statistical software 
package, version 14 (StataCorp, College Station, TX, USA). 
 
Results  
Of 323 eligible preterm infants, 146 consented to the current study and 119 infants had Early MRI 
and clinical assessments completed and were included in this analysis (7 became medically 
unstable, 1 died, 7 cancelled due to MRI equipment failures, 7 MRI slots unavailable, 1 withdrew, 2 
had an MRI-incompatible surgical clip and 2 unsuccessful MRIs due to movement artefact). Of 
these, 102/119 infants also had MRI and clinical data available at Term (10 failed to attend, 4 had 
clinical assessment but no MRI - 2 MRI’s cancelled due to technical equipment difficulties, 1 
declined Term MRI, 1 hospitalized remotely at Term; 3 excluded as PMA at MRI>42 weeks). 
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Statistical analysis of the birth and maternal characteristics of the 17 infants without a term MRI 
compared with the 102 with a term MRI, revealed no significant differences except for social risk. 
A higher social risk has been demonstrated to be associated with poorer neurodevelopmental 
outcomes and an increased risk of cerebral palsy28, 29, and so all multivariable analyses included 
social risk as a covariate. Demographic and perinatal details of the included cohort are summarized 
in Table 1; MRI and clinical assessment scores are presented in Table 2.  
 
Early MRI structure-function relationships  
Results of multivariable regression analyses between Early MRI and concurrent clinical measures 
are presented in Table 3; results of univariable analyses are presented in Supplementary Table 1. 
Strongest associations were between cerebellar scores and HNNE Reflexes (β=-0.17; 95%CI=-0.30, 
-0.05; p=0.006), NNNS Hypertonicity (β=0.49; 95%CI=0.18, 0.80; p=0.002), Premie-Neuro 
Neurological subscale (β=-0.06; 95%CI=-0.09, -0.04; p<0.001) and cramped-synchronized GMs 
(β=1.10; 95%CI=0.57, 1.63; p<0.001). Cortical GM scores were associated with the HNNE 
subscales of Posture and Tone (Regression coefficient β=-0.11; 95% confidence interval CI=-0.19, -
0.03; p=0.008) and Tone Patterns and the NNNS subscales of Regulation and Hypotonicity. Deep 
GM was associated with Stress on the NNNS. 
 
Term MRI structure-function relationships  
Results of multivariable regression analyses between Term MRI and concurrent clinical measures 
are presented in Table 4; results of univariable analyses are presented in Supplementary Table 2. 
White matter was associated with the TIMP (β=-1.04; 95%CI=-1.71, -0.38; p=0.002), HNNE 
Abnormal Signs and NNNS Hypertonicity. Cortical GM was associated with HNNE Tone patterns 
and Orientation and Behavior. Deep GM was associated with the TIMP and HNNE Orientation and 
Behavior. Cerebellar scores were associated with HNNE Posture and Tone and NNNS Hyper- and 
Hypotonicity. Global scores were associated with the TIMP (β=-1.62; 95%CI=-2.66, -0.58; 
p=0.003), HNNE abnormal signs and NNNS Hypertonicity. No associations were found between 
any MRI subscale scores and the GMs or visual scores. 
 
Discussion  
This study is, to our knowledge, the first to present structure-function relationships between Early 
structural MRI and concurrent clinical measures of motor, neurological and neurobehavioral 
function in infants born very preterm. It is also the first study with clinical correlates of a structural 
Early MRI scoring system that includes evaluation of deep GM and the cerebellum. Of the Early 
MRI subscale scores, the cerebellar scores were most strongly associated with clinical measures. 
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Neurological and motor items were the predominant functional correlates found for the Early 
cerebellar scores. These findings contribute to a growing body of evidence of the vital role of the 
cerebellum in early neurodevelopment30. The fact that cerebellar abnormality is associated with 
neurological test items demonstrates the likely important role of the cerebellum in mediating 
neurological function during this critical period of development. To our knowledge, these are the 
first direct functional correlates of Early cerebellar structural abnormality. It is pertinent to interpret 
these findings with caution; further follow up is necessary to determine if the structure-function 
relationships presented here are maintained as infants get older, and whether they represent 
clinically important differences related to longer term outcomes. 
 
Cerebellar scores in the scoring system employed here consist of evaluation of signal abnormality 
and volume reduction11, 12. Between Early and Term MRI a small proportion of signal abnormalities 
resolved (n=3), while volume reduction remained stable at 17%. The rate of cerebellar development 
surpasses most other structures between 24-40 weeks PMA and it is of interest that cerebellar 
volume reduction was already present at Early MRI in 17% of our cohort31.  
 
The lack of associations between Early WM scores and clinical measures is of particular interest. In 
contrast, the majority of Term MRI studies have found WM abnormalities to correlate with 
concurrent clinical presentations and predict later neurodevelopmental outcomes5, 6, 32. The present 
study confirms this with significant associations found between Term WM scores and motor 
function on the TIMP, as well as neurological features on the HNNE (Abnormal Signs) and NNNS 
(Hypertonicity). As research is moving from qualitative evaluation of structural MRI to more 
advanced diffusion and volumetric imaging, the focus has remained on WM injury, development 
and maturation. The data presented here supports inclusion of the cerebellum and deep gray matter 
in Early MRI studies30. 
 
Cortical GM scores at Early MRI demonstrate associations with the neurological elements of 
posture, tone and hypotonicity and the neurobehavioural feature of regulation. It must be noted that 
this subscale has the lowest reliability of the MRI subscales and so these relationships should be 
interpreted with caution11. 
 
At Term MRI, structure-function relationships were found for all MRI subscale scores. Of the 
subscales, WM and global scores demonstrated the strongest associations with clinical measures, 
predominantly with the TIMP which is a motor assessment tool. Term WM abnormality has been 
demonstrated to be significantly associated with motor performance on the TIMP at 10-15 weeks 
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CA33. We have demonstrated that these associations are present concurrently at TEA. Term MRI 
cerebellar scores were associated with neurological test items (HNNE Posture and Tone; NNNS 
Hyper- and Hypotonicity).  
 
The secondary aim of this study was to evaluate which of the clinical measures demonstrated the 
strongest relationships with Early and Term MRI scores. At Early MRI, no single clinical tool 
showed substantial associations with MRI scores, although the Premie-Neuro neurological subscale 
and cramped-synchronized GMs demonstrated strong associations with cerebellar scores (p<0.001). 
At Term, the TIMP demonstrated the strongest associations of the tools with MRI. Follow up is 
required to determine if use of these clinical measures afford meaningful contributions to clinical 
practice. 
 
A large number of statistical comparisons were undertaken in this study. All were based on robust 
hypotheses that clinical presentations of motor, neurological or neurobehavioural performance 
would be correlated with structural brain abnormalities measured by this comprehensive structural 
MRI scoring system. Analyses are exploratory in an area where very little published data exist, and 
so no correction for multiple comparisons was performed to ensure that all significant associations 
were identified. While it is pertinent to remain cautious about these findings, biological plausibility 
is suggested by the consistency with which similar items from different clinical measures were 
found to demonstrate significant associations with the MRI scores, for example neurological items 
from different clinical tests with both Early and Term MRI cerebellar scores. We have been careful 
to emphasize only the strongest associations throughout the results and discussion of this paper 
(p<0.01). Ultimately, replication of the study is required to determine if these findings are 
reproducible in other cohorts of preterm infants. 
 
Strengths of the current study include the large sample of Early MRI data coupled with concurrent 
clinical data of infants born very preterm, in a contemporaneous study cohort with blinded clinical 
and MRI assessment. Limitations of the study include the relatively wide age range at Early MRI. 
The study protocol set the window for MRI at 30-32 weeks PMA, with sicker and more fragile 
infants undergoing MRI once they became medically stable and up to a maximum PMA of 36 
weeks. This ensured that sicker infants were included in the sample, which was necessary for our 
results to be generalizable to other populations of very preterm infants. The MRI scoring system has 
been rigorously designed to account for brain changes in size and volume that are the result of 
variable PMA at MRI, thereby minimizing potential scoring bias due to PMA at MRI11. Another 
potential limitation is our use of an established scoring system for structural images rather than 
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more complex volumetric or diffusion based systems. This is a clinically accessible MRI scoring 
system to examine associations that may be present with clinical bedside measures and is an 
important first step in understanding Early MRI data. It is less resource-intensive and more readily 
clinically available than advanced MRI measures. It also enables classification of all MRI’s in a 
cohort whereas advanced diffusion imaging frequently excludes participant MRI’s due to artefact. 
Further evidence of clinical utility is required of both the early MRI scoring system employed in 
this study, and the concurrent clinical measures, to determine the extent to which these findings 
may contribute to clinical patient care. Our MRI acquisition techniques used a slice thickness of 
4mm which may be a potential limitation, as some subtle abnormalities may have been missed. As 
this is a qualitative scoring system, we anticipate that the majority of injuries were detected and 
scored appropriately. Gradient echo techniques have been shown to be superior to conventional 
techniques in detection of cerebellar abnormalities. The T1 gradient echo sequence is very 
disruptive to the infant, often waking them up, although we did try to acquire the sequence at the 
end of the scan. The scorer (SF), in each case, selected the most appropriate image (whether T1 or 
T2) that best showed the underlying pathology for scoring.  We recognize that an important future 
step is to report the longer term outcomes of this cohort. Cognitive and motor outcomes to 12 
months CA for a subset of the present cohort are available and longer term follow up is underway11. 
Future work will investigate the relationship between volumetric, cortical thickness and cortical 
folding measures and the clinical assessments. 
 
Conclusion  
Structure-function relationships exist between structural MRI and concurrent clinical measures of 
motor, neurological and neurobehavioural function both Early and at Term in infants born preterm. 
At Early MRI, cerebellar subscale scores have the strongest associations with clinical measures. 
Early MRI cerebellar scores relate to neurological and motor rather than neurobehavioural items. At 
Term MRI, the strongest associations were with motor performance on the TIMP. White matter 
abnormality scores are related to motor and neurological performance at Term but not at Early MRI. 
These findings are an important contribution to the understanding of very early brain structure-
function relationships in preterm infants.  
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Table 1: Characteristics of the study sample included in paper 4  
 
 Sample with Early MRI 
n=119 
Sample with additional 
Term MRI n=102 
Birth and Maternal Data  n (%), Median [25th-75th centiles] or Mean (SD), range 
Gestational age at birth (weeks-
w, days-d) 
28w3d [26w6d-29w3d], 
range 23w1d – 30w6d 
28w5d [26w5d-29w4d], 
range 23w6d – 30w6d 
Birth weight (g) 1093 (321), 
range 494 – 1886 
1079 (329), 
range 494 – 1886 
Birth head circumference (cm) 25.77 (2.36), n=114 25.68 (2.43), n=98 
Males 73 (61%) 61 (60%) 
Multiple births 36 (30%) 29 (28%) 
Premature rupture of membranes 27 (23%) 21 (21%) 
Caesarian section 84 (71%) 75 (74%) 
Chorioamnionitis 18 (15%) 16 (16%) 
Antenatal steroids 83 (70%) 72 (71%) 
Magnesium sulphate 63 (64%), n=98 56 (66%), n=85 
Higher social risk 58 (49%), n=117 46 (45%) 
Acquired medical factors From birth to Early MRI From birth to Term MRI 
Patent ductus arteriosus 59 (50%) 54 (53%) 
Any intraventricular hemorrhage  30 (25%) 26 (25%) 
Intraventricular hemorrhage 
grade III or IV 
8 (7%) 8 (8%) 
Periventricular leukomalacia 4 (3%) 4 (4%) 
Hydrocephalus 4*(3%) 4 (4%) 
Seizures treated with 
anticonvulsant therapy 
1 (1%) 1 (1%) 
NEC diagnosed or suspected 5 (4%) 4 (4%) 
Confirmed sepsis 5 (4%) 4 (4%) 
Total parenteral nutrition (days)  11 [7–14], range 0 – 36 11 [9-15], range 0-36 
Postnatal corticosteroids 20 (17%) 19 (19%) 
Ventilation (days) 2 [0–10], range 0 – 50 2 [0–15], range 0 – 50 
CPAP (days) 14 [7–25], range 0 – 47 26 [7–47], range 0 – 81 
Oxygen therapy (hours) 37 [2–210], 
Range 0 – 1515, n=105 
63 [3–543], 
range 0 – 3912, n=92 
Bronchopulmonary dysplasia#  32 (31%) 
PMA at MRI (weeks-w, days-d) 32w1d (1w3d), 
range 29w3d – 35w2d 
40w4d (1w), 
range 38w3d – 42w5d 
Weight at MRI (g) 1500 (340), 
range 858-2715 
3019 (510), 
range 1900 – 4300 
PMA at clinical assessment 
(weeks-w, days-d) 
32w3d (1w3d), 
range 29w4d – 36w3d 
40w6d (1w1d), 
range 38w4d – 44w1d 
Key: PMA postmenstrual age; NEC necrotizing enterocolitis; CPAP continuous positive airway 
pressure; #defined as oxygen requirement at 36 weeks; *All 4 infants with hydrocephalus also had IVH 
grade III/IV. 
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Table 2: Summary of MRI and clinical scores for the sample included in paper 4  
 
 Preterm sample with 
Early MRI 
n=119 
Preterm sample with 
additional Term MRI 
N=102 
MRI Scores median [25th-
75th centiles] 
  
WM  3 [2-5] 2 [1-3] 
Cortical GM  0 [0-1] 0 [0-1] 
Deep GM  0 [0-1] 0 [0-1] 
Cerebellum  0 [0-0] 0 [0-1] 
Global  4 [3-7] 3 [1-5] 
GMs n (%)  n=97 
Normal 39 (33%) 31 (32%) 
Poor Repertoire 72 (61%) 57 (59%) 
Cramped Synchronized 8 (7%) 9 (9%) 
HNNE n, mean (SD)   
Posture & Tone  n=111 3.80 (1.90) 6.85 (1.67) 
Tone Patterns  n=111 3.91 (0.78) 3.65 (0.84) 
Reflexes  n=113 2.43 (0.99) 4.18 (1.13) 
Spontaneous movements  n=110 1.04 (0.84) 2.29 (0.79) 
Abnormal signs  n=119 2.03 (0.60) 2.55 (0.53) 
Orientation & Behavior  n=118 2.96 (1.49) 5.19 (1.26) 
HNNE total score n=109 16.17 (3.73) 24.71 (3.82) 
NNNS mean (SD)  n=100 
Quality of movement  3.43 (0.61) 4.38 (0.57) 
Regulation  n=118 4.14 (0.61) 4.95 (0.63) 
Nonoptimal reflexes  6.96 (1.50) 6.61 (2.80) 
Stress/Abstinence 0.22 (0.07) 0.18 (0.07) 
Arousal  3.11 (0.57) 4.26 (0.56) 
Hypertonicity  0.12 (0.39) 0.19 (0.60) 
Hypotonicity  1.54 (1.15) 0.50 (0.72) 
Asymmetric reflexes  0.92 (0.95) 0.75 (0.98) 
Excitability  2.94 (1.71) 3.67 (1.84) 
Lethargy  8.48 (1.96) 5 (2.19) 
Premie-Neuro n, mean (SD)   
Factor 1 Neurological   31.63 (4.28)  
Factor 2 Movement  n=118 34.20 (4.57)  
Factor 3 Responsiveness  n=111 31.33 (3.54)  
Total score  n=111 97.42 (7.79)  
TIMP mean (SD)   
z-score   -0.60 (0.66) 
Visual Score; n, mean (SD)   
Total score   15.95 (6.13) 
Key: WM white matter; GM gray matter; GMs General Movements Assessment; HNNE 
Hammersmith Neonatal Neurological Examination; NNNS NICU Neonatal Neurobehavioral 
Scale; TIMP Test of Infant Motor Performance; SD standard deviation; IQR Interquartile range;  
higher scores better;  lower scores better. 
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Table 3: Multivariable regression results of relationships between Early MRI scores and concurrent clinical data (model covariates: GA at birth, sex, social 
risk). N=118 as 1 participant had no social risk data available. 
 Early MRI Scores  
 WM Cortical GM Deep GM Cerebellum Global 
GMs (n=118) ß  95%CI p ß  95%CI p ß  95%CI p ß  95%CI p ß  95%CI p 
Normal ref   ref   ref   ref   ref   
Poor Repertoire -0.17 -0.93, 0.58 0.65 0.04 -0.28, 0.36 0.82 0.12 -0.31, 0.56 0.58 0.12 -0.14, 0.38 0.35 0.11 -1.13, 1.35 0.86 
Cramped 
Synchronized 
0.37 -1.17, 1.92 0.63 -0.10 -0.76, 0.55 0.75 0.07 -0.81, 0.96 0.87 1.10 0.57, 1.63 <0.001 1.45 -1.09, 3.98 0.26 
HNNE                 
Posture & Tone n=110 0.08 -0.12, 0.28 0.44 -0.11 -0.19, -0.03 <0.01 0.03 -0.08, 0.14 0.54 -0.01 -0.08, 0.06 0.76 -0.01 -0.34, 0.32 0.95 
Tone Patterns n=110 0.09 -0.37, 0.54 0.71 0.21 0.02, 0.40 0.03 0.10 -0.16, 0.35 0.46 0.15 -0.01, 0.30 0.06 0.53 -0.20, 1.27 0.15 
Reflexes n=112 -0.08 -0.43, 0.27 0.64 -0.05 -0.20, 0.09 0.47 -0.06 -0.24, 0.12 0.49 -0.17 -0.30, -0.05 <0.01 -0.37 -0.91, 0.17 0.17 
Spontaneous 
movements n=109 
-0.27 -0.70, 0.17 0.23 -0.05 -0.23, 0.14 0.62 0.02 -0.19, 0.24 0.84 -0.05 -0.21, 0.11 0.51 -0.34 -1.01, 0.33 0.32 
Abnormal signs 0.03 -0.53, 0.59 0.92 0.04 -0.20, 0.28 0.72 0.21 -0.11, 0.52 0.20 -0.03 -0.24, 0.17 0.77 0.25 -0.67, 1.17 0.60 
Orientation & 
Behavior n=117 
0.07 -0.15, 0.30 0.51 0 -0.09, 0.10 0.99 0.10 -0.03, 0.22 0.13 0.01 -0.07, 0.09 0.81 0.18 -0.19, 0.55 0.33 
HNNE total n=108 0.01 -0.09, 0.10 0.91 -0.03 -0.07, 0.02 0.21 0.01 -0.04, 0.06 0.73 -0.02 -0.05, 0.01 0.29 -0.03 -0.18, 0.12 0.70 
NNNS                
Quality of movement -0.16 -0.72, 0.40 0.57 0.07 -0.17, 0.30 0.59 0.18 -0.14, 0.50 0.27 -0.08 -0.28, 0.13 0.46 0.01 -0.92, 0.93 0.99 
Regulation n=117 -0.31 -0.86, 0.25 0.28 -0.29 -0.52, -0.06 0.01    -0.03 -0.35, 0.30 0.85 -0.16 -0.36, 0.05 0.13 -0.78 -1.69, 0.12 0.09 
Non-optimal reflexes 0.01 -0.21, 0.24 0.90 0.06 -0.04, 0.16 0.21 -0.04 -0.17, 0.09 0.57 0.06 -0.02, 0.14 0.13 0.10 -0.27, 0.47 0.60 
Stress -1.82 -6.77, 3.14 0.47 1.02 -1.09, 3.12 0.34 -3.11 -5.89,-0.32 0.03 1.73 -0.07, 3.53 0.06 -2.18 -10.36, 5.99 0.60 
Arousal 0.00 -0.59, 0.59 0.99 0.08 -0.17, 0.33 0.54 -0.07 -0.41, 0.27 0.67 -0.16 -0.37, 0.06 0.15 -0.15 -1.12, 0.83 0.76 
Hypertonicity 0.26 -0.62, 1.14 0.56 -0.06 -0.43, 0.32 0.76 0.15 -0.36, 0.65 0.56 0.49 0.18, 0.80 <0.01 0.84 -0.60, 2.28 0.25 
Hypotonicity -0.08 -0.37, 0.22 0.60 0.13 0.01, 0.25 0.04 -0.06 -0.23, 0.11 0.49 0.01 -0.10, 0.12 0.84 0.00 -0.48, 0.49 0.99 
Asymmetric reflexes 0.05 -0.30, 0.41 0.76 0.05 -0.10, 0.20 0.53 0.18 -0.02, 0.38 0.08 -0.03 -0.16, 0.10 0.64 0.25 -0.33, 0.83 0.40 
Excitability -0.04 -0.24, 0.15 0.68 0.02 -0.06, 0.11 0.60 -0.06 -0.17, 0.05 0.27 0.01 -0.06, 0.08 0.74 -0.07 -0.39, 0.25 0.67 
Lethargy -0.02 -0.19, 0.16 0.85 0.01 -0.06, 0.09 0.77 -0.03 -0.13, 0.07 0.55 -0.03 -0.09, 0.04 0.40 -0.07 -0.36, 0.22 0.65 
Premie-Neuro                
Neurological  -0.04 -0.12, 0.04 0.36 -0.01 -0.05, 0.02 0.42 -0.01 -0.06, 0.04 0.65 -0.06 -0.09, -0.04 <0.001 -0.13 -0.265, 0.01 0.06 
Movement n=117 0.04 -0.04, 0.11 0.31 0.01 -0.02, 0.04 0.61 0.03 -0.02, 0.07 0.21 0.01 -0.02, 0.03 0.63 0.08 -0.04, 0.20 0.20 
Responsiveness n=109 -0.04 -0.14, 0.06 0.46 0.01 -0.03, 0.06 0.49 0.01 -0.05, 0.07 0.72 -0.01 -0.04, 0.03 0.63 -0.02 -0.19, 0.15 0.80 
Total n=109 -0.01 -0.05, 0.04 0.81 0 -0.02, 0.02,  0.95 0.01 -0.01, 0.04 0.40 -0.01 -0.03, 0 0.06 -0.01 -0.08, 0.06 0.80 
Key: Early MRI, 30-32 weeks postmenstrual age (range 29-35 weeks); WM, white matter; GM, gray matter; GMs, General Movements Assessment; HNNE, Hammersmith Neonatal 
Neurological Examination; NNNS, NICU Neonatal Neurobehavioral Scale; CI, confidence interval; ref, reference level. 
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Table 4: Multivariable regression results of relationships between Term MRI scores and concurrent clinical data (model covariates: GA at birth, sex, social 
risk) 
 Term MRI Scores 
 WM Cortical GM Deep GM Cerebellum Global 
GMs (n=97) ß 95%CI p ß 95%CI p ß 95%CI p ß 95%CI p ß 95%CI p 
Normal ref   ref   ref   ref   ref   
Poor Repertoire -0.39 -1.45, 0.67 0.47 -0.18 -0.57, 0.21 0.37 -0.09 -0.54, 0.37 0.71 0.10 -0.24, 0.44 0.57 -0.56 -2.23, 1.12 0.51 
Cramped 
Synchronized 
-0.76 -2.56, 1.04 0.41 0.15 -0.52, 0.82 0.66 -0.32 -1.09, 0.46 0.42 -0.02 -0.60, 0.57 0.95 -0.95 -3.79, 1.90 0.51 
HNNE                
Posture & Tone -0.01 -0.28, 0.26 0.93 -0.01 -0.11, 0.09 0.79 -0.09 -0.20, 0.03 0.14 -0.11 -0.19, -0.02 0.02 -0.22 -0.64, 0.21 0.31 
Tone Patterns 0.26 -0.27, 0.79 0.33 -0.20 -0.39, -0.01 0.04 0.10 -0.12, 0.33 0.37 -0.05 -0.22, 0.12 0.53 0.11 -0.72, 0.94 0.79 
Reflexes 0.03 -0.37, 0.43 0.88 -0.05 -0.20, 0.09 0.48 0.05 -0.13, 0.22 0.59 -0.01 -0.14, 0.12 0.86 0.01 -0.61, 0.64 0.97 
Spontaneous 
movements 
-0.09 -0.72, 0.53 0.77 -0.13 -0.36, 0.10 0.26 -0.17 -0.44, 0.09 0.20 -0.06 -0.26, 0.14 0.58 -0.45 -1.43, 0.52 0.36 
Abnormal signs -0.96 -1.80, -0.11 0.03 -0.13 -0.45, 0.19 0.43 -0.28 -0.65, 0.09 0.14 -0.19 -0.47, 0.09 0.18 -1.55 -2.87, -0.23 0.02 
Orientation & 
Behavior 
-0.18 -0.55, 0.19 0.33 -0.14 -0.27, -0.01 0.04 -0.18 -0.34, -0.03 0.02 -0.02 -0.14, 0.10 0.73 -0.52 -1.10, 0.05 0.07 
HNNE total  -0.03 -0.15, 0.09 0.64 -0.04 -0.09, 0 0.07 -0.04 -0.09, 0.01 0.13 -0.03 -0.07, 0.01 0.09 -0.14 -0.34, 0.05 0.14 
NNNS n=100                
Quality of 
movement 
-0.19 -0.99, 0.62 0.65 -0.09 -0.39, 0.21 0.54 -0.19 -0.53, 0.16 0.28 -0.07 -0.33, 0.19 0.58 -0.54 -1.80, 0.72 0.40 
Regulation -0.33 -1.07, 0.40 0.37 -0.21 -0.48, 0.06 0.12 -0.22 -0.54, 0.09 0.17 -0.07 -0.30, 0.17 0.59 -0.83 -1.98, 0.31 0.15 
Nonoptimal 
reflexes 
0 -0.17, 0.16 0.98 0.03 -0.04, 0.09 0.39 0 -0.07, 0.08 0.91 0.05 0, 0.10 0.07 0.08 -0.18, 0.34 0.56 
Stress -3.16 -9.25, 2.94 0.31 0.13 -2.14, 2.40 0.91 0.31 -2.34, 2.95 0.82 0.36 -1.62, 2.33 0.72 -2.37 -11.97, 7.24 0.63 
Arousal 0.43 -0.43, 1.30 0.32 0.21 -0.11, 0.53 0.20 -0.02 -0.40, 0.35 0.90 -0.10 -0.38, 0.18 0.48 0.52 -0.84, 1.87 0.45 
Hypertonicity 0.85 0.08, 1.63 0.03 0.16 -0.14, 0.45 0.30 0.22 -0.12, 0.56 0.21 0.26 0.01, 0.52 0.04 1.50 0.28, 2.70 0.02 
Hypotonicity 0.11 -0.51, 0.74 0.71 0.19 -0.04, 0.42 0.10 0.23 -0.04, 0.50 0.09 0.21 0.01, 0.40 0.04 0.74 -0.23, 1.72 0.13 
Asym. reflexes -0.13 -0.60, 0.33 0.57 -0.09 -0.26, 0.08 0.31 0.10 -0.10, 0.31 0.31 0 -0.15, 0.15 1 -0.12 -0.86, 0.62 0.75 
Excitability 0.11 -0.15, -0.36 0.42 0.08 -0.02, 0.17 0.12 0.02 -0.09, 0.13 0.69 -0.01 -0.10, 0.07 0.76 0.19 -0.21, 0.60 0.35 
Lethargy 0.14 -0.07, 0.35 0.20 0 -0.08, 0.08 0.94 0.03 -0.06, 0.12 0.49 -0.01 -0.08, 0.06 0.84 0.16 -0.17, 0.49 0.34 
TIMP                
z-score -1.04 -1.71, -0.38 <0.01 -0.04 -0.30, 0.21 0.74 -0.34 -0.63, -0.05 0.02 -0.20 -0.42, 0.02 0.08 -1.62 -2.66, -0.58 <0.01 
Visual n=100                
Total  0.01 -0.07, 0.08 0.85 0.01 -0.02, 0.03 0.71 -0.02 -0.05, 0.01 0.28 0.02 -0.01, 0.04 0.14 0.01 -0.11, 0.13 0.83 
Key: Term MRI, 40-42 weeks postmenstrual age (range 38-42 weeks); WM, white matter; GM, gray matter; GMs, General Movements Assessment; HNNE, Hammersmith 
Neonatal Neurological Examination; NNNS, NICU Neonatal Neurobehavioral Scale; TIMP, Test of Infant Motor Performance; CI, confidence interval; ref, reference level; asym 
asymmetric. 
Chapter 5 
 137 
Supplementary Tables 
Supplementary Table 1: Univariable regression results of the relationships between Early MRI scores and concurrent clinical data. 
 Early MRI Scores 
 WM Cortical GM Deep GM Cerebellum Global 
GMs (n=118) ß 95%CI p ß 95%CI p ß 95%CI p ß 95%CI p ß 95%CI p 
Normal ref   ref   ref   ref   ref   
Poor Repertoire -0.07 -0.80, 0.66 0.85 0.08 -0.23, 0.39 0.62 0.17 -0.25, 0.59 0.42 0.11 -0.13, 0.36 0.36 0.29 -0.92, 1.50 0.64 
Cramped 
Synchronized 
0.93 -0.50, 2.36 0.20 0.06 -0.54, 0.67 0.83 0.34 -0.48, 1.15 0.42 1.07 0.60, 1.54 <0.001 2.40 0.04, 4.76 0.05
* 
HNNE                
Posture & Tone n=111 -0.04 -0.23, 0.15 0.71 -0.12 -0.20, -0.05 <0.01 -0.01 -0.12, 0.09 0.80 -0.03 -0.09, 0.03 0.38 -0.20 -0.51, 0.11 0.21 
Tone Patterns n=111 0.12 -0.34, 0.58 0.59 0.22 0.04, 0.41 0.02 0.11 -0.15, 0.37 0.40 0.14 -0.02, 0.29 0.08 0.59 -0.17, 1.35 0.13 
Reflexes n=113 -0.16 -0.51, 0.20 0.37 -0.07 -0.22, 0.07 0.33 -0.08 -0.25, 0.10 0.40 -0.18 -0.30, -0.06 <0.01 -0.49 -1.04, 0.06 0.08 
Spontaneous 
movements n=110 
-0.39 -0.80, 0.03 0.07 -0.08 -0.25, 0.10 0.39 -0.09 -0.30, 0.12 0.40 -0.05 -0.20, 0.10 0.52 -0.60 -1.26, 0.06 0.07 
Abnormal signs  0.09 -0.48, 0.66 0.75 0.07 -0.17, 0.31 0.55 0.22 -0.10, 0.55 0.17 -0.03 -0.24, 0.17 0.74 0.36 -0.59, 1.30 0.46 
Orientation & 
Behavior n=118 
0.09 -0.14, 0.31 0.46 0 -0.09, 0.10 0.92 0.11 -0.02, 0.23 0.11 0.01 -0.07, 0.09 0.82 0.20 -0.18, 0.59 0.29 
HNNE total n=109 -0.03 -0.12, 0.07 0.55 -0.03 -0.07, 0.01 0.10 -0.01 -0.05, 0.04 0.83 -0.02 -0.05, 0.01 0.15 -0.09 -0.24, 0.06 0.24 
NNNS                
Quality of movement -0.07 -0.63, 0.50 0.81 0.09 -0.14, 0.33 0.44 0.17 -0.15, 0.49 0.29 -0.05 -0.25, 0.15 0.61 0.15 -0.79, 1.08 0.76 
Regulation n=118 -0.37 -0.94, 0.19 0.19 -0.31 -0.54, -0.08 <0.01 -0.05 -0.37, 0.27 0.75 -0.18 -0.38, 0.02 0.08 -0.91 -1.84, 0.01 0.05 
Nonoptimal reflexes 0.05 -0.18, 0.27 0.69 0.07 -0.03, 0.16 0.17 -0.03 -0.15, 0.10 0.70 0.06 -0.02, 0.14 0.15 0.15 -0.23, 0.52 0.45 
Stress -1.48 -6.53, 3.57 0.56 1.19 -0.91, 3.30 0.26 -2.90 -5.73, -
0.07 
0.04 1.68 -0.09, 3.45 0.06 -1.51 -9.92, 6.91 0.72 
Arousal 0 -0.61, 0.60 0.99 0.08 -0.17, 0.34 0.51 -0.08 -0.43, 0.26 0.63 -0.15 -0.36, 0.06 0.17 -0.15 -1.15, 0.85 0.77 
Hypertonicity 0.12 -0.74, 0.99 0.78 -0.10 -0.46, 0.26 0.59 0.15 -0.34, 0.64 0.55 0.46 0.17, 0.76 <0.01 0.63 -0.80, 2.07 0.38 
Hypotonicity -0.05 -0.35, 0.25 0.74 0.13 0.01, 0.25 0.04 -0.05 -0.22, 0.12 0.57 0.01 -0.10, 0.12 0.85 0.04 -0.46, 0.53 0.88 
Asymmetric reflexes 0.04 -0.32, 0.40 0.82 0.05 -0.10, 0.20 0.55 0.16 -0.05, 0.36 0.13 -0.04 -0.16, 0.09 0.58 0.21 -0.39, 0.80 0.49 
Excitability -0.04 -0.24, 0.16 0.66 0.02 -0.06, 0.10 0.61 -0.06 -0.17, 0.06 0.33 0.01 -0.06, 0.08 0.73 -0.07 -0.40, 0.27 0.69 
Lethargy -0.06 -0.23, 0.12 0.53 -0.01 -0.08, 0.06 0.77 -0.04 -0.14, 0.06 0.46 -0.03 -0.09, 0.03 0.35 -0.13 -0.42, 0.16 0.37 
Premie-Neuro                
Neurological  -0.07 -0.15, 0.01 0.09 -0.02 -0.06, 0.01 0.15 -0.02 -0.07, 0.02 0.37 -0.06 -0.09, -0.04 <0.001 -0.18 -0.31, 0.05 0.01 
Movement n=118 0.04 -0.04, 0.11 0.36 0.01 -0.02, 0.04 0.60 0.02 -0.02, 0.07 0.28 0.01 -0.02, 0.03 0.66 0.07 -0.05, 0.20 0.25 
Responsiveness n=111 0 -0.10, 0.10 0.98 0.02 -0.02, 0.07 0.27 0.02 -0.03, 0.08 0.40 0 -0.04, 0.03 0.89 0.04 -0.13, 0.21 0.61 
Total n=111 -0.01 -0.06, 0.04 0.66 0 -0.02, 0.02 0.84 0.01 -0.02, 0.03 0.54 -0.02 -0.03, 0 0.04 -0.02 -0.10, 0.06 0.61 
Key: Early MRI, 30-32 weeks postmenstrual age (range 29-35 weeks); WM, white matter; GM, gray matter; GMs, General Movements Assessment; HNNE, Hammersmith Neonatal 
Neurological Examination; NNNS, NICU Neonatal Neurobehavioral Scale; CI, confidence interval; ref, reference level; *p=0.047 
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Supplementary Table 2: Univariable regression results of the relationships between Term MRI scores and concurrent clinical data. 
 Term MRI Scores 
 WM Cortical GM Deep GM Cerebellum Global 
GMs (n=97) ß 95%CI p ß 95%CI p ß 95%CI p ß 95%CI p ß 95%CI p 
Normal ref   ref   ref   ref   ref   
Poor Repertoire 0.10 -0.96, 1.16 0.85 -0.12 -0.50, 0.25 0.52 0.09 -0.37, 0.55 0.69 0.20 -0.13, 0.53 0.22 0.27 -1.44, 1.97 0.76 
Cramped 
Synchronized 
0.20 -1.59, 2.00 0.82 0.31 -0.33, 0.95 0.34 0.02 -0.76, 0.81 0.96 0.15 -0.40, 0.71 0.58 0.69 -2.20, 3.58 0.64 
HNNE                
Posture & Tone -0.10 -0.37, 0.18 0.48 -0.04 -0.14, 0.06 0.47 -0.11 -0.23, 0.01 0.07 -0.11 -0.20, -0.03 <0.01 -0.36 -0.80, 0.08 0.11 
Tone Patterns 0.22 -0.33, 0.77 0.43 -0.22 -0.41, -0.03 0.03 0.07 -0.18, 0.31 0.59 -0.05 -0.22, 0.12 0.57 0.02 -0.86, 0.90 0.97 
Reflexes -0.12 -0.52, 0.29 0.57 -0.07 -0.22, 0.08 0.34 -0.01 -0.19, 0.17 0.89 -0.04 -0.17, 0.09 0.53 -0.24 -0.89, 0.41 0.47 
Spontaneous 
movements 
-0.52 -1.10, 0.06 0.08 -0.20 -0.40, 0.01 0.06 -0.33 -0.57, -0.08 0.01 -0.12 -0.30, 0.06 0.17 -1.17 -2.07, -0.26 0.01 
Abnormal signs -0.78 -1.64, 0.05 0.07 -0.05 -0.36, 0.27 0.77 -0.14 -0.52, 0.25 0.49 -0.19 -0.46, 0.08 0.17 -1.14 -2.54, 0.25 0.11 
Orientation & 
Behavior 
-0.34 -0.70, 0.02 0.06 -0.17 -0.30, -0.04 0.01 -0.23 -0.39, -0.08 <0.01 -0.05 -0.16, 0.07 0.40 -0.79 -1.36, -0.22 <0.01 
HNNE total  -0.09 -0.21, 0.03 0.13 -0.05 -0.09, -0.01 0.02 -0.06 -0.11, -0.01 0.02 -0.04 -0.08, -0.01 0.03 -0.25 -0.44, -0.06 0.01 
NNNS n=100                
Quality of 
movement 
-0.42 -1.24, 0.41 0.32 -0.12 -0.41, 0.18 0.43 -0.25 -0.60, 0.11 0.18 -0.12 -0.37, 0.13 0.35 -0.90 -2.21, 0.41 0.18 
Regulation -0.51 -1.25, 0.24 0.18 -0.21 -0.47, 0.06 0.13 -0.30 -0.62, 0.02 0.06 -0.10 -0.33, 0.13 0.40 -1.11 -2.29, 0.06 0.06 
Nonoptimal 
reflexes 
0.05 -0.12, 0.22 0.57 0.03 -0.03, 0.09 0.33 0.01 -0.06, 0.09 0.72 0.06 0.01, 0.11 0.03 0.15 -0.12, 0.42 0.27 
Stress -1.44 -7.75, 4.87 0.65 0.44 -1.83, 2.71 0.70 0.77 -1.99, 3.53 0.58 0.65 -1.29, 2.59 0.51 0.42 -9.69, 10.53 0.94 
Arousal 0.22 -0.62, 1.07 0.60 0.14 -0.17, 0.44 0.37 -0.02 -0.39, 0.36 0.93 -0.12 -0.38, 0.14 0.35 0.22 -1.14, 1.58 0.75 
Hypertonicity 0.85 0.08, 1.62 0.03 0.09 -0.20, 0.37 0.54 0.16 -0.18, 0.50 0.36 0.29 0.05, 0.52 0.02 1.39 0.15, 2.62 0.03 
Hypotonicity 0.13 -0.53, 0.78 0.70 0.20 -0.04, 0.43 0.10 0.24 -0.05, 0.52 0.10 0.21 -0.01, 0.40 0.04 0.76 -0.28, 1.80 0.15 
Asymmetric 
reflexes 
-0.18 -0.66, 0.30 0.47 -0.08 -0.26, 0.09 0.33 0.11 -0.10, 0.32 0.30 -0.02 -0.17, 0.13 0.81 -0.17 -0.94, 0.60 0.67 
Excitability 0.16 -0.09, 0.42 0.21 0.07 -0.02, 0.16 0.12 0.06 -0.05, 0.17 0.29 0 -0.08, 0.08 0.97 0.29 -0.11, 0.70 0.16 
Lethargy 0.23 0.02, 0.44 0.04 0.02 -0.05, 0.10 0.55 0.08 -0.02, 0.17 0.11 0.01 -0.06, 0.07 0.85 0.33 -0.01, 0.67 0.05 
TIMP                
z-score -1.12 -1.79, -0.46 <0.01 -0.12 -0.37, 0.13 0.34 -0.41 -0.71, -0.12 <0.01 -0.19 -0.40, 0.03 0.09 -1.85 -2.91, -0.78 <0.01 
Visual n=100                
Total  -0.02 -0.10, 0.05 0.53 0 -0.03, 0.02 0.79 -0.03 -0.07, 0 0.05 0.01 -0.01, 0.03 0.31 -0.05 -0.17, 0.07 0.43 
Key: Term MRI, 40-42 weeks postmenstrual age (range 38-42 weeks); WM, white matter; GM, gray matter; GMs, General Movements Assessment; HNNE, Hammersmith 
Neonatal Neurological Examination; NNNS, NICU Neonatal Neurobehavioral Scale; TIMP, Test of Infant Motor Performance; CI, confidence interval; ref, reference level. 
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5.3 Summary of Chapter 5 
This paper found structure-function relationships between MRI and concurrent clinical measures of 
motor, neurological and neurobehavioural function at both Early and Term MRI. At Early MRI, 
cerebellar subscale scores demonstrated the strongest associations with clinical measures. Early 
MRI cerebellar scores were related to neurological rather than neurobehavioural or motor items in 
the clinical measures. At Term MRI, the strongest associations were with the TIMP. White matter 
abnormality scores were related to motor and neurological performance at Term but not at Early 
MRI. 
 
Having determined validity and diagnostic accuracy of the Early structural MRI scoring system and 
elucidated the associations with concurrent clinical features, the next step was to examine brain 
microstructural development with MR diffusion imaging. 
 
Chapter 6 
143 
Chapter 6: Very early brain microstructure measured with MR diffusion 
imaging at 32 and 40 weeks postmenstrual age in relation to 12-month motor 
outcome in very preterm born infants 
6.1 Introduction to Chapter 6 
Qualitative evaluation of structural images demonstrates that motor and cognitive outcomes can be 
determined earlier than TEA. The structural MRI scoring system developed in this thesis is valid 
and reproducible but has limitations, which include relatively low sensitivity. Advanced diffusion 
imaging is able to quantify microstructural development, and so the next step was to evaluate 
diffusion measures of fractional anisotropy (FA) and mean diffusivity (MD) in regions known to be 
involved in motor performance and determine their associations with 12 month outcomes.  
 
Results from the systematic review in Chapter 2 guided the selection of brain regions for 
examination at Early MRI. This chapter presents results of preliminary analyses of the relationships 
between diffusion measures of FA and MD in the corpus callosum, posterior limb of the internal 
capsule (PLIC) and cerebral peduncles, with motor outcomes at 12 months corrected age. It is 
written as a manuscript so as to be consistent with previous chapters.  
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Very early brain microstructure measured with MR diffusion imaging at 32 and 40 weeks 
postmenstrual age in relation to 12-month motor outcome in very preterm born infants. 
George JM, Fripp J, Pannek K, Shen K, Ware RS, Rose SE, Colditz PB, Boyd RN 
 
Abstract  
Aim The aim of this study was to examine brain microstructure using diffusion MRI at 30-32 
weeks postmenstrual age (‘Early MRI”, PMA) and 40-42 weeks PMA (‘Term MRI’) in brain 
regions known to be associated with motor function. The relationship with motor and neurological 
outcomes at 12 months corrected age was evaluated.  
Method Infants born <31 weeks’ gestational age in this prospective cohort study underwent Early 
and Term MRI at 3T. A reference sample of healthy term-born infants underwent MRI at 40-
42weeks PMA. Brain tissue microstructure was analyzed globally and in 3 regions of interest for 
motor function defined on the JHU neonate atlas (automatic segmentation): the posterior limb of the 
internal capsule, corpus callosum and cerebral peduncle. Infants with significant structural brain 
lesions were excluded due to challenges in automated segmentation and processing. Regional 
fractional anisotropy (FA) and mean diffusivity (MD) were calculated. At 12 months corrected age, 
preterm infants were assessed with the Bayley Scales of Infant and Toddler Development 3rd edition 
(Bayley III), the Alberta Infant Motor Scale (AIMS), the Neurosensory Motor Developmental 
Assessment (NSMDA) and a structured neurological assessment by a paediatrician. Univariable and 
multivariable regression was employed to examine associations between preterm infant FA and MD 
at Early and Term MRI, and 12 month motor outcomes. Unpaired t-tests were used to compare FA 
and MD of the preterm infant Term MRI with that of the reference sample.  
Results Forty-eight preterm infants (born at median gestation 28+5 weeks, 30 male) with Early MRI 
at median 32+3weeks PMA had useable diffusion images and 12 month outcome data available. 
Sixty-five preterm infants (born at median gestation 28+4 weeks, 39 male) with Term MRI at a 
median 40+5 weeks PMA had useable diffusion images and 12 month outcome data available. 
Outcomes were assessed at a mean 12 months and 4 days corrected age. Eighteen term born infants 
made up the reference sample (median gestational age at birth of 39+2 weeks, median PMA at MRI 
41 weeks, 9 males). Early MRI FA and MD were not associated with any of the motor or 
neurological outcomes. Term MRI FA was not associated with motor or neurological outcomes. 
Term MRI MD in the corpus callosum on the left was associated with neurological outcome and 
MD in the right cerebral peduncle was associated with motor outcome on the AIMS and NSMDA. 
Corpus callosum FA and MD was significantly different between the preterm infants imaged at 
Term, and the term reference sample. 
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Interpretation Early MRI microstructure in this very preterm cohort without significant brain 
lesions was not associated with motor or neurological outcomes at 12 months corrected age. Future 
work may require manual segmentation of diffusion images in infants in this cohort who had 
significant structural brain lesions if the full representative cohort is to be included in analyses. 
 
Introduction 
Preterm infants are at risk of adverse motor outcomes including cerebral palsy and developmental 
co-ordination disorder 1. Neuroimaging has improved identification of infants at risk of adverse 
motor development and prognostication of outcomes2. Evaluation of brain macrostructure on 
structural MRI offers qualitative information of brain injury and impaired brain growth3-8. Diffusion 
MRI provides evaluation of brain tissue microstructure and is increasingly used in studies 
measuring preterm brain development9. It involves mapping the random motion of water particles in 
brain tissue, and the degree to which it is hindered and restricted by tissue microstructure 10.  
 
Quantitative diffusion measures of fractional anisotropy (degree of anisotropy, FA) and mean 
diffusivity (overall diffusivity, MD) demonstrate changes from preterm birth to term equivalent 
age11-14 and show promise for use as biomarkers to predict later motor outcomes9. Brain maturation 
results in an increased fibre density, greater fibre organisation and increased myelination of fibers in 
white matter, all of which restrict water diffusion and increase the primary directionality (i.e. 
increase FA) and decrease overall diffusivity (i.e. decrease MD)15. Diffusion MRI studies of 
preterm infants shortly after birth and again at term equivalent age show an increase in FA and a 
decrease in MD over this period11-14, 16.  
 
Diffusion MRI measures at term equivalent age are reported to be associated with poorer motor 
outcome and a diagnosis of cerebral palsy at 18-24 months corrected age (CA); reduced FA and 
increased MD in the posterior limb of the internal capsule (PLIC) 17-19, splenium 19 and the corona 
radiata 20, higher radial diffusivity in the corpus callosum, fornix, internal and external capsule 21, 22, 
and increased MD in the cerebellum 23. Earlier imaging studies report that reduced FA as early as 
30 weeks PMA has been associated with poorer motor outcomes 24-26.  
 
The aim of this study was to evaluate brain microstructure on Early and Term MRI in regions 
known to be involved in motor function, the posterior limb of the internal capsule (PLIC), corpus 
callosum and cerebral peduncle, and then to examine the association of these early microstructural 
measures with motor outcome at 12 months CA. A secondary aim was to compare preterm brain 
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microstructure in the 3 defined regions at Term MRI with a term born reference sample imaged at 
approximately 40-42 weeks PMA.  
 
Methods  
Study Design and Participants 
Recruitment was conducted at the Royal Brisbane and Women’s Hospital between February 2013 
and April 2016 as part of the PPREMO study27. Infants were eligible if they were born <31 weeks 
gestational age, without chromosomal abnormality and with English speaking families/caregivers 
who lived within a 200km radius of the hospital. A reference sample of infants born between 38-41 
weeks gestational age, with a birthweight >10th percentile following an uncomplicated pregnancy, 
delivery and postpartum period, were recruited. Informed parental consent was obtained for all 
participants. Ethical approval was obtained from the RBWH Human Research Ethics Committee 
(HREC/12/QRBW/245), The University of Queensland (2012001060) and the trial was registered 
with the Australian New Zealand Clinical Trials Registry (ACTRN12613000280707).  
 
MRI Acquisition  
Brain MRI was performed during natural sleep and without sedation at 30-32 weeks PMA (‘Early 
MRI’), or when the infant was sufficiently medically stable to allow safe transport to the MRI 
(range 29-35 weeks PMA). A second MRI was performed at 40-42 weeks PMA (‘Term MRI’). 
Infants were scanned using a 3T Siemens Tim Trio (Erlangen, Germany), utilizing a MR 
compatible incubator with dedicated neonatal head coil (LMT Lammers Medical Technology, 
Lübeck, Germany). The term born reference sample was imaged at 40-42 weeks PMA and at least 1 
week post birth. Diffusion MRI data were acquired along 64 non-collinear directions, using a b-
value of 2000 s/mm2, along with one minimally diffusion weighted image (b=0). Acquisition 
parameters were: TR/TE 9500/130 ms, flip angle 90°, field of view 224x224mm, matrix 128x128, 
47 slices, slice thickness 2 mm, iPAT 2. A field map to assist in the correction of susceptibility 
distortions was acquired using a Gradient Recalled Echo sequence. Scans with significant motion 
were repeated if time was available. 
 
Diffusion analysis  
Diffusion data were preprocessed using previously established protocols 28, 29. In brief, volumes 
containing within-volume motion artefacts were automatically detected using a registration based 
approach30, and removed from analysis. Susceptibility distortions were corrected using the field 
map, using tools available in FSL, with adjustment of signal intensities 31, 32. Head motion between 
volumes was corrected using rigid-body registration, with adjustment of the b-matrix. Signal 
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intensity outliers (e.g. due to bulk head motion or cardiac pulsation) were automatically detected 33 
and replaced in the raw image space prior to resampling 34. Intensity homogeneities were reduced 
using a bias field correction method 35. Diffusion tensors were estimated from the corrected 
diffusion data using the iteratively reweighted least squares method, and measures of FA and MD 
were calculated.  
 
A study specific brain MRI template was created separately for the Early and Term MRI time 
points. This was implemented using an in-house implementation of the Advanced Normalization 
Tools – Symmetric Normalization - Groupwise (ANTs-SyN-GW) extension of tract-based spatial 
statistics 36. It was performed independently on Early (N=78) and Term MRI data (N =90 which 
included Term MRI and term reference group data). In short, this involves the creation of a 
groupwise population specific template using the ANTS registration framework37. The importance 
of this groupwise alignment has been highlighted38, and involves the iterative groupwise 
coregistration of the images by alternating between registering each image to a shape-based mean of 
the inputs and recomputing this target as the mean over the coregistered set38. The generated 
template is usually the same resolution and voxel space as the original inputs and can be used as a 
registration target for voxel based analysis or tract-based spatial statistics. In this work we specified 
a higher resolution template space (2x) to more closely match the resolution of the JHU-SS-
neonate atlas (0.6 mm isotropic). The ANTs-SyN-GW template was non-linearly aligned with the 
Johns Hopkins University (JHU) single subject FA neonate atlas39 using ANTs (symmetric 
diffeomorphic registration37) and the atlas labels propagated onto the template. Example images of 
the FA template with JHU labelling at Early MRI is presented in Figure 1. 
 
Each infant’s diffusion images were then registered with the population template and the JHU 
labeling was resampled into the infant space after composing the transforms. White matter 
microstructure was then defined by the JHU labeling, with threshold values of MD < 0.006 mm2/s 
and FA > 0.15. The use of this threshold in WM on near term and term equivalent neonate DTI data 
is well accepted28, 40, 41 and balances the inclusion of less mature WM regions, which may better 
represent progression of development during the neonatal period, while minimizing inclusion of 
gray matter and partial volume effects. The JHU labelling was qualitatively scored (unusable, poor 
and good) with subjects with poor labelling defined as moderate mislabeling (> 10% of boundary 
with errors) along major tracts (e.g. corpus callosum, PLIC). Unusable data occurred from complete 
or significant failure of the registration; typically, this occurred in a subset of subjects with 
significant structural brain lesions. 
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Motor Outcome at 12 months CA 
At 12 months CA motor outcome was evaluated using the Bayley Scales of Infant and Toddler 
Development 3rd edition (Bayley III), the Alberta Infant Motor Scale (AIMS) and the Neurosensory 
Motor Developmental Assessment (NSMDA). The assessments were conducted by an experienced 
pediatric physiotherapist, blinded to Early and Term MRI findings and clinical history. This 
combination of motor assessments was selected because although the Bayley III is the outcome 
assessment of choice for preterm follow up studies, the motor subscale demonstrates only moderate 
predictive validity for later motor outcomes42. The AIMS is a gross motor assessment with good 
predictive validity43 and concurrent validity with the Bayley II44. The NSMDA assesses gross and 
fine motor performance as well as balance, posture, neurological performance and sensory motor 
function. At 12 months CA it demonstrates good predictive validity for school age motor and 
cognitive outcomes45 and CP at 5 years46. The AIMS and NSMDA have been recommended for use 
at 12 months CA in a clinimetric review of neuromotor measures for use in the first year following 
preterm birth47. 
 
Neurological outcome at 12 months CA 
A structured neurological assessment was conducted by a pediatrician, specialized in early infant 
development and neurological evaluation and blinded to Early and Term MRI findings. The 
neurological outcome was summarized as ‘normal’ (entirely normal neurological examination), 
‘unspecified signs’ (e.g. hypotonia, asymmetric reflexes) or ‘abnormal’ (definitely abnormal 
neurological presentation/possible cerebral palsy) [Thesis appendix 10]. 
 
Statistical Analysis 
To investigate the associations between Early FA and MD in each brain region and 12-month motor 
outcome, univariate linear regression was performed, followed by multivariate analysis adjusting 
for sex, and PMA at MRI. Corrected age at 12-month assessment was included as a covariate for 
analyses with the AIMS and NSMDA. To investigate the associations between Early MRI measures 
and neurological outcome, univariate logistic regression was performed followed by multivariate 
analysis adjusting for sex, PMA at Early MRI and corrected age at 12-month assessment. This was 
replicated to examine the associations between the Term MRI and 12-month motor and 
neurological outcomes.  Results are presented as regression coefficients with 95% confidence 
intervals and the level of significance was set at 5%. Brain microstructure in the 3 regions in 
preterm infants imaged at Term age was compared with the term reference sample using un-paired 
t-tests. Analysis was performed using the Stata statistical software package, version 14 (StataCorp, 
College Station, TX, USA). 
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Results  
Of 323 eligible preterm infants, 146 were recruited to the study. Diffusion MRI was acquired Early 
in 114 infants, and at Term in 98 infants. Early MRI with diffusion measures of sufficient quality in 
the brain regions of interest and 12 month outcome was available for 48 infants (42%); 48 (42%) 
were excluded due to motion, spikes or other artefact; 11 (10%) were excluded due to failure during 
diffusion processing and 7 (6%) were excluded due to failure of the automatic segmentation 
process. Term MRI with diffusion measures of sufficient quality in the brain regions of interest and 
12 month outcome was available for 65 infants (66%); 6 (6%) were excluded due to motion, spikes 
or other artefact; 16 (16%) were excluded due to failure during diffusion processing and 11 (11%) 
were excluded due to failure of the automatic segmentation process. Thirty-one term born infants 
were recruited as a reference sample, of whom 18 infants had diffusion data of sufficient quality for 
analysis (58%). Demographic and perinatal details are summarized in Table 1; summary data of the 
motor and neurological outcomes for the preterm infants are presented in Table 2. Detail of 
numbers of study participants with diffusion MRI acquired and reasons for exclusion from analyses 
are detailed in Table 3. Summary data of FA and MD for the specified regions are presented in 
Table 4. 
 
Associations between Early MRI microstructure and 12-month motor outcome 
Results of univariable and multivariable regression analyses between Early MRI FA and 12 month 
outcomes are presented in the coefficient plot in Figure 2. Early MRI MD and 12 month outcomes 
are presented in Figure 3. No significant associations were found between FA or MD from Early 
MRI and any of the motor or neurological outcomes at 12 months CA on either univariable or 
multivariable regression.  
 
Associations between Term MRI microstructure and 12-month motor outcome 
Results of univariable and multivariable regression analyses between Term MRI FA and 12 month 
outcomes are presented in the coefficient plot in Figure 4. Term MRI MD and 12 month outcomes 
are presented in Figure 5. Term MRI FA demonstrated no associations with motor or neurological 
outcomes on univariable or multivariable regression. A higher MD in the left corpus callosum was 
associated with poorer neurological outcome both univariably and multivariably (multivariable 
regression coefficient β=17317; 95% confidence interval CI= 884, 33750; p=0.039). Mean 
diffusivity in the right cerebral peduncle was negatively associated with the AIMS (β= -88115; 95% 
CI= -174567, -1664; p=0.046) and NSMDA (β= -44186; 95% CI= -82843, -5529; p=0.026) on 
multivariable regression. Mean diffusivity in the left cerebral peduncle demonstrated a strong 
negative association as demonstrated in Figure 5. 
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Comparison of diffusion measures for preterm and term reference group at Term MRI   
The results of comparisons between the Term MRI for the preterm group and the data of the term 
reference sample are presented in Table 5. Corpus callosum FA and MD were significantly different 
between the preterm infants and term infants at TEA. Left corpus callosum FA mean difference = -
0.040; 95%CI=-0.055, -0.025; p<0.001. Left corpus callosum MD mean difference=0.072e-03 
s/mm2; 95%CI= 0.048e-03 s/mm2, 0.100e-03 s/mm2; p<0.001. 
  
Discussion  
Diffusion measures of FA and MD at Early MRI in the corpus callosum, PLIC and cerebral 
peduncles were not associated with motor or neurological outcomes at 12 months CA in this cohort 
of infants born < 31 weeks GA. Term MRI FA in the 3 regions were also not associated with motor 
or neurological outcomes at 12 months CA. Term MRI MD in the left corpus callosum was 
associated with neurological outcome; in the right cerebral peduncle it was associated with motor 
outcome on the AIMS and NSMDA. Corpus callosum FA and MD were significantly different 
between the preterm born cohort imaged at Term compared to the term born reference group. 
 
Preterm samples at Early and Term MRI in these analyses are not representative of all infants born 
<31 weeks GA. Only 42% of Early MRI and 66% of Term MRI scans were useable in the present 
study, however this is similar to other diffusion studies in preterm infant populations40. Motion 
artefact is a challenge for all studies of diffusion MRI. In the present study, 42% of Early and 6% of 
Term MRI scans were excluded due to motion or other artefacts (Table 3). Failure of the automatic 
segmentation process occurred predominantly in cases with large structural lesions, and was 
responsible for exclusion of 6% of Early and 11% of Term data (Table 3). Exclusion of participants 
who failed the automatic segmentation process due to structural brain lesions is biasing the sample 
towards those with less or no structural brain injury. Manual segmentation of regions of interest is 
the alternative to automatic segmentation processes; however, this requires suitably skilled 
personnel and is time consuming and resource intensive. The benefit is that scans with distorted 
anatomy as a result of structural lesions can usually still be segmented and the data included in 
analyses. The exclusion of subjects with structural brain lesions in the present study renders this a 
low-risk group of very preterm infants. 
 
Fractional anisotropy and MD in the PLIC presented here are comparable with other studies of 
preterm infants with diffusion imaging around 30 weeks PMA and Term14, 39, 48. Fractional 
anisotropy increased and MD decreased from Early to Term MRI in all regions studied in this 
preterm cohort; consistent with studies of maturational changes in diffusion measures in very 
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preterm infants11, 13, 14, 16, 40. Fractional anisotropy in the corpus callosum was higher and MD was 
lower in the term reference group compared to the preterm infants imaged at Term. Differences in 
the corpus callosum FA between term and preterm infants have been established and this data 
supports previous findings22, 49, 50.  
 
This study found no association between FA in the 3 regions studied at Early or Term MRI and 
motor outcomes. There are conflicting reports of Early diffusion MRI associations with motor 
outcome in the literature. Associations between lower FA in the PLIC at 30 weeks PMA and poorer 
motor outcomes have been reported in a small study of 12 participants, with manual segmentation 
of the PLIC and inclusion of infants with an outcome of CP24. A larger study (n=157) which 
included some MRI which were performed >36 weeks PMA, found a lower FA in the corpus 
callosum, PLIC and optic radiation when the cohort was grouped by motor outcome on the Bayley 
III25. Using the same cohort, but stratifying the group into 27-29, 30-33 and 34-36 weeks PMA at 
MRI, no associations were found between FA in the corpus callosum and motor outcomes51. Once 
again, in the same cohort, lower FA in the corpus callosum genu and splenium was found to be 
associated with poorer motor outcomes, but analyses pooled the Early and Term MRI data26.  
 
Our finding of no associations between Term MRI FA and motor outcomes contrasts with other 
published data which have reported a lower FA in the PLIC associated with poorer motor 
outcomes17-19, 24. Those studies had similar inclusion criteria in terms of GA at birth, one study 
excluded infants with structural brain lesions on conventional MRI17, while the others did not 
exclude any infants with brain lesions18, 19. The key difference is that those studies all used manual 
delineation of regions of interest, not automatic segmentation as employed in the current study. 
Another difference between our sample and those published data is that none of the infants in our 
analyses had an outcome of CP, whereas their samples ranged from 5%17-6%18. 
 
An additional factor that makes Early MRI more challenging than Term MRI analyses was that 
sicker infants in the present study have their MRI at later PMA when they are medically stable for 
transport to MRI compared with stable and robust infants who are able to undergo MRI earlier. As 
FA increases rapidly with maturation between 30 and 40 weeks PMA, it is possible that FA in a 
more stable infant imaged earlier and a sick infant imaged later are similar, but if they had been 
imaged at the same PMA, the sicker infant (most at risk for subsequent poorer motor outcomes) 
may have had a lower FA. All multivariate analyses were adjusted for PMA at MRI but this may 
not be sufficient to account for these rapid changes. More detailed examination of this cohort 
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stratified by week of PMA at MRI may elucidate if this variability in PMA at MRI is clouding 
findings of lower FA being associated with poorer motor outcomes. 
 
It is possible that the threshold for ‘useable quality diffusion MRI data’ in the present study was too 
strict resulting in exclusion of too much data. Future work will investigate if the threshold can be 
relaxed by either improving post processing methods or investigating additional statistical analysis 
techniques. The effect of removal of volumes on FA and MD may be less severe with 64-direction 
HARDI data than with traditional 30-direction DTI data, because there is an increased redundancy 
of data available for fitting the diffusion tensor. Future work in the current cohort will be to perform 
manual segmentation of the cases excluded due to failure of the automatic segmentation which was 
the result of significant structural brain lesions. Examination of diffusion measures such as NODDI 
(neurite orientation dispersion and density imaging) and FOD (fibre orientation distribution) will 
also be undertaken, which may be more sensitive. 
 
Strengths of the current study include advanced diffusion imaging data acquired in 64 encoding 
directions and motor outcomes assessed using a combination of tools with good predictive validity 
(AIMs and NSMDA) in addition to the Bayley III. Limitations include an underrepresentation of 
infants with structural brain lesions and the fact that neurological status was assessed with a 
structured assessment by an experienced paediatrician, but a validated tool such as the 
Hammersmith Infant Neurological Examination which generates a continuous score might have 
been better able to detect clinically meaningful differences between infants. 
 
Conclusion  
This study found no associations between Early MRI FA or MD, and 12 month motor or 
neurological outcomes in this cohort of very preterm infants without significant structural brain 
lesions. No associations were found between Term MRI FA and 12 month outcomes; however, MD 
in the corpus callosum was associated with neurological outcome, and MD in the right cerebral 
peduncle was associated with motor outcome on the AIMS and NSMDA. Loss of data due to 
motion artefact is inevitable in diffusion MRI studies. Loss of data due to failure of automatic 
segmentation methods reduces the potential of diffusion imaging studies to answer clinically 
meaningful questions in representative populations of very preterm infants. Until automatic 
segmentation methods can handle tissue distortion from structural brain lesions, this methodology 
remains confined to studies of predominantly normative or low risk populations of preterm infants. 
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Figure 1: Early brain MRI fractional anisotropy template at 32 weeks postmenstrual age (built from 
n=78 preterm infant Early MRI). Regions of interest delineated by John Hopkins University 
labelling on (left to right) axial, sagittal and coronal images. Colours: green, right corpus callosum; 
red, left corpus callosum; pink, right posterior limb of the internal capsule (PLIC); blue, left PLIC; 
orange, right cerebral peduncle; yellow, left cerebral peduncle.  
 
 
Chapter 6 
 154 
Table 1: Characteristics of the study samples included in chapter 6  
 
 Sample with Early 
MRI n=48 
Sample with Term MRI 
n=65 
Term Reference 
Sample n=18 
Birth & Maternal Data  n(%), Median[IQR] or Mean(SD), range 
Gestational age at birth 
(weeks.days) 
28.5 [27.4-29.4], 
23.1-30.6 
28.4 [27.1-29.3], 23.1-
30.6 
39.2 [38.4-40], 38.2-
41.3 
Birth weight (g) 1152 (285), 580-
1886 
1090 (312), 524-1886 
3386 (272), 2932-
3940 
Birth head circumference 
(cm) 
26.15 (2.00), 22.50-
30.50, n=44 
25.74 (2.10), 21.50-
30.50, n=63 
34.48 (1.10), 32.50-
36.40, n=17 
Males 30 (63%) 39 (60%) 9 (50%) 
Multiple births 12 (25%) 19 (29%) 0 
Premature rupture of 
membranes 
10 (21%) 14 (22%) 
1 (6%), n=17 
Caesarian section 33 (69%) 49 (75%) 5 (29%), n=17 
Chorioamnionitis 4 (8%) 10 (15%)  
Antenatal steroids 35 (73%) 49(75%)  
Magnesium sulphate 25 (52%), n=39 37 (57%), n=57  
Higher social risk 19 (40%) 25 (38%) 2 (11%) 
    
Acquired medical 
factors 
From birth to Early 
MRI 
From birth to Term 
MRI 
 
Patent ductus arteriosus 21 (44%) 36 (55%)  
IVH any grade 11 (23%) 7 (11%)  
IVH grade 3 or 4 4 (8%) 3 (5%)  
Periventricular 
leukomalacia 
1 (2%) 1 (2%) 
 
Hydrocephalus 0 0  
NEC diagnosed or 
suspected 
2 (4%) 1 (2%) 
 
Confirmed sepsis 2 (4%) 3 (5%)  
Total parenteral nutrition 
(days)  
11.5 [6.5-14.5], 0-30 11 [9-14], 0-36 
 
Postnatal corticosteroids 6 (13%) 9 (14%)  
Ventilation (days) 2 [0-5.5], 0-50 2 [0-7], 0-50  
CPAP (days) 14.5 [6.5-24], 0-47 15 [7-22], 1-47  
Oxygen therapy (hours) 12 [2-82], 0-1515, 
n=45 
33.5 [2-127], 0-1264, 
n=56 
 
O2at 36 weeks PMA 8 (17%) 16 (25%)  
PMA at MRI 
(weeks.days) 
32.3 [31.2-33.2], 
30.2-35 
40.5 [40-41.3], 38.3-42.5 
41 [40.1-41.2], 39.2-
42.4 
Weight at MRI (g) 1545 [1308-1729], 
1023-2715 
3000 [2700-3375], 1900-
4114 
3400 [3100-3600], 
2810-3880 
Key: Early MRI, 29-35 weeks PMA; Term MRI, approximately 40-42 weeks PMA; PMA, 
postmenstrual age; IVH, Intraventricular hemorrhage; NEC, necrotizing enterocolitis; CPAP, 
continuous positive airway pressure. 
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Table 2: Summary of motor and neurological outcome data for the preterm group included in 
chapter 6 
 
 Sample with Early MRI n=48 Sample with Term MRI n=65 
Bayley III motor composite  100 [92.5-110], 67-127 97 [88-110], 52-127 
AIMS total  53 [52-53.5], 31-58 53 [51-53], 16-58 
NSMDA total  186 [178.5-191], 146-199 185 [174-190], 117-199 
Neurological outcome:   
 Normal 32 (70%) 45 (74%) 
 Unspecified signs 12 (26%) 16 (26%) 
 Definitely abnormal 2 (4%) 0 
Key: Early MRI, 29-35 weeks PMA; Term MRI, approximately 40-42 weeks PMA; Bayley III 
Bayley Scales of Infant and Toddler Development Version III, AIMS Alberta Infant Motor Scale, 
NSMDA Neurosensory Motor Developmental Assessment. 
 
Table 3: MRI acquisition numbers and reasons for exclusion from analyses in chapter 6 
 
 Early MRI Term MRI 
Diffusion MRI acquired 114 98 
Useable diffusion data and 12 month outcomes and included in 
analyses 
48 (42%) 65 (66%) 
Excluded due to motion (>10% of volumes), spikes or other artefact 48 (42%) 6 (6%) 
Excluded due to failure of post-processing diffusion modelling  11 (10%) 16 (16%) 
Excluded due to failure of automatic segmentation  7 (6%) 11 (11%) 
Key: Early MRI, 29-35 weeks PMA; Term MRI, approximately 40-42 weeks PMA 
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Table 4: Summary of FA and MD in corpus callosum, PLIC and cerebral peduncles for infants 
included in chapter 6 
 
 Preterm group Early 
MRI n=48 
Preterm group Term 
MRI n=65 
Term reference group 
n=18 
 Fractional Anisotropy 
Region Mean SD Mean SD Mean SD 
Global 0.214 0.005 0.230 0.006 0.237 0.006 
Corpus Callosum L  0.299 0.018 0.350 0.029 0.390 0.024 
Corpus Callosum R  0.299 0.019 0.345 0.029 0.390 0.022 
PLIC L 0.354 0.022 0.433 0.022 0.426 0.016 
PLIC R 0.357 0.020 0.429 0.021 0.425 0.016 
Cerebral peduncle L 0.301 0.018 0.374 0.023 0.376 0.017 
Cerebral peduncle R 0.307 0.020 0.374 0.024 0.380 0.014 
 Mean Diffusivity (×10E-3 s/mm2) 
 Mean SD Mean SD Mean SD 
Global 1.296 0.023 1.232 0.034 1.202 0.039 
Corpus Callosum L 1.409 0.035 1.347 0.042 1.275 0.056 
Corpus Callosum R 1.416 0.036 1.360 0.046 1.297 0.051 
PLIC L 1.118 0.040 0.956 0.031 0.964 0.027 
PLIC R 1.122 0.042 0.971 0.035 0.968 0.025 
Cerebral peduncle L 1.137 0.032 1.071 0.049 1.051 0.032 
Cerebral peduncle R 1.144 0.036 1.080 0.048 1.059 0.030 
Key: Early MRI, 29-35 weeks PMA; Term MRI, approximately 40-42 weeks PMA; L left; PLIC 
posterior limb of the internal capsule; R right; SD standard deviation 
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Figure 2: Coefficient plots of Early MRI fractional anisotropy and 12 month motor outcomes. Solid 
lines represent univariable analyses; dashed lines represent multivariable analyses. 
 
Figure 3: Coefficient plots of Early MRI mean diffusivity and 12 month motor outcomes. Solid 
lines represent univariable analyses; dashed lines represent multivariable analyses. 
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Figure 4: Coefficient plots of Term MRI fractional anisotropy and 12 month motor outcomes. Solid 
lines represent univariable analyses; dashed lines represent multivariable analyses. 
 
Figure 5: Coefficient plots of Term MRI mean diffusivity and 12 month motor outcomes. Solid 
lines represent univariable analyses; dashed lines represent multivariable analyses.
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Table 5: Results of comparison between preterm infant Term MRI (n=65) and term reference group 
(n=18) 
 
 Fractional Anisotropy Mean Diffusivity (×10E-3 s/mm2) 
 Mean 
difference 
95% CI p Mean 
difference 
95% CI p 
Global -0.007 -0.010, 
-0.004 
0.000 0.029 0.011,    
0.048 
0.002 
Corpus 
Callosum left 
-0.040 -0.055, 
-0.025 
0.000 0.072 0.048,   
0.100 
0.000 
Corpus 
Callosum right 
-0.043 -0.057, 
-0.028 
0.000 0.063 0.038,    
0.088 
0.000 
PLIC left 0.007 -0.004,    
0.018 
0.207 -0.008 -0.024,    
0.008 
0.337 
PLIC right 0.004 -0.006,     
0.015 
0.428 0.003 -0.015,    
0.020 
0.751 
Cerebral 
peduncle left 
-0.001 -0.013,    
0.010 
0.802 0.019 -0.005,    
0.044 
0.120 
Cerebral 
peduncle right 
-0.006 -0.018,     
0.005 
0.317 0.022 -0.002,     
0.045 
0.073 
Key: CI confidence interval; PLIC posterior limb of the internal capsule 
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6.2 Summary of Chapter 6 
This chapter reported results of diffusion measures of FA and MD in the corpus callosum, PLIC and 
cerebral peduncle on Early and Term MRI, and the relationship with 12 month motor and 
neurological outcomes. Early MRI FA and MD were not associated with either motor or 
neurological outcomes. Term MRI FA was not associated with motor or neurological outcome. 
Term MRI MD in the left corpus callosum was associated with neurological outcome and MD in 
the right cerebral peduncle was associated with motor outcome on the AIMS and NSMDA. Corpus 
callosum FA and MD were significantly different between the preterm born group imaged at Term 
compared to the term born reference group. 
 
Although not presented in this thesis, further examination of our diffusion data found similarities 
with other studies of low risk cohorts, in particular that by Rose et al, 201427. Our data at a median 
PMA 32 weeks was consistent with their data at near-term and TEA, with a regional pattern of 
higher FA and lower MD suggestive of more advanced development in posterior compared to 
anterior regions of subcortical WM structures. A relationship in WM with PMA at MRI was found, 
but limited evidence of an effect of GA at birth. 
 
Infants with significant structural brain lesions were excluded from analyses with diffusion MRI 
data in chapter 6, biasing the sample towards those with less or no structural brain injury. To 
examine the similarities and differences between the sample included in the diffusion analyses 
compared to the overall recruited cohort and the samples included in papers 3 and 4, the following 
tables are presented: Supplementary Table 1 presents perinatal and medical characteristics of each 
sample; Supplementary Table 2 presents 12 month outcome data.  
 
For the birth and maternal data, analyses were conducted to determine any statistically significant 
differences between each paper/chapter’s sample and the infants recruited but not included in that 
analysis. For example, 146 infants were recruited to the study, of whom 119 underwent Early MRI 
and concurrent clinical assessment and are included in the analyses in paper 4. Statistical analysis 
compared these 119 included infants with the 27 infants recruited but without Early MRI. A 
discussion of the data presented in Supplementary Tables 1 and 2 follows the tables. 
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Supplementary Table 1:  Perinatal and medical characteristics of the overall PPREMO cohort, followed by each of the samples included in the 
analyses for each paper/chapter presented in this thesis 
 Recruited 
With Early MRI &  
clinical correlates 
 (paper 4; chapter 5) 
sMRI validation 
sample 
 (paper 3; chapter 4) 
Number included in 
Early DWI analysis 
(chapter 6) 
Number included in 
Term DWI analysis 
(chapter 6) 
Number 146 119 83 48 65 
Birth & Maternal Data   
Gestational age at birth 
(weeks.days) 
28.1 [26.2-29.2], 
23-30.6 
28.3 [26.6-29.3], 23.1-
30.6* 
28.4 [26.6-29.3], 23.6-
30.6 
28.5 [27.4-29.4], 23.1-
30.6* 
28.4 [27.1-29.3], 23.1-
30.6 
Birth weight (g) 1066 (317), 494-
1886 
1093 (321), 494-1886* 1069 (312), 494-1886 1152 (285), 580-1886* 1090 (312), 524-1886 
Birth head circumference 
(cm) 
25.57 (2.40), 
20.50-30.50 n=139 
25.77 (2.36), 20.50-
30.50*  
n=114 
25.62 (2.38), 20.50-
30.50 n=80 
26.15 (2.00), 22.50-
30.50 n=44 
25.74 (2.10), 21.50-
30.50 n=63 
Males 91 (62%) 73 (61%) 49 (59%) 30 (63%) 39 (60%) 
Multiple births 39 (27%) 36 (30%)* 24 (29%) 12 (25%) 19 (29%) 
Premature rupture of 
membranes 
37 (26%) 27 (23%) 19 (23%) 10 (21%) 14 (22%) 
Caesarean section 96 (66%) 84 (71%)* 60 (72%) 33 (69%) 49 (75%)* 
Chorioamnionitis 26 (18%) 18 (15%) 14 (17%) 4 (8%)* 10 (15%) 
Antenatal steroids 102 (70%), n=145 83 (70%) 62 (75%) 35 (73%) 49(75%) 
Magnesium sulphate 76 (52%), n=113 63 (64%), n=98 43 (52%), n=66 25 (52%), n=39 37 (57%), n=57 
Higher social risk 71 (53%), n=134 58 (49%), n=118* 40 (48%) 19 (40%)* 25 (38%)* 
Acquired medical factors      
Patent ductus arteriosus  59 (50%) 39 (47%) 21 (44%) 36 (55%) 
IVH   30 (25%) 17 (20%) 11 (23%) 7 (11%) 
IVH grade 3 or 4  8 (7%) 4 (5%) 4 (8%) 3 (5%) 
Periventricular leukomalacia   4 (3%) 2 (2%) 3 (6%)  3 (5%) 
Hydrocephalus   4 (3%) 2 (2%) 0 0 
NEC diagnosed or suspected  5 (4%) 3 (4%) 2 (4%) 1 (2%) 
Confirmed sepsis  5 (4%) 3 (4%) 2 (4%) 3 (5%) 
Anti-convulsant treatment   1 (1%) 1 (1%) 0 0 
Postnatal corticosteroids  20 (17%) 14 (17%) 6 (13%) 9 (14%) 
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Total parenteral nutrition 
(days) 
 11 [7-14], 0-36 11 [8-14], 0-30 11.5 [6.5-14.5], 0-30 11 [9-14], 0-36 
Ventilation (days)  2 [0-10], 0-50, n=118 3 [0-12], 0-48 2 [0-5.5], 0-50 2 [0-7], 0-50 
CPAP (days)  14 [7-25], 0-47, n=118 15 [7-25], 0-47 14.5 [6.5-24], 0-47 15 [7-22], 1-47 
Oxygen therapy (hours) 
 
37 [2-210], 0-1515, 
n=105 
12 [1-125], 0-1515, 
n=69 
12 [2-82], 0-1515, 
n=45 
33.5 [2-127], 0-1264, 
n=56 
36week PMA oxygen 
requirement  
 34 (29%) 23 (28%) 8 (17%) 16 (25%) 
Early MRI      
PMA at MRI (weeks.days) 
 
31.6 [31.1-33.4], 29.3-
35.2 
32 [31.1-33.4], 29.3-
35.2 
32.3 [31.2-33.2], 30.2-
35 
 
Weight at MRI (g) 
 
1474 [1242-1684], 
858-2715 
1445 [1242-1670], 
883-2715 
1545 [1308-1729], 
1023-2715 
 
Term MRI  n=105 n=77   
PMA at MRI (weeks.days) 
 
40.4 [40-41.3], 38.3-
46.4 
40.6 [40-41.3], 38.3-
46.4 
 
40.5 [40-41.3], 38.3-
42.5 
Weight at MRI (g) 
 
3000 [2700-3400], 
1900-5150 
3000 [2711-3500], 
1900-5150 
 
3000 [2700-3375], 
1900-4114 
Key: Data are presented as number (%), Median [IQR] or Mean (SD), range. Birth and maternal data was compared using unpaired t-tests for normally 
distributed continuous data, mann-whitney tests for non-normally distributed continuous data and chi2 tests for dichotomous variables. * Represents 
statistically significant differences between the included sample and the remaining infants which make up the 146 overall recruited cohort (p<0.05). 
 
Chapter 6 
 167 
Supplementary Table 2: Comparison of outcome data for each sample included in analyses in this thesis, including detail of the participants excluded 
from diffusion MRI analyses due to failure of the automatic segmentation process. 
 
Early MRI &  
clinical correlates 
 (paper 4; ch. 5) 
sMRI validation 
sample 
 (paper 3; ch. 4) 
Included in Early 
DWI analysis  
(ch. 6) 
Excluded from 
Early DWI 
analyses due to 
failure of AS 
Included in Term 
DWI analysis  
(ch. 6) 
Excluded from 
Term DWI 
analyses due to 
failure of AS 
12 month outcomes 104 83 48 
7 (5/7 with 12 
month outcomes) 
65 
11 (10/11 with 12 
month outcomes) 
Age at assessment 12mo 4days (1wk 
2days) 
12mo 2days (1wk 
2days) 
12mo 4days (1wk 
2days) 
12mo 4days (1wk 
6days) 
12mo 3days (1wk 
2days) 
12mo 2days (1wk 
2days) 
Bayley III Motor n=103    n=4   
Composite 97 [88-110], 46-
127 
97 [88-110], 46-
127 
100 [92.5-110], 
67-127 
95.5 [86.5-103], 
85-103 
97 [88-110], 52-
127 
98.5 [85-103], 46-
121 
Composite ≤100  66 (64%) 53 (64%) 30 (63%) 2 (50%) 42 (65%) 7 (70%) 
Composite ≤85  16 (16%) 15 (18%) 5 (10%) 1 (25%) 8 (12%) 3 (30%) 
Bayley III cognitive    n=4   
Composite 105 [100-110], 60-
130 
105 [100-115], 60-
130 
110 [100-115], 85-
125 
97.5 [90-105], 85-
110 
105 [100-110], 60-
125 
95 [85-110], 70-
120 
Composite ≤100  46 (45%) 36 (43%) 16 (33%) 3 (75%) 30 (46%) 6 (60%) 
Composite ≤85  7 (7%) 6 (7%) 1 (2%) 1 (25%) 4 (6%) 3 (30%) 
NSMDA n=103   n=4   
total  184 [174-190], 98-
199 
185 [174-191], 98-
199 
186 [178.5-191], 
146-199 
184.5 [172-191.5], 
164-194 
185 [174-190], 
117-199 
183.5 [164-192], 
98-194 
AIMS n=104   n=5  n=10 
total 53 [50.5-54], 14-
58 
53 [50-54], 14-58 
53 [52-53.5], 31-
58 
52 [47-57], 47-58 
53 [51-53], 16-58 
51 [47-56], 14-58 
Total <5th percentile 11 (11%) 10 (12%) 1 (2%) 0 6 (9%) 2 
Neurological Outcome n=100 n=82 n=46 n=5 n=61  
Normal 70 (70%) 57 (70%) 32 (70%) 2 (40%) 45 (74%) 6 (60%) 
Unspecified signs 25 (25%) 21 (26%) 12 (26%) 3 (60%) 16 (26%) 2 (20%) 
Abnormal/likely CP 5 (5%) 4 (5%) 2 (4%)  0 0 2 (20%) 
Confirmed CP  4 (4%) 3 (4%) 0 1 (20%) 1 (2%) 3 (30%) 
Key: Data are presented as number (%), Median [IQR] or Mean (SD), range. AIMS, Alberta Infant Motor Scale; AS automatic segmentation; Bayley III, 
Bayley Scales of Infant and Toddler Development 3rd edition; CP, cerebral palsy; NSMDA, Neurosensory Motor Developmental Assessment; DWI 
diffusion weighted imaging. 
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Comparison of birth and maternal data across samples 
The 27 infants recruited but who did not undergo Early MRI (and therefore did not progress further 
in the study) compared to the 119 who did undergo Early MRI, had a significantly lower 
birthweight, younger GA at birth, smaller head circumference, were more likely to be from a 
multiple birth and/or delivered by caesarean, and born to a family classified at higher social risk. 
This makes sense as 30% of the 27 infants did not undergo Early MRI because they were medically 
unstable, and 1 of the infants died. When comparing the 83 infants in the validation paper sample 
and the remaining 63 which make up the 146 recruited cohort, no statistically significant differences 
were found.  
 
The 48 infants with useable Early MRI diffusion data compared to the 98 that make up the 
difference to 146: were born at older GA, with a greater birthweight, a lower incidence of 
chorioamnionitis and lower rates of social risk. All four of these variables have been associated with 
neurodevelopmental outcomes and so these differences are likely clinically relevant, and support 
the conclusion that the sample in the Early diffusion MRI group represent a lower risk sample than 
the overall cohort and other representative populations of very preterm infants. The 65 infants 
included in the Term MRI diffusion analyses only differed from the remaining 81 recruited by 
being born by caesarean section and had the lowest rate of higher social risk of all the samples. 
 
When we examined the absolute values between the overall group of 146 and each of the other 
samples, the differences are not of a major magnitude and do not represent clinically important 
differences between the overall groups, except the lower incidence of chorioamnionitis, greater GA 
at birth and greater birthweight in the Early MRI diffusion group. For example, a difference of 2mm 
in head circumference between the 146 recruited and the 119 with Early MRI is less than the 
measurement error within the tool, and is likely of limited importance.  
 
The presence of medical factors such as IVH, PVL, NEC, and sepsis were very similar across the 
groups, except for the absence of cases with hydrocephalus in the diffusion MRI analysis groups. 
The Early MRI diffusion analysis group also had a lower percentage of infants who had postnatal 
corticosteroids and a lower percentage of infants who were diagnosed with bronchopulmonary 
dysplasia (defined as an oxygen requirement at 36 weeks PMA). 
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Comparison of outcome data across samples 
Table 2 presents detail of outcomes for each sample analysed, as well as specific data of the 
participants excluded from analyses in chapter 6 due to failure of the automatic segmentation 
process. The 104 infants in the first column represent all infants who had early MRI and 12 month 
outcomes. The samples in paper 3 and 4, as well as the Term MRI diffusion analysis sample in 
chapter 6 demonstrate similar motor and cognitive outcomes.  
 
The infants included in the Early MRI diffusion analysis had a median 5 points higher cognitive 
composite score and 3 points higher motor composite score compared to the other groups. While 
this is not a very large difference, of likely importance is that for the AIMS, NSMDA, and Bayley 
III motor and cognitive composite scores, the lower limits were much higher in the Early diffusion 
sample. This indicates that none of the infants with the very poorest motor and cognitive outcomes 
were included in this latter sample. This is further evidenced by the much lower percentage of 
infants in the Early MRI diffusion sample who were classified as <5th percentile on the AIMS (2%), 
compared to 11% in the overall cohort and 12 % in the validation paper cohort. A similar pattern is 
seen with the cognitive outcome, with only 2% of the Early MRI diffusion analysis group having 
cognitive composite scores <85 compared with 7% of the other samples having cognitive composite 
scores <85, and 35% with cognitive composite scores <100 compared with 52% <100 in the overall 
cohort. 
 
The prevalence of CP in the present cohort study was 4% (4/100). Although the study aimed to 
evaluate prediction of CP it was acknowledged that 12 months is early to confirm a diagnosis of 
CP. Most infants in the present cohort study have subsequently consented to a further study which 
follows the infants up at 2 years CA (Neurodevelopment of the preterm infant; NHMRC grant 
number 1084032). Two infants in the PPREMO study who were classified with ‘definitely 
abnormal neurological function /possible CP’ at 12 months CA were neurologically normal at 
subsequent clinical assessments at a local hospital and on their 2 year neurological assessment. One 
infant classified at 12 months CA with ‘unspecified signs’ on their neurological assessment was 
subsequently diagnosed at 2 years CA with hypotonic CP. That infant was born to parents who are 
both significantly intellectually impaired, and further investigations into genetic determinants for 
the child’s clinical presentation are in progress. Based on this information, the current total 
confirmed cases of CP in the PPREMO cohort is 4 out of 100 (4%). Due to the discrepancies 
between 12 month neurological findings, and confirmed outcomes at 2 years CA, the data collected 
from the paediatricians neurological assessment has been handled with caution in this thesis, and at 
times, only relationships with the validated motor assessments were presented, such as in paper 3.  
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The rate of CP of 4% is comparable with that in other contemporary cohorts. Data on rates of CP in 
the Australian state of Victoria for infants born between 2001 and 2009, report a rate of 3% for 
infants born between 28 and 31 weeks GA, and a rate of 8% in infants born <28 weeks GA21. A 
cohort of infants born <30 weeks GA in 2005-2006 in Melbourne, Australia reported a rate of CP of 
6% (5/86). Data from 20 population based CP registers of infants born in 2003 reported prevalence 
rates of CP in very low birthweight infants (1000-1499g) of 3.6% and of extremely low birthweight 
infants (<1000g) of 4.2%22. In an Italian study of infants born in 2005-2006 with a birthweight of 
<1500g, 3.2% (5/156) were diagnosed with CP. These data indicate that in terms of CP outcome, 
our cohort is representative of contemporary populations of very preterm born infants.  
 
If we examine our motor outcome data in relation to other studies of MRI in preterm infants, our 
Bayley III mean of 97 and SD of 14 is similar to a study of 45 infants who reported a mean 98 (SD 
14)28, and slightly higher than another Early MRI study of 52 infants who had a mean 93 (SD 14)29. 
A study of 65 infants that reported a lower mean of 85 (SD 11), had a mean GA at birth of their 
cohort of 26.6 and mean birthweight of 941g, which were both lower than the present study and 
likely explain the lower mean Bayley III motor score30. From this data we conclude that outcomes 
on the Bayley III motor composite score are comparable to other similar studies of very preterm 
infants with Early MRI. Interestingly, an Australian study with data of a term born reference sample 
of 211 infants, assessed at 12 months with the Bayley III, report a mean motor composite score of 
97 (SD 12)31, 32. This indicates that our preterm cohort performed comparably to healthy term born 
infants when assessed with the Bayley III.  
 
A study of 86 infants born <30 weeks GA between 2005 and 2006, also assessed motor outcome at 
12 months CA with the AIMS and NSMDA33. Their cohort’s mean GA at birth was a week younger 
than the present study, but their rates of IVH grade III and IV, PVL and oxygen requirement at 36 
weeks was the same as the present cohort, and their rate of CP was 6%33. Interestingly, although the 
rates of CP were similar, 35% of their cohort compared with our 11%, were classified as <5th 
percentile on the AIMS, and 18% compared with our 8%, were classified as having mild-severe 
dysfunction on the NSMDA.  
 
In conclusion, the data presented here confirm that the sample included in the Early MRI diffusion 
analyses in this chapter represent a lower risk cohort with more favourable birth characteristics and 
better motor and cognitive outcomes compared to the overall study sample. None of the infants with 
confirmed CP were included in the Early MRI diffusion analysis sample. Infants excluded due to 
Chapter 6 
 171 
failure of automatic segmentation processes had poorer motor and cognitive outcomes than those 
included in analyses with diffusion data. 
 
Brain macrostructure and microstructure have now been examined, together with clinical correlates 
and the relationships with 12 month motor outcomes which completes all stated aims of this thesis. 
I now turn to the general discussion and conclusions in chapter 7 to be drawn from these series of 
studies. 
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Chapter 7: Discussion and Conclusions 
7.1 Summary of Research Results 
This chapter presents a summary of findings for each aim. This is followed by a general discussion 
synthesizing and critiquing the findings in the context of other published literature on Early MRI 
and the relationship to outcomes in very preterm populations. Study strengths and limitations are 
then elucidated, followed by clinical and research implications and recommendations for future 
research. 
 
Aim 1 To examine the diagnostic accuracy of early MRI (<36 weeks PMA) to determine adverse 
motor outcomes or a confirmed diagnosis of CP, at or beyond one year CA in infants born preterm.  
 
The systematic review evaluated 30 papers, 5 of which reported diagnostic accuracy and another 5 
reported data sufficient for diagnostic accuracy to be calculated. Meta-analyses revealed that Early 
structural MRI global scores had good sensitivity and specificity to detect a later diagnosis of CP. 
To determine motor outcomes, global scores had a higher sensitivity and specificity than WM 
scores, but both were lower than for detection of CP. The lack of reporting of diagnostic accuracy in 
the majority of studies limited the ability to interpret the findings of Early MRI and their potential 
to provide prognostic information for use in routine clinical care.  
 
This systematic review is current at the time of submission of this thesis and evaluates all published 
literature until March 2017. Systematic searching of the literature at the start of this PhD (2012) 
revealed only 11 papers of Early MRI and motor outcomes, which included only 1 study of 12 
participants with Early diffusion MRI and motor/CP outcomes20. The need for further investigation 
of both structural and advanced diffusion MRI Early in the neonatal period for infants born very 
preterm was clearly warranted. I therefore set out to acquire both structural and advanced diffusion 
imaging coupled with concurrent clinical measures and neurodevelopmental follow up to 12 months 
CA in a large, prospectively collected cohort of very preterm infants.  
 
Initial investigations of the structural MRI data were required before progressing to evaluation and 
interpretation of the advanced diffusion data. The need for a comprehensive Early structural MRI 
scoring system that incorporated evaluation of deep GM and the cerebellum was identified, as well 
as the requirement to identify and report not only associations between Early MRI findings and 
motor outcomes, but also measures of diagnostic accuracy to facilitate clinical utility.  
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Aim 2  To validate a structural MRI scoring system previously developed for very preterm infants 
at TEA in a cohort of infants born <31 weeks PMA with MRI between 29 and 35 weeks PMA. The 
study aimed to establish predictive validity for motor and cognitive outcomes at 12 months CA. 
Secondary aims were to examine inter- and intrarater reproducibility and to examine relationships 
between global brain abnormality categories and known perinatal risk factors.  
 
Early MRI scores were associated with both motor and cognitive outcomes at 12 months CA in the 
cohort of infants born <31 weeks PMA, validating the scoring system and addressing Aim 2 of this 
thesis. Early MRI WM, deep GM and global brain abnormality scores were associated with Bayley 
III motor and cognitive scores and outcome on the NSMDA. Early cerebellar scores were also 
associated with outcome on the NSMDA. These associations were reconfirmed at Term MRI. 
Cerebellar scores at Term MRI were also associated with Bayley III motor and cognitive outcomes 
at 12 months CA. Inter- and intrarater reproducibility of the scoring system was demonstrated. 
Reliability and agreement were excellent for the Early and Term MRI global score and all subscales 
except cortical GM. Early MRI scores detected both motor and cognitive outcomes with good 
specificity and lower sensitivity.  
 
Inclusion of evaluation of deep GM and cerebellar structures and the use of regional measures to 
capture the impact of secondary growth impairment differentiates this scale from previously 
validated methods for Early MRI10, 11. Of the subscales and overall global score, deep GM scores 
demonstrated the strongest associations with motor and cognitive outcomes and the highest 
sensitivity and specificity for motor outcomes. These findings support inclusion of evaluation of 
deep GM in Early MRI scoring systems. Early MRI cerebellar scores were associated with the 
NSMDA but not Bayley III motor outcome. This is an interesting finding and might be related to 
the Bayley III assessing motor achievement while the NSMDA evaluates motor quality, including 
postural and balance reactions, functions known to be modulated by the cerebellum. 
 
The method to correct for PMA at MRI for regional measurements developed in this study 
effectively ‘age standardises’ the data. This ensured any differences found in regional measures 
between infants were not an effect of head or brain size due to PMA at MRI, but rather differences 
due to growth impairment. The use of term reference data to generate cut-points for scoring of the 
regional measurements was a potentially valuable modification to the original scale upon which this 
scale was based26. Having addressed Aim 2, the next aim was to elucidate associations between 
these Early and Term MRI scores and concurrent clinical measures of motor, neurological and 
neurobehavioural function.  
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Aim 3 To examine the structure-function relationships between structural MRI brain abnormality 
scores and concurrent clinical measures of neuromotor, neurological and neurobehavioral 
performance at 30-32 weeks PMA (Early MRI) and again at 40-42 weeks PMA (Term MRI). A 
secondary aim was to evaluate which clinical measures demonstrated the strongest association with 
a) Early MRI and b) Term MRI.  
 
This study aimed to define the associations between clinical measures and concurrently collected 
Early and Term structural MRI scores. A broad range of clinical tools were tested evaluating 
neurological, motor and neurobehavioural function. Both Early and Term MRI scores were found to 
demonstrate associations with concurrent clinical measures. Cerebellar subscale scores 
demonstrated the strongest associations with clinical measures at Early MRI, and predominantly 
with neurological items of the tests. Early MRI cerebellar scores were associated with the domain of 
reflexes on the HNNE, hypertonicity on the NNNS, the Premie-Neuro neurological subscale and 
cramped-synchronised GMs. At Term MRI, the strongest associations were with the TIMP, a 
neuromotor test. The TIMP demonstrated associations with WM, deep GM and global MRI scores 
indicating that increasing severity of brain injury was associated with poorer motor function.  
 
An interesting finding was the lack of associations between Early WM scores and clinical measures. 
In contrast, the majority of Term MRI studies have found WM abnormalities to correlate with 
concurrent clinical performance, and our Term MRI data confirmed this with strong associations 
found with motor performance on the TIMP as well as abnormal signs on the HNNE and 
hypertonicity on the NNNS. These findings further support evaluation of deep GM structures and 
the cerebellum in Early MRI studies of preterm infants. 
 
To our knowledge, this work presents the first structure-function relationships between Early 
structural MRI and concurrent clinical measures of motor, neurological and neurobehavioral 
function in infants born very preterm. It is also the first study of Early and Term clinical 
associations with a structural MRI scoring system that includes evaluation of deep GM and the 
cerebellum. It addresses and achieves the third aim of the thesis, and the next step was to begin 
evaluation of the diffusion MRI data. 
 
Aim 4 To evaluate brain microstructure on Early and Term MRI in regions known to be involved in 
motor function, the corpus callosum, posterior limb of the internal capsule, and cerebral peduncle 
and then examine the association of these early microstructural measures with motor outcome at 12 
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months CA. A secondary aim was to compare preterm brain microstructure in the 3 defined regions 
at Term MRI with a term born reference sample imaged at approximately 40-42 weeks PMA.  
 
The systematic review in chapter 2 identified studies which found lower FA in the PLIC and corpus 
callosum to be associated with poorer motor outcomes20, 34, 35. This informed the selection of 
regions for inclusion in these initial analyses of the diffusion MRI data. In this cohort of infants 
born <31 weeks GA with useable diffusion imaging and 12 month outcome data available, no 
associations were found between FA or MD at Early MRI in the corpus callosum, PLIC and 
cerebral peduncles and motor or neurological outcomes. Term MRI FA was also not associated with 
motor or neurological outcomes at 12 months CA. Left corpus callosum MD at Term MRI was 
associated with neurological outcome; right cerebral peduncle MD at Term MRI was associated 
with motor outcome on the AIMS and NSMDA. When the preterm cohort Term MRI data was 
compared to the term reference group, corpus callosum and global FA and MD were significantly 
different between the groups. 
 
Exclusion of infants with diffusion data of useable quality but who failed the automatic 
segmentation process due to the presence of structural lesions distorting the brain tissue, likely 
impacted our results as those with the worst brain structure were excluded. All infants in the cohort 
who developed CP were excluded from the analyses of Early MRI with 12 month outcomes. The 
results presented in chapter 6 address Aim 4. 
 
7.2 General discussion 
Identifying very preterm infants at risk of adverse motor outcomes and CP using Early MRI and 
clinical correlates was the premise underpinning this thesis. The results confirm that prediction of 
motor outcomes is possible earlier than the current standard of TEA. The scoring system developed 
for Early structural MRI was valid and reproducible and the data are consistent with previous 
studies of early structural MRI which show significant associations with motor and 
neurodevelopmental outcomes 10, 11. The Early structural MRI scoring system contributes to the 
current literature in 3 important ways.  It is the first scoring system for Early structural MRI that 
includes evaluation of deep GM and the cerebellum, and includes regional measurements of the 
brain which aim to quantify the secondary impacts on brain growth and development following 
structural brain injury. Clinical correlates of the Early MRI structural scores are presented, and to 
our knowledge are the only concurrent clinical associations reported for Early structural MRI. 
Analysis of the Early diffusion MRI demonstrated that microstructural development measured by 
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fractional anisotropy and mean diffusivity in the corpus callosum, PLIC and cerebral peduncle, 
were not associated with 12 month motor or neurological outcomes.  
 
The process of validating the Early structural MRI scoring system examined the associations 
between Early MRI scores and 12 month motor outcomes and then the sensitivity and specificity of 
Early MRI scores to determine motor and cognitive outcomes. Establishing diagnostic accuracy is 
more challenging than finding associations, a fact demonstrated in the validation study where strong 
associations were found, but the sensitivity and specificity of the scores to predict motor and 
cognitive outcomes were more limited. The preterm infant brain is developing rapidly following 
birth and up to TEA, there are a myriad of potential perinatal, environmental and genetic factors 
that play a role in the developmental trajectory. Brain MRI, evaluated macro- or microstructurally 
may not be sufficiently sensitive to capture some or all of the brain changes related to premature 
birth and the medical and social sequelae.  
 
There is now clear evidence that the rate of CP is declining globally in infants born preterm21, 22. 
This makes the task of predicting an outcome of CP following premature birth even more difficult, 
and requires larger samples of preterm born infants in prospective cohort studies. Adverse motor 
outcomes in very preterm born infants have also been reported as lower in contemporary cohorts 
compared with cohorts from the decade prior36. Prevalence of CP or adverse motor outcomes in a 
cohort has a direct impact on positive and negative predictive value; a lower prevalence results in 
poorer predictive values for any diagnostic test24, 37. Studies of diagnostic accuracy in preterm 
populations frequently employ sensitivity and specificity measures which impart valuable 
diagnostic information, as well as enable data from multiple studies with different prevalence rates 
of CP to be combined in meta-analyses. Sensitivity and specificity are not measures of prediction: at 
a defined sensitivity and specificity, where there is a low prevalence of the outcome of interest (CP 
or adverse motor outcomes), it becomes more difficult to predict from an adverse finding on MRI or 
clinical tests, and easier to predict from a normal MRI or clinical test result24, 37, 38. As discussed in 
detail in chapter 6, the rate of CP in the PPREMO cohort of 4% is consistent with other 
contemporaneous cohorts of very preterm born infants.  
 
Research in representative samples of very preterm born infants share a fundamental difficulty; 
class imbalance in the data39. Although very preterm infants display poorer motor outcomes than 
their term born peers, within a representative cohort of very preterm infants there are commonly 
only a very small number of infants who have significantly worse motor outcomes than the rest of 
the cohort. It is often the small number of infants with CP who display these significantly lower 
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motor scores. This results in the data being heavily skewed towards relatively better motor 
outcomes, and is referred to as class imbalance, where a sample contains only a few abnormal 
cases. When regression analyses are conducted to identify relationships between MRI scores and 
later outcomes, the few cases with markedly worse motor outcomes effectively drive the 
associations. Often, if the few severe cases are removed, the relationships fail to remain significant. 
Complex statistical methods have been developed to address class imbalance, such as LSI (local 
synthetic instances) or SMOTE (synthetic minority over sampling technique), but the complexity of 
these methods preclude them from widespread use40, 41. Class imbalance in the data will remain a 
core challenge for research in populations of preterm infants, especially given a declining rate of CP 
in this population. 
 
The sensitivity and specificity of the structural MRI scoring system developed in this thesis share 
similarities with studies of TEA MRI in preterm infants6, 25, 33. All scoring systems had higher 
specificity than sensitivity for motor and cognitive outcomes indicating that a normal MRI is highly 
indicative of a normal outcome, whereas infants with moderate to severe abnormalities on MRI 
progress to variable motor/cognitive outcomes. The global score from the Early structural MRI 
scoring system developed in this thesis had a 50% sensitivity and 86% specificity for cognitive 
outcomes on the Bayley III at 12 months CA42, higher than the widely used qualitative scoring 
system for structural MRI at TEA6, 9which reported a sensitivity 41% and specificity 84% for 
cognitive outcomes at 2 years CA. For motor outcomes, our Early MRI global score determined 
motor outcome on the NSMDA with a sensitivity of 43% and specificity of 86%, comparable with 
sensitivity 44% and specificity 96% from a study of TEA WM abnormality to determine motor 
outcome on the NSMDA33. Most subscales and the overall global total in our structural MRI 
scoring system, demonstrated higher sensitivity at Early MRI compared to Term MRI, although the 
specificities were comparable at both time points42.  
 
Our studies of Early structural MRI scores and 12 month outcomes (Chapter 4), and concurrent 
clinical associations with Early structural MRI scores (Chapter 5), present important findings in 
relation to the cerebellum. The cerebellum grows rapidly in the third trimester, increasing in size by 
258% between 30 and 40 weeks PMA whilst growing at a faster rate than any other cerebral 
structure43, 44. This makes the cerebellum particularly vulnerable to perturbations and injury, both in 
terms of injury caused by infarction, infection or haemorrhage, or due to impaired or restricted 
development45. Cerebellar abnormalities have been associated with adverse cognitive, language and 
behavioural abnormalities in infants born preterm46, and a reduction in remote cerebral cortical 
growth47. Early and Term MRI cerebellar scores in the present cohort were associated with 
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cognitive outcome on the Bayley III and motor outcome on the NSMDA. Early MRI cerebellar 
scores also demonstrated the strongest associations of the MRI subscales and global score, with 
concurrent clinical measures, notably with neurological elements of the various clinical measures. 
These findings support inclusion of evaluation of the cerebellum in studies of Early MRI. 
 
Generalisability of findings from this PPREMO study has been discussed in the summary of chapter 
6. The recruited sample is representative of contemporary preterm populations born <31 weeks GA, 
with comparable outcomes in terms of rates of CP. During development of the study protocol, the 
literature was comprehensively reviewed to determine which perinatal variables were reported as 
risk factors for poorer motor development or an outcome of CP.  The most relevant risk factors 
were collected in the cohort study and have been presented in Table 1 (Summary of Chapter 6). 
Examination of these perinatal data reveals that most perinatal and clinical features of our cohort 
are similar to contemporary cohorts, except that we seemed to have a significantly lower rate of 
sepsis. Only 4% of our cohort had culture positive sepsis, compared with approximately 30%29, 30, 48 
in other cohorts with Early MRI. Confirmed sepsis increases the risk of adverse motor and cognitive 
outcomes and CP5, 49. The low rate of nosocomial infection in our study would have resulted in less 
inflammatory triggers for brain inflammation which may explain the better motor outcomes relative 
to some other studies30, 33. 
   
Selection of perinatal risk factors to correct for in statistical analyses is challenging. A number of 
perinatal variables demonstrate co-linearity (e.g. GA at birth and birth weight), and addition of 
perinatal factors may even improve certain models. For example, a recent study reported diffusion 
MRI network analysis predicted motor and cognitive outcomes when presented as a combined 
model of network measure features and perinatal data including sex, GA at birth and WMI 40. When 
the analysis was replicated in the same cohort but without the addition of the perinatal risk factors, 
network analysis alone failed to predict motor and cognitive outcomes41.  
 
In the validation paper, the relationship between the perinatal risk factors, and increasing severity of 
MRI abnormality scores was evaluated. Gestational age at birth, birthweight, retinopathy of 
prematurity and days of ventilation were significantly positively associated with MRI scores at both 
Early and Term MRI. In addition, Early MRI abnormality scores were associated with the presence 
of patent ductus arteriosus, administration of postnatal corticosteroids, and oxygen therapy. Term 
MRI abnormality scores were associated with higher social risk, an oxygen requirement at 36 weeks 
PMA and a requirement for home oxygen. In relation to the Early MRI abnormality scores, these 
associations are perhaps not surprising as they suggest the babies most acutely sick soon after birth 
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and likely to go on to have the worst lung outcomes already had experienced the stressors resulting 
in acute changes in the structural MRI. To a certain extent the same factors held over to the Term 
MRI, but of interest is that fact that social risk now had an association with adverse MRI score 
suggesting that postnatal, potentially cumulative events had operated in the intervening period to 
leave an MRI biomarker by the time of the Term MRI. 
 
7.3 Strengths of the Thesis  
This thesis describes the successful design, implementation and analysis of a complex and 
challenging study involving fragile preterm infants with 2 MRIs and multiple outcome measures 
concurrent with MRI, and at 3 and 12 months CA. A prospective cohort study design, ranked higher 
in the hierarchy of evidence than a retrospective study design, was coupled with strong 
methodological quality. Scorers of MRI were blinded to clinical history and concurrent clinical 
assessment findings. Clinical assessors at Early and Term time points were blinded to MRI findings 
and clinical history. Outcome assessors were blinded to all early MRI and clinical findings. Clinical 
assessors were trained and accredited in all relevant assessment measures, and raters of GMs videos 
were advanced, accredited raters.  
 
All infants were imaged on the same MRI scanner with the same MR protocol and at high field 
strength (3T). Advanced diffusion sequences were acquired in addition to structural images. 
Inclusion of concurrent clinical correlates for MRI differentiates this study from the majority of 
other Early MRI studies. Validated tools were utilised for outcome assessments. The Bayley III is 
the outcome of choice for most preterm follow up studies, however it has limited predictive validity 
for later motor and cognitive outcomes, and concerns have been raised that it underestimates motor 
and cognitive delays. The current study protocol included assessment with the AIMS and NSMDA 
at 12 months CA to supplement motor outcome data obtained using the Bayley III.  
 
Recruitment of a large, unselected consecutive cohort, representative of contemporaneous cohorts 
of preterm infants born <31 weeks ensures good generalisability of the results. Very good retention 
of study participants to 12 months CA (87%) was achieved. Systematic literature searching at the 
start ensured relevant study design and facilitated implementation of the study. The systematic 
review presented in this thesis evaluated the literature to March 2017 and therefore presents an up to 
date, detailed evaluation of the literature regarding Early MRI and motor outcomes in infants born 
preterm, including meta-analyses. 
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7.4 Limitations of the Thesis 
A number of potential limitations can be identified. Twelve months CA is early to determine motor 
and cognitive outcomes for very preterm infants. Follow up at 2 years CA would have been 
preferable, however that was not possible within the timeframe available for this thesis. The 
research team that includes me has been successful in procuring funding for a follow on project that 
will enable follow up at 2 years CA of the PPREMO participants.   
 
It was acknowledged from the outset that 12 months CA would be early to evaluate the presence of, 
or confidently determine an absence of CP. I observed in some of the earlier PPREMO recruits that 
some who presented with abnormal neurological function at 12 months CA progressed to normal 
motor and neurological outcomes when assessed at 2 years CA in the follow on study. This limits 
the confidence with which we are able to use our 12 month neurological assessment data. Use of 
another standardised neurological assessment such as the Hammersmith Infant Neurological 
Examination (HINE), which generates a continuous score for neurological outcome, may have 
complemented our current neurological assessment50-52. 
 
The atlas-based automatic segmentation method utilised with the diffusion MRI data resulted in 
exclusion of infants with significant structural brain lesions. Further automated approaches or 
manual segmentation will be needed if future research questions require analyses to include the full 
representative cohort. Infants who did not have a successful Early MRI did not progress through the 
study. The study design should possibly have allowed follow up of all infants recruited, to be able 
to determine if those who were recruited but had no MRI were similar or different in outcome to the 
samples included in each of the other analyses. Data of acquired medical factors in Table 1, chapter 
6 was not collected for infants recruited but with no Early MRI, and limited comparison of these 
data for the full recruited sample compared to each of the analysed samples. This is something that 
could be addressed retrospectively and would enhance comparisons between groups for future work 
in this cohort. 
 
A small amount of attrition occurred within this study, 87% of infants with Early MRI were 
followed up at 12 months CA. This follow rate was better than that of many other studies of early 
MRI in which rates ranged from 30-75%11, 20, 28, 53-58. Potential bias is created by incomplete follow-
up. Poorer outcomes are reported for preterm infants who fail to return for follow up compared to 
those who are followed up59, and greater biological and social risk factors for disabilities occur in 
those who fail to access follow up services60.  
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7.5 Clinical and Research Implications and Recommendations for Future Research 
The findings of this research have a number of important clinical and research implications. Early 
MRI offers the benefit of earlier identification of brain injury and/or impaired development with 
potential for an earlier start of interventions. In the absence of interventions, early identification has 
the potential to increase anxiety for parents at a vulnerable and immensely difficult time61. The 
landscape is changing however, with intervention studies becoming available which aim to improve 
infant and family outcomes62-64. Recent 8 year follow up data from the Vibes + study showed that 
mothers of babies who received intervention with psychological support in the first year after 
preterm birth demonstrated sustained improvements in mental health to 8 years65. While the specific 
early intervention applied in that study demonstrated limited effects on motor and cognitive 
development in the preterm born children, sustained improvements in parental mental health 
represent a vitally important contribution66.  Research into neuroprotective strategies such as 
hypothermia, magnesium sulphate, erythropoietin, creatine, and melatonin are all underway, as well 
as early massage, developmental care and environmental enrichment and will require methods to 
identify infants for inclusion in studies, as well as biomarkers to evaluate outcomes.  
 
The GMs assessment has higher sensitivity and specificity for an outcome of CP in preterm 
populations than MRI, and should be included in clinical and research settings of very preterm 
infants67. International recommendations accepted for publication in the journal JAMA Pediatrics 
recommend both MRI and GMs assessment for early detection of CP and to diagnose others ‘at 
high risk of CP’ to enable early interventions to be implemented (personal communication). General 
Movement assessment data was collected and future work is planned to evaluate the predictive 
validity of GMs along with the other early clinical data collected.  No studies to date have evaluated 
a combination of Early MRI and clinical measures to determine motor outcomes or CP. Studies of 
Term MRI have demonstrated improved prediction of outcomes, when MRI data and neuromotor or 
neurological data are combined33, 67-70. Evaluation of the combination of Early MRI and concurrent 
clinical measures to predict motor outcomes and CP is planned with the data collected in the 
PPREMO study.  
 
Longitudinal changes in diffusion measures between Early and Term MRI have been related to 
motor outcomes20, 30, 34. A slower increase in FA between Early and Term MRI in the PLIC and 
occipital WM was reported as associated with poorer motor outcomes in one study20 but not in 
another34. A slower increase in FA in the basal nuclei34, and a difference in the slope of FA between 
left & right inferior temporal lobe, where FA increases more slowly on the left than the right30 have 
been reported as associated with poorer motor outcomes. Structural and diffusion imaging measures 
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of growth of the hippocampus between Early and Term MRI were not associated with motor 
outcomes71. Growth of the putamen and caudate predicted cognitive outcomes72. We have examined 
the relationships between MRI measures at each time point and later motor outcomes as presented 
in Chapters 4 and 6 of this thesis. Future work could examine growth and/or maturation of 
structures between Early and Term MRI and the ability of these changes (rate/magnitude of change) 
to determine outcomes.  
 
This thesis focussed on motor outcomes and CP. Future work will examine the structural and 
diffusion imaging findings in relation to cognitive and behavioural outcomes. Further structural and 
microstructural evaluation of the cerebellum is indicated given the findings in this study of 
relationships between Early structural MRI cerebellar scores and 12 month motor and cognitive 
outcomes, as well as strong associations with concurrent clinical measures. 
 
Evidence of injury to some structures appears over time73 as well as growth impairment becoming 
more evident at Term MRI compared to Early MRI as demonstrated in paper 3 of this thesis42. An 
example of this is the thalamus, where no volumetric differences were noted on Early MRI but 
significant differences were evident on Term MRI, suggesting that damage to the thalamus is 
secondary to brain injury in the corticospinal tract occurring earlier73. This suggests that when 
looking for biomarkers at Early MRI, future research potentially needs to examine different 
structures to those known at TEA to be related to outcomes. A study of spectroscopic imaging in 
normative preterm infants found the corticospinal tract to have the highest NAA/Cho ratio 
suggesting that of the 14 regions of interest that they examined, the CST appeared to have matured 
first74. This may support choosing the corticospinal tract as a structure to examine at Early MRI. 
That report also found that the parietal white matter had higher NAA/Cho ratio than the frontal 
white matter, possibly demonstrating the sensory pathway is quicker to mature compared with the 
motor pathway.  
 
The structural MRI scoring system developed and described in this thesis had good specificity for 
motor outcomes but relatively low sensitivity. Future research of this and other MRI scoring 
systems could explore ways to improve the diagnostic accuracy of the existing scoring systems. 
Removal of redundant scoring items and optimisation of cut points for MRI scores and for 
outcomes could be evaluated. Weighting individual items or subscale scores within the global total 
score may improve diagnostic accuracy. Data augmentation methods such as local synthetic 
instances (LSI40) and synthetic minority over-sampling technique (SMOTE41, 75) to address class 
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imbalance issues inherent in studies of preterm infants, and/or machine learning or deep learning 
statistical modelling could be employed. 
 
Future research should continue to search for new, very early biomarkers of outcome for very 
preterm born infants. Early and advanced imaging potentially has a lot to offer in this task. 
Acquisition types include structural and diffusion as presented in this thesis, as well as 
spectroscopic, functional and quantitative T1 and T2 methods. In addition to qualitative scoring of 
structural images and region of interest analyses in diffusion MRI, cortical thickness measures, 
tractography including along-tract analysis76, voxel based analyses such as tract based spatial 
statistics77, fixel-based analysis78, connectome79 and network analyses80 potentially offer valuable 
insights into early brain development. High angular resolution diffusion imaging acquires more 
directions and has a higher diffusion weighting than standard diffusion tensor imaging, addressing 
the challenges of crossing fibres and can be used for constrained spherical deconvolution81 or q-ball 
imaging82. Multi-shell approaches with multiple diffusion weightings or different number of 
directions per diffusion weighting can be used with NODDI83, diffusion kurtosis imaging84 or 
multi-shell multi-tissue constrained spherical deconvolution85. Additional microstructural measures 
available from NODDI include, intra-cellular volume fraction, isotropic volume fraction and 
orientation dispersion83, 86, 87. From FOD, fibre density, fibre bundle cross-section and combined 
measures of fibre density and bundle cross-section can be calculated78. From diffusion kurtosis 
imaging: intra-axonal water fraction, intra-axonal axial diffusivity, extra-axonal axial and radial 
diffusivities can be calculated84, 86, 88.  
 
7.6 Conclusion 
In this thesis I have successfully investigated “The relationship between brain structure and function 
of very preterm infants, and the ability to predict neurodevelopmental outcomes”. I have generated 
a dataset of Early and Term MRI at high field strength (3T), with advanced diffusion MRI 
acquisition, concurrent clinical correlates and motor and cognitive outcomes to 12 months corrected 
age. I have validated a structural MRI scoring system for use at Early and Term MRI and assessed 
the relationship between qualitative scores of brain macrostructure and concurrent clinical function. 
I have investigated the relationship between early brain microstructure and motor and neurological 
outcome and, in the process, profiled and described the cohort. The challenge and opportunity from 
here will be to maximise and optimise the learning from this valuable dataset. 
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Parent Information and Consent Form (PICF) (Version 5; 14/05/14) 
 
Title of the Research study:   Prediction of PREterm Motor Outcomes (PPREMO) 
Thank you for taking the time to read the information in this form. These pages contain information 
about a research project we are inviting you and your baby to take part in.  The purpose of this 
information is to explain to you clearly and openly all the steps and procedures of this project. The 
information is to help you to decide whether or not you would like to take part in the study.  Please 
read this information carefully.  You can ask us questions if you wish. You may also wish to talk 
about the project with others e.g. friends or a health care worker.  When you understand what the 
project is about, you can sign the consent form attached if you agree to take part.  You will be given 
a copy of this PICF to keep. 
 
What is the Research Project about? 
This project is for babies born before 31 weeks gestation (preterm).  Some babies who are born 
preterm can have problems later in life (for example with learning, movement or behaviour).  It is 
difficult to know which babies will have problems and which babies won’t.   This makes it difficult 
for doctors to know which babies will need extra help with their development of learning and 
movement skills.    
 
Magnetic Resonance Imaging (MRI) scans of your baby’s brain can be performed safely at an 
earlier stage (30 weeks) than has been possible in the past (at term). MRI’s are safe and provide 
information about your baby’s brain and how it compares to babies born at term.  Early brain scans 
are one of the tests we will be investigating in this study. 
  
The purpose of this research project is to learn which tests (clinical and MRI) can be used at 30 
weeks and 40 weeks, to accurately identify which babies may have problems later in life, so that 
those babies and their families can be provided with the help they need as early as possible. 
 
Why are you being invited to be in the study? 
We are inviting all parents/guardians of babies born at less than 31 weeks in this hospital to 
participate in the study. We will also invite some babies born at term to serve as a comparison. 
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What are your alternatives to participating in this project? 
There is no obligation to participate in this study. Should you choose not to participate in this 
project you and your baby will have all the usual access to treatment.  
 
What does this study involve? 
There are 4 stages of this study: 
At 30-36 weeks of age, while your baby is still in the nursery we will carry out the following: 
 clinical and medical information will be collected from the baby’s chart 
 Video of their movements in their incubator or cot (up to 1 hour of video; no handling of the 
baby)    
 A neurological/neurobehavioural assessment (15-20 minutes; involves a small amount of 
handling).This assessment is videoed for scoring purposes. 
 A brain scan (MRI) which takes about an hour (20 minutes preparation and 40 minutes in the 
scanner) 
 
At 40 weeks which is term equivalent age; if you have returned home we will ask you to visit the 
hospital. We will complete: 
 A video of their movements for a short period (up to 15 minutes) 
 Movement assessments and a neurological assessment (30-40 minutes).This assessment is 
videoed for scoring purposes. 
 Assessment of their visual functions (5 minutes) 
 A brain scan (MRI) which takes up to one hour (20 minutes preparation and 40 minutes in the 
scanner) 
 A recording of their brain’s electrical activity (EEG; 30 minutes preparation and 30 minutes 
recording). 
 Ask you to complete a brief questionnaire of social and environmental factors that relate to your 
family 
 
At 12 weeks corrected age (3 months after term); we will visit you at home and: 
 Video your baby’s movements for a short period (5-15 minutes) 
 Perform a movement assessment (40 minutes). This assessment is videoed for scoring purposes. 
 Assess their visual function (5 minutes) 
 
At 12 months corrected age; we will ask you to visit the hospital: 
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 A paediatrician will assess your baby’s general development (30 minutes) 
 We will perform movement assessments (11/2 hours). These assessments are videoed for 
scoring purposes. 
 
What is an MRI and what does it involve? 
A magnetic resonance scan (MRI) involves your baby being transported by a doctor and a nurse 
from the nursery to the MRI facility on the 3rd floor of the Royal Brisbane and Women’s hospital in 
a special incubator that allows similar monitoring to that in the nursery.  MRI is safe, there is no 
radiation, it has no known dangerous or harmful effects, causes no pain, and no sedation or any 
drugs are given to your baby.  
 
The MRI will be performed in the same way as for all babies who require MRI in the hospital. You 
will be provided with an MRI Fact Sheet that is made available to parents of all babies having an 
MRI in the hospital. The scanner will take pictures of your infant’s brain using magnetic and radio 
waves.  No medications or X-rays are used, there is no radiation involved and there is no potential 
for harm. Before the scan your baby will be fed in the usual way to encourage him/her to sleep 
during the scan. He/she will then be positioned in a comfortable pillow in the scanner and 
monitored over the scan time (approximately 40 minutes).  During the scan most infants sleep as it 
is after a feed.   
 
Ear muffs will be placed over their ears as part of the MRI scan is noisy. A sensor will be placed on 
the hand or foot to monitor heart rate and oxygen levels as a safety measure, because during the 
MRI the baby is not clearly visible. A doctor and a nurse from the Neonatal Nursery will be with 
the baby at all times to monitor the baby and the Hospital has an established emergency protocol to 
follow in the unlikely event that vomiting or apnoea (stopping breathing) occurs. MRI does not 
increase the risk of these events which can happen to any baby at any time.   
 
What is an EEG and what does it involve? 
EEG is a standard method to measure brain waves in babies. It involves placing a cap on your 
baby’s head that contains a number of small sponges. This does not hurt your baby and there is no 
potential for harm.  Brain waves are recorded to a computer. The recording, which lasts for up to 
about 30 minutes can be made regardless of whether your baby is asleep or awake.  
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What is the Neonatal assessment of visual functions? 
When your baby is alert, we will test how your baby looks at (fixes and follows) a series of cards 
designed to test their vision. 
 
What are neurological and neurobehavioural assessments? 
These assessments look at how your baby is developing their skills of movement and posture, and 
how they are interacting with and responding to their environment. The researcher will move your 
baby’s arms and legs, test their reflexes, place them in different positions such as on their tummy 
and back and observe their movements, and provide some stimulation such as shaking a rattle or 
bell and observing how they respond. These assessments are video recorded for scoring purposes. 
 
What is the Questionnaire I will be asked to complete? 
Any child’s development is influenced by both medical or biological factors (such as prematurity, 
illness etc.) and social or environmental factors (such as the home environment).   The information 
you provide in the questionnaire is totally confidential, and will allow us to understand which 
information from our assessments is as a result of their prematurity.   We are only investigating the 
biological or medical factors relating to prematurity. 
 
Who are the Researchers? 
Joanne George, a physiotherapist, leads the project and will perform all assessments on your baby. 
Other researchers involved in this project include: Professor Paul Colditz (a neonatologist and 
Professor of Perinatal medicine), Professor Roslyn Boyd (a physiotherapist), Associate Professor 
Stephen Rose and Kerstin Pannek (physicists’ who will analyse your baby’s MRI scan), Professor 
Alan Coulthard (a radiologist), Sonia Sam and Rebecca Caesar (physiotherapists who will also 
perform some motor assessments), Dr Barbara Lingwood (a scientist who may analyse some of the 
data), Karen Taylor (a research nurse), and Dr Robert Ware (a biostatistician who will analyse some 
of the data). 
 
What are the benefits of participating in this study? 
Additional assessments will be performed, compared to babies not in the study. The information 
from these assessments will be provided to your child’s doctor who will pass the information on to 
you in your regular appointments.  You will have the opportunity to gain a set of MRI scan films of 
your infant’s brain for the future record of your child. If any neurodevelopmental issues arise when 
your child is older, the MRI scans may be helpful. You will have the opportunity to discuss your 
child’s progress in depth and discuss any concerns with experienced staff. You will have an 
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opportunity for in depth neurodevelopmental assessments at 40 weeks (term), as well as at 12 weeks 
post term and 12 months of age.   
 
Is there likely to be a benefit to other babies in the future? 
If MRI and/or movement assessments performed at 30 weeks and 40 weeks are shown to be 
accurate in terms of predicting movement development at 1 year of age, then this finding will 
benefit many babies in the future. If future practice is made better, this may benefit other premature 
babies in the future. 
 
What are the possible risks and/or side effects for my baby? 
There are no anticipated risks to your baby as a result of being part of this research project.  
However if any risks become evident at any time, we will let you know immediately. 
 
There are no known risks of Magnetic Resonance Imaging.  MRI is commonly done for research 
purposes for infants born preterm.  Most infants will sleep or rest during the scan.  If your baby 
becomes distressed for any reason the study will be stopped.  Your baby will be monitored carefully 
throughout the scan by trained medical and/or nursing staff.  
 
There is the possibility that the MRI scan will show up something in your infant’s brain that we had 
not expected.  If this happens, we will arrange for you to meet with a medical professional who can 
explain the findings to you.  If any of the results of the MRI, or neurodevelopmental assessments, 
are distressing for you we will arrange specific counseling to discuss the findings with specially 
trained staff.  Although detecting a significant brain abnormality is extremely unlikely, you should 
be aware that if an abnormality is detected in your child and you are told about it, then this 
knowledge may have consequences for your child. Knowing about an abnormality may affect their 
ability to work in certain professions, obtain life or health insurance and other facets of daily living; 
however you should be aware that this is unlikely. Please take the time to consider carefully what it 
would mean if we told you your child had an abnormality in their brain that might, or might not, 
affect your child in later life. If you do not wish to know this, then you may wish to discuss this 
further before agreeing to participate.   You can choose to participate in the study but not receive 
information from the scans and movement assessments. 
 
What are the possible discomforts and/or inconveniences for my baby or me? 
The inconvenience to you and your baby is the time that the assessments will take, and the trips you 
will need to make to the hospital.  Families will have to make between 1 and 2 trips to the hospital 
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for the assessments.  We will make the appointments at a time that suits you and provide some 
compensation for travel costs and parking. 
 
The MRI scanner is noisy, so protective earmuffs will be positioned over your infant’s ears during 
the scan.   
 
What will be done to make sure the information is confidential? 
All results of all assessments will be stored without your child’s name on it.  All hard copy data will 
be stored in a secure filing cabinet and only the researchers will have access to these. Video will 
only be viewed by study personnel for the purposes of data collection and assessment scoring.  If 
we talk or write about the results of this research, we will not use any names.  All data is only 
accessible to the study personnel.  
 
Queensland Health guidelines require the storage of research data involving minors to be kept for 
15 years after the child has turned 18 years of age. 
 
As is regular procedure in infant studies, the name of the family GP will be collected in order to 
allow direct sharing of information and concerns regarding potential risks for the child if necessary. 
 
Will I be informed of the results when the research project is finished? 
A regular 6 monthly newsletter will also be sent to you to keep you updated on study recruitment 
and progress. At the conclusion of the study all families will be sent a meaningful summary of the 
overall study results, and copies of publications if requested. 
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Participation in future research 
In the consent form we will ask you if you agree to be contacted in the future if further follow up 
studies are developed.    Your consent to be contacted would only apply to extended research which 
relates to the current research project.   Full ethical approval would be sought by the research team 
and a new consent process undertaken.   You can choose to participate in this study but decline to 
be contacted for future research. 
 
Participation in this study is voluntary 
You can decide whether or not you wish to take part in this research project.  You can decide 
to withdraw from this research project at any time.  No explanation is needed.   You may like 
to discuss your participation in this research project with your family and/or with your 
doctor.  You can ask for further information before deciding if your child will take part.   
 
This study has been reviewed and approved by the Royal Brisbane & Women’s Hospital, 
Human Research Ethics Committee (HREC). Should you wish to discuss the study in 
relation to your rights as a participant or should you wish to make an independent complaint, 
you may contact the Coordinator or Chairperson, Human Research Ethics Committee, Royal 
Brisbane & Women’s Hospital, Herston, Qld 4029 or telephone (07) 3646 5490, email 
Ethics@health.qld.gov.au  
 
If you would like more information about the study or if you need to contact a study 
representative in an emergency, the person to contact is: 
Professor Paul Colditz, 
Royal Brisbane and Women’s Hospital 
Contact telephone:   (07) 3346 6014 
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STANDARD INFORMED CONSENT  
FOR PARENTS / GUARDIANS TO GIVE CONSENT  
FOR THEIR BABY TO PARTICIPATE IN A RESEARCH PROJECT  
 
Title of Project:    Prediction of Preterm Early Motor Outcomes (PPREMO) 
 
Principal and 
associate 
Investigators 
Professor Paul Colditz, Professor Roslyn Boyd, Joanne George, , Sonia Sam, A/Prof Stephen 
Rose, Kerstin Pannek, Professor Alan Coulthard, Rebecca Caesar, Karen Taylor, Dr Barbara 
Lingwood, Dr Robert Ware 
 
I/We  (Parents/Guardians name)                                           
Parents/Guardians of (baby’s name)  
voluntarily consent to him / her taking part in the above titled Research Project, explained to me by  
Mr / Ms / Dr / Professor  
1. I/We have received a Participant Information and Consent Form (PICF) to keep and I/we understand the 
purpose, extent and possible effects of my baby’s involvement 
1. I/We have been asked if I/we would like to have a family member or friend with me/us while the project 
is explained 
2. I/We have had the opportunity to ask questions and I/we am/are satisfied with the answers I/we have 
received/We understand that the researcher has agreed not to reveal results of any information involving 
my/our baby, subject to legal requirements 
3. I/We understand that the name of our family GP will be collected in order to allow direct sharing of 
information and concerns regarding potential risks for the child if necessary. 
4. I/We agree to video recording of assessments for data collection and scoring purposes.  
5. If information about this project is published or presented in any public form, I/we understand that the 
researcher will not reveal my/our baby’s identity.  
6. I/We understand that if I/we refuse to consent, or if I/we withdraw my/our baby from the study at any time 
with or without explanation, this will not affect my/our baby’s access to the standard treatment that all 
babies receive. 
7. I/We agree to be contacted in future if a further research study is planned.   Yes           No 
 I/We understand I/we will receive a copy of this consent form. 
 
 Printed Name Signature Date 
PARENT/GUARDIAN 1    
PARENT/GUARDIAN 2    
 
I have explained the study to the parents/guardians who has signed above, and believe that they 
understand the purpose, extent and possible effects of their involvement in this study. 
 Printed Name Signature Date 
 
RESEARCHER  
  
 
 
 
Note: All parties signing the Consent Form must date their own signature. 
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Parent  Information and Consent Form (PICF) (Version 5; 14/05/14) 
 
Title of the Research study:   Prediction of PREterm Motor Outcomes (PPREMO) 
Thank you for taking the time to read the information in this form. These pages contain information 
about a research project we are inviting you and your baby to take part in.  The purpose of this 
information is to explain to you clearly and openly all the steps and procedures of this project. The 
information is to help you to decide whether or not you would like to take part in the study.  Please 
read this information carefully.  You can ask us questions if you wish. You may also wish to talk 
about the project with others e.g. friends or a health care worker.  When you understand what the 
project is about, you can sign the consent form attached if you agree to take part.  You will be given 
a copy of this PICF to keep. 
 
What is the Research Project about? 
Some babies who are born prematurely can have problems later in life (for example with learning, 
movement or behaviour).  It is difficult to know which babies will have problems and which babies 
won’t.   This makes it difficult for doctors to know which babies will need extra help with their 
development of learning and movement skills.    
  
We are investigating whether early brain scans and other assessments can help us accurately 
identify which babies may have problems later in life, so that those babies and their families can be 
provided with the help they need as early as possible.   To do this we also need brain scans of 
healthy infants born at full term as a comparison. 
 
Why are you being invited to be in the study? 
We are looking for healthy babies born at full term to act as a reference group for our study.   By 
having information and brain scans of healthy babies, it will help us to understand the brain scans of 
the premature infants. 
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Who is eligible for this study? 
1. Healthy infants born between 38 and 41 weeks gestation. 
2. Infants may not be growth restricted i.e. must be above the 10th percentile on the growth chart at 
birth. 
3. Infants may not have been admitted to the nursery after birth. 
4. English speaking families as we don’t have access to interpreters. 
5. Families need to be available to attend the hospital for a visit when their baby is 1 week old. 
 
What are your alternatives to participating in this project? 
There is no obligation to participate in this study. Should you choose not to participate in this 
project you and your baby will have all the usual medical care.   
What does this study involve? 
When your baby is 1 week old we will ask you to visit the hospital where we will perform: 
 A brain scan (MRI) which takes up to one hour (20 minutes preparation and 40 minutes 
in the scanner) 
 A recording of their brain’s electrical activity (EEG; 30 minutes preparation and 30 
minutes recording). 
 Assessment of their visual functions (5 minutes) 
 A neurological/neurobehavioural assessment (20minutes). This assessment is videoed 
for data collection and scoring purposes. 
 Ask you to complete a confidential questionnaire 
 
What is an MRI and what does it involve? 
A magnetic resonance scan is a brain scan that takes pictures of your baby’s brain.   It is safe, there 
is no radiation, it has no known dangerous or harmful effects, causes no pain, and no sedation or 
any drugs are given to your baby.  
 
The MRI will be performed in the same way as for all babies who require MRI in the hospital. You 
will be provided with an MRI Fact Sheet that is made available to parents of all babies having an 
MRI in the hospital. The scanner will take pictures of your infant’s brain using magnetic and radio 
waves.  No medications or X-rays are used, there is no radiation involved and there is no potential 
for harm. Before the scan your baby will be fed in the usual way to encourage him/her to sleep 
during the scan. He/she will then be positioned in a comfortable pillow in the scanner and 
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monitored over the scan time (approximately 40 minutes).  During the scan most infants sleep as it 
is after a feed.   
 
Ear muffs will be placed over their ears as part of the MRI scan is noisy. A sensor will be placed on 
the hand or foot to monitor heart rate and oxygen levels as a safety measure, because during the 
MRI the baby is not clearly visible. A doctor from the Neonatal Nursery will be with the baby at all 
times to monitor the baby. 
 
What is an EEG and what does it involve? 
EEG is a standard method to measure brain waves in babies. It involves placing a cap on your 
baby’s head that contains electrodes in the form of small sponges. This does not hurt your baby and 
there is no potential for harm.  Brain waves are recorded to a computer. The recording, which lasts 
for up to about 30 minutes can be made regardless of whether your baby is asleep or awake.  
 
What is the Neonatal assessment of visual functions? 
When your baby is alert, we will test how your baby looks at (fixes and follows) a series of cards 
designed to test their vision. 
 
What are neurological and neurobehavioural assessments? 
These assessments look at how your baby is developing their skills of movement and posture, and 
how they are interacting with and responding to their environment. The researcher will move your 
baby’s arms and legs, test their reflexes, place them in different positions such as on their tummy 
and back and observe their movements, and provide some stimulation such as shaking a rattle or 
bell and observing how they respond.  These assessments are video recorded for scoring purposes. 
 
What is the Questionnaire I will be asked to complete? 
Any child’s development is influenced by both medical or biological factors (such as prematurity, 
illness etc.) and social or environmental factors (such as the home environment).   The information 
you provide in the questionnaire is totally confidential, and will allow us to understand which 
information from our assessments is as a result of biological factors or environmental factors.   We 
are only investigating the biological or medical factors in this study. You can choose not to answer 
questions in the questionnaire. 
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Who are the Researchers? 
Joanne George, a physiotherapist, leads the project and will perform all assessments on your baby. 
Other researchers involved in this project include: Professor Paul Colditz (a neonatologist and 
Professor of Perinatal medicine), Professor Roslyn Boyd (a physiotherapist), Associate Professor 
Stephen Rose and Kerstin Pannek (physicists’ who will assess your baby’s MRI scan), Professor 
Alan Coulthard (a radiologist), Sonia Sam and Rebecca Caesar (physiotherapists who will also 
perform some motor assessments), Dr Barbara Lingwood (a scientist who may analyse some of the 
data), Karen Taylor (a research nurse), and Dr Robert Ware (a biostatistician who will analyse some 
of the data). 
 
What are the benefits of participating in this study? 
You may request a report of the MRI which will be provided to your child’s Paediatrician or GP. 
 
Is there likely to be a benefit to other babies in the future? 
If MRI and/or movement or neurological assessments performed at 30 weeks and 40 weeks are 
shown to be accurate in terms of predicting movement development at 1 year of age, then this 
finding will benefit many babies in the future. If future practice is made better, this may benefit 
other premature babies in the future. 
 
What are the possible risks and/or side effects for my baby? 
There are no anticipated risks to your baby as a result of being part of this research project.  
However if any risks become evident at any time, we will let you know immediately. 
 
There are no known risks of Magnetic Resonance Imaging.  Most infants will sleep or rest during 
the scan.  If your baby becomes distressed for any reason the study will be stopped.  Your baby will 
be monitored carefully throughout the scan by trained medical and/or nursing staff.  
 
There is the possibility that the MRI scan will show up something in your infant’s brain that we had 
not expected.  If this happens, we will arrange for you to meet with a medical professional who can 
explain the findings to you.  If any of the results of the MRI, or neurodevelopmental assessments, 
are distressing for you we will arrange specific counseling to discuss the findings with specially 
trained staff.  Although detecting a significant brain abnormality is extremely unlikely, you should 
be aware that if an abnormality is detected in your child and you are told about it, then this 
knowledge may have consequences for your child. Knowing about an abnormality may affect their 
ability to work in certain professions, obtain life or health insurance and other facets of daily living, 
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however you should be aware that this is unlikely. Please take the time to consider carefully what it 
would mean if we told you your child had an abnormality in their brain that might, or might not, 
affect your child in later life. If you do not wish to know this, then you may wish to discuss this 
further before agreeing to participate.   You can choose to participate in the study but not receive 
information from the scans and other assessments. 
 
What are the possible discomforts and/or inconveniences for my baby or me? 
The inconvenience to you and your baby is the time that the assessments will take, and the trip you 
will need to make to the hospital.  We will make the appointment at a time that suits you and 
provide some compensation for travel costs and parking. The MRI scanner is noisy, so protective 
earmuffs will be positioned over your infant’s ears during the scan.   
 
What will be done to make sure the information is confidential? 
All results of all assessments will be stored without your child’s name on it.  All hard copy data will 
be stored in a secure filing cabinet and only the researchers will have access to these. Video will 
only be viewed by study personnel for the purposes of data collection and assessment scoring. If we 
talk or write about the results of this research, we will not use any names.  All data is only 
accessible to the study personnel.  
 
Queensland Health guidelines require the storage of research data involving minors to be kept for 
15 years after the child has turned 18 years of age. As is regular procedure in infant studies, the 
name of the family GP will be collected in order to allow direct sharing of information or concerns 
regarding potential risks for the child if necessary. 
 
Participation in future research 
In the consent form we will ask you if you agree to be contacted in the future if further follow up 
studies are developed.    Your consent to be contacted would only apply to extended research which 
relates to the current research project.   Full ethical approval would be sought by the research team 
and a new consent process undertaken.   You can choose to participate in this study but decline to 
be contacted for future research. 
 
Will I be informed of the results when the research project is finished? 
If you would like to be informed of the study’s progress a regular 6 monthly newsletter will be sent 
to you to keep you updated on study recruitment and progress. At the conclusion of the study all 
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families will be sent a meaningful summary of the overall study results, and copies of publications 
if requested.   
 
Participation in this study is voluntary 
You can decide whether or not you wish to take part in this research project.  You can decide to 
withdraw from this research project at any time.  No explanation is needed.   You may like to 
discuss your participation in this research project with your family and/or with your doctor.  You 
can ask for further information before deciding if your child will take part.   
 
 
This study has been reviewed and approved by the Royal Brisbane & Women’s Hospital, 
Human Research Ethics Committee (HREC). Should you wish to discuss the study in 
relation to your rights as a participant or should you wish to make an independent complaint, you 
may contact the Coordinator or Chairperson, Human Research Ethics Committee, Royal Brisbane & 
Women’s Hospital, Herston, Qld 4029 or telephone (07) 3636 5490, email 
Ethics@health.qld.gov.au 
If you would like more information about the study or if you need to contact a study 
representative in an emergency, the person to contact is: 
Professor Paul Colditz, 
Royal Brisbane and Women’s Hospital 
                 Contact telephone:   (07) 3346 6014 
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STANDARD INFORMED CONSENT  
FOR PARENTS / GUARDIANS TO GIVE CONSENT  
FOR THEIR BABY TO PARTICIPATE IN A RESEARCH PROJECT  
 
Title of Project - Prediction of Preterm Early Motor Outcomes (PPREMO) 
 
Principal and associate 
Investigator(s) 
Professor Paul Colditz, Professor Roslyn Boyd, Joanne George, Sonia Sam, A/Prof 
Stephen Rose, Kerstin Pannek, Rebecca Caesar, Karen Taylor, Dr Barbara 
Lingwood, Dr Robert Ware 
 
I/We  (Parents/Guardians name)                                           
Parents/Guardians of (baby’s name)  
voluntarily consent to him / her taking part in the above titled Research Project, explained to me by  
Mr / Ms / Dr / Professor  
8. I/We have received a Participant Information and Consent Form (PICF) to keep and I/we understand the 
purpose, extent and possible effects of my baby’s involvement 
2. I/We have been asked if I/we would like to have a family member or friend with me/us while the project 
is explained 
9. I/We have had the opportunity to ask questions and I/we am/are satisfied with the answers I/we have 
received/We understand that the researcher has agreed not to reveal results of any information involving 
my/our baby, subject to legal requirements 
10. I/We understand that the name of our family GP will be collected in order to allow direct sharing of 
concerns regarding potential risks for the child if necessary.  
11. I/We agree to video recording of assessments for data collection and scoring purposes. 
12. If information about this project is published or presented in any public form, I/we understand that the 
researcher will not reveal my/our baby’s identity.  
13. I/We understand that if I/we refuse to consent, or if I/we withdraw my/our baby from the study at any time 
with or without explanation, this will not affect my/our baby’s access to the standard treatment that all 
babies receive. 
14. I/We agree to be contacted in future if a further research study is planned.   Yes           No 
15. I/We understand I/we will receive a copy of this consent form. 
16. I/We have been asked if we wish to have a report of the MRI sent to our baby’s doctor. 
Yes, I would like a report       No thanks       Doctor’s name: 
 
 Printed Name Signature Date 
PARENT/GUARDIAN 1    
PARENT/GUARDIAN 2    
 
I have explained the study to the parents/guardians who has signed above, and believe that they 
understand the purpose, extent and possible effects of their involvement in this study. 
 Printed Name Signature Date 
 
RESEARCHER  
  
 
 
Note: All parties signing the Consent Form must date their own signature. 
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  PPREMO  
(Prediction of Preterm Motor Outcomes) 
Audio-visual/Photographic/Media Consent Form (Version 2; 20/9/13) 
 
The PPREMO research team would like your permission to take images or make audio-visual 
recordings of your child for the PPREMO research study assessments. 
 
These images or recordings will be stored carefully and sensitively.  They may be reused for the 
purposes of: 
 
1. Research records – they will be used by the researchers to make assessments. 
 
2. Education and training – they may be used in presentations at medical conferences, seminars or 
lectures where information is shared amongst health professionals for teaching purposes.  The 
identity of your child will be protected at all times.  
  
3. Publications – they may be used in medical journals, on medical conference posters, in health 
professional newsletters, reports or brochures, and on restricted access internet pages for health 
professionals.  The identity of your child will be protected at all times.   
 
 
If you change your mind at any time, you are welcome to contact a research team member to 
withdraw your consent.   
 
 
  
If you would like more information about the use of imaging/videos in the study 
or need to contact a study representative, please contact: 
 
 Ms Joanne George 
Royal Brisbane & Women’s Hospital 
Ph.:   (07) 3646 9609 
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STANDARD INFORMED CONSENT 
FOR PARENTS / GUARDIANS TO GIVE CONSENT  
FOR IMAGES/VIDEO TO BE RECORDED OF THEIR CHILD AS PART OF THE 
PPREMO STUDY  
 
Title of Project:    Prediction of Preterm Early Motor Outcomes (PPREMO) 
 
I/We  (Parent’s/Guardian’s name)                                           
Parent’s/Guardians of (babies’ name/s)  
consent to him / her taking part in the above, explained to me by  
Mr / Ms / Dr / Professor 
(please initial in the box to consent) 
 
17. I/We have received an Audio-visual/Photographic/Media Consent Form to keep and  
I/we give consent for images/video to be taken of our child for the PPREMO study. 
 
18. I/We consent to the video recordings being used for assessments. 
 
19. I/We consent to the images and video recordings to be used for education and  
  training purposes in medical conferences, seminars, lectures for teaching health  
professionals.  I understand that the identity of my/our child will be protected  
at all times.   
 
20. I/We consent to the images and video recordings to be used in publications,  
such as medical journals, on medical conference posters, in health professional 
newsletters, reports and brochures, and on restricted access internet pages for  
health professionals.  I understand that the identity of my/our child will be protected  
at all times.   
 
21. I/We understand that we can withdraw consent at any time without affecting 
our standard of care 
 
 
 
 
 Printed Name Signature Date 
PARENT/GUARDIAN 1    
PARENT/GUARDIAN 2    
 
I have explained the reason for this consent to the parents/guardians who has signed above, and believe 
that they understand the purpose, extent and possible effects of this consent. 
 Printed Name Signature Date 
 
RESEARCHER  
  
 
 
 
Note: All parties signing the Consent Form must date their own signature. 
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PPREMO (Prediction of PREterm Motor Outcomes) 
 
            
What is this study about?   Learning new ways to identify which premature babies need extra help 
with their development.   New, safe, brain scan technology is available and we aim to learn how 
these brain scans can help identify babies who may need help, at an earlier stage.    
How can you help?    If your baby was born before 31 weeks gestation we would like to discuss 
with you whether you would like to participate in the study. 
What do you need to do?    Ask your doctor about the study and whether we can come and talk to 
you about it. 
Benefits:     ● your baby will have additional assessments to check their development which would 
not be available to babies not in the study.   This information will be given to your 
doctor to feed back to you in your regular appointments. 
 ● you will be assisting us to gather information that may improve the care of 
premature babies and provide better outcomes for their future.   
 
If you would like to find out more or know someone who might be interested, please contact: 
 
Professor Paul Colditz (Principal Investigator) 
 ph.: 3346 6014 mob: 0416290018   email: p.colditz@uq.edu.au 
 
Joanne George (Principal Investigator)  
ph.: 3646 9609  mob: 0423968680   email: j.george2@uq.edu.au 
   
 
 
 
(Version 3; 14/5/14)
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Healthy babies to be a reference group  
For our PPREMO study:  
Prediction of PREterm Motor Outcomes 
 
What is this study about?    
Learning new ways to identify which premature babies need extra help with their development.   
New, safe, brain scan technology is available and we aim to learn how these brain scans can help 
identify babies who may need help, at an earlier stage.    
How can you help?     
We need healthy babies born at term to act as a reference group to help us understand our research 
findings.   It involves one visit to the hospital when your baby is 1 week old. 
What do you need to do?     
Contact us using the details below if your baby meets the following criteria: 
1. Healthy baby born between 38 and 41 weeks gestation 
2. English speaking family as we have no interpreters 
3. Able to visit the hospital for a few hours when your baby is 1 week old 
Benefits:      
You will be assisting us to gather information that may improve the care of premature babies and 
provide better outcomes for their futures.   
 
If you would like to find out more or know someone who might be interested, please contact: 
Professor Paul Colditz (Principal Investigator) 
 ph.: 3346 6014 mob: 0416290018   email: p.colditz@uq.edu.au 
Joanne George (Principal Investigator)  
ph.: 3646 9609  mob: 0423968680   email: j.george2@uq.edu.au 
 
 
   
 
(Version 2; 25/7/13) 
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PPREMO 
 
Prediction of PREterm Motor Outcomes 
 
 
 
Questionnaire for the 
 
Mother or Primary caregiver 
 
 
 
 
 
 
 
STUDY NUMBER:    
   
       
TODAY’S DATE:       
 D D M M Y Y 
 
 
 
INSTRUCTIONS: 
 
This questionnaire is designed for the mother, or primary caregiver, of the preterm child in our 
study.   It contains a number of questions about you and your family. All your responses are totally 
confidential and only members of the research team will have access to this information. 
 
Most questions involve ticking the most appropriate response, or writing some simple notes.  Please 
feel free to write additional comments in the spaces provided.  If you would like assistance with any 
part of the questionnaire, please ask one of the research team.  
 
Thank you again for taking the time to fill in this questionnaire.  
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FAMILY DETAILS 
 
PERSON COMPLETING THIS FORM 
 
1 What is your relationship to the child in our study? (please tick one) 
  Biological mother  
  Biological father  
  Step mother  
  Step father  
  Foster parent  
  Family relation (e.g. aunt, grandmother)  
  Other, please specify:  
 
2 a) Are you the primary caregiver?   Yes No 
 b) If no, who is the child’s primary caregiver? (please tick one) 
  Biological mother  
  Biological father  
  Step mother  
  Step father  
  Foster parent  
  Family relation (e.g. aunt, grandmother)  
  Other, please specify:  
 
3 Family Living Situation (please tick one) 
  Child living with mother & father  
  Child living with mother only  
  Child living with father only  
  Parents separated/divorced but both have custody rights   
  Other, please specify:   
 
4  How many brothers and sisters does your child have?  
 
5  How many children live at home?  
 
6  How many adults (older than 21 years) live at home?  
 
7 Language spoken at home (please circle one)  
  Only language spoken at home is English  
  English is one of the languages spoken at home  
  Little or no English spoken at home  
  Please indicate which is the other main language spoken at home (if not 
English)…………………………………………………………………
……………………… 
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Child’s Mother or Primary Caregiver  
 
8 How old were you at your last birthday? Years  
 
9 What ethnic groups do you belong to or identify with? (e.g. Australian, Aboriginal, 
Italian, Greek) 
  1. 
  2.  
  3.  
 
10 Which of the following best describes your highest level of education? (please circle 
one) 
  Left school between 13-16 years, no formal qualifications  
  Completed Year 11  
  High School Certificate (completed Yr 12)  
  Professional qualifications without a degree  
  University degree  
  Post graduate degree  
 
11 a) Do you have other qualifications (e.g. trade, secretarial)   Yes No 
 b) If yes, please specify 
………………………………………………………………………………………………
……………………………………………. 
 
12 a) Are you working at the moment?  
  Yes, full time  
  Yes, part time (< 30hours)  
  No.  
 
b) If yes, please provide a title & description of the job. 
 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
__________________ 
 
13 Are you currently living with a partner? 
  Yes, legally married  
  Yes, defacto relationship  
  No    
  If you answered “No”, please go to section 19. 
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Primary Caregiver’s Partner 
 
14 How old was your partner at his/her last birthday? Years  
 
15 What ethnic groups does your partner belong to or identify with? (e.g. Australian, 
Aboriginal Italian, Greek) 
  1. 
  2.  
  3.  
 
16 Which of the following best describes your partner’s highest level of education? (please 
circle one) 
  Left school between 13-16 years, no formal qualifications  
  Completed Year 11  
  High School Certificate (completed Year 12)  
  Professional qualifications without a degree  
  University degree  
  Post graduate degree  
  Don’t know  
 
17 a) Does your partner have other qualifications (e.g. trade, secretarial)   Yes No 
 b) If yes, please specify 
………………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
………………………… 
 
18 a) Is the partner working at the moment?  
  Yes, full time  
  Yes, part time (< 30hours)  
  No.  
 
b) If yes, please provide a title & description of the job 
 
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
____________ 
 
19 Any other comments?   Yes No 
 b) If yes, please specify 
………………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
………………………… 
 
Thank you for completing this questionnaire 
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Parameters of the proposed imaging sequences: 
Sequence Parameters T2 map (3 
echo) 
T1-
MPRAGE 
Field 
Map 
DWI-30 
(b=1000s/mm2) 
DWI-65 
(b=2000s/mm2) 
ASL T1-TSE2 T2-Haste 
(Axial) 
T2-Haste 
(Cor) 
T2-Haste 
(Sag) 
Repetition time (ms) 10580 2100 488 9500 9500 3427.5 1490 2000 2000 2000 
Echo time (ms) 27, 122, 189 3.18 4.9, 7.4 130 130 21 12 90 101 88 
Flip Angle 150 9 60 90 90 90 147 150 150 150 
Field of view (mm) 180 160 160 224 224 256 180 180 180 200 
FoV Phase 79.70% 100% 100% 100% 100% 100% 70% 70% 70% 80% 
Matrix 256 x 204 128 x 128 64 x 64 128 x 128 128 x 128 64 x 64 256 x 
180 
320 x 224 320 x 224 320 x 256 
Voxel size (mm) 0.7 x 0.7  1.25x1.25 2.5 x 2.5 1.75 x 1.75 1.75 x 1.75 4 x 4 0.7 x 0.7  0.56 x 0.56 0.56 x 0.56 0.625 x 
0.625 
Dist. Factor  0%   25% 0% 0% 10% 0% 20% 20% 20% 
Slice thickness (mm) 2.0 1.3 2.6 2.0 2.0 5.0 2.0 4.0 4.0 4.0 
Number of slices 47 96 29 47 47 17 47 21 21 23 
Fat Suppression None None None Fat sat (weak) Fat sat (weak) Fat Sat (Strong) None None None None 
Phase partial fourier Off Off Off  6/8  6/8  7/8 Off  5/8  5/8  5/8 
Grappa 
(accel/RefLines) 
None "2/24" None "2/24" "2/24" None None "2/24" "2/24" "2/24" 
Bandwidth (Hz/Px) 130 180 260 1400 1400 2230 260 400 400 400 
Echo spacing (ms) 13.5 7.7   0.82 0.82 0.51 11.5 5.2 5.2 5.2 
Turbo (echo 
trains)/EPI Factor 
5 (31)     128 128 64 2 (68) 179 179 205 
Examination time 
(m:s) 
5:20 3:00 1:05 5:25 10:48 5:17 1:44 0:44 0:44 0:48 
# Flow compensated. 
* ASL perfusion parameters are Inversion time (1/2) = 700 and 1800 ms. Saturation stop time 1600 ms. 
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PPREMO Study (Prediction of PREterm Motor Outcomes) 
Paediatrician Assessment (Version 1; 30/5/14) 
Study ID: Date: 
Child’s name  
Mother’s name  
Fathers name  
EDD  
Corrected Age   
Weight                   kg /                 percentile 
Height                   cm /                percentile 
Head Circumference                    cm /                percentile 
Method of nutrition Not assessed =0 Comments 
Full Oral Feeds =1  
Modified textures = 2  
Tube- nasogastric =3 
PEG = 4 
Visual impairment 
(after correction, on the 
better eye) 
Not assessed =0  
Normal/No visual impairment =1 
Squint =2 
Impaired =3 
Severely impaired (blind or no useful vision) =4  
Hearing impairment 
(before correction, on the 
better ear) 
Not assessed =0  
 
 
Normal =1 
Impaired =2 
Severely impaired (hearing loss > 70 dB) =3 
General Observation: No abnormality =0 Abnormality=1  
Face  0 1 
dysmorphism  0 1 
general nutritional state 0 1 
Body proportions  0 1 
Muscle bulk 0 1 
symmetry  0 1 
tongue fasciculation 0 1 
excessive drooling 0 1 
other 0 1 
Motor development: Yes=0 No=1  
 
 
 
 
 
 
Rolling independently 0 1 
Sitting independently 0 1 
Crawling indep. 0 1 
Pull-to-stand indep. 0 1 
Standing independently 0 1 
Walking independently 0 1 
Gait: 
 
Not assessed = 0  
 
 
 
Age appropriate = 1 
Toe walking = 2 
Asymmetrical gait = 3 
Appendices 
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Neurological Signs: 
Tone: Left Right 
Upper 
Limbs 
Not 
tested 
= 0 
Normal 
=1 
Hypotonic 
=2 
Hypertonic 
=3 
Not 
tested  
= 0 
Normal 
=1 
Hypotonic 
=2 
Hypertonic 
=3 
Lower 
limbs 
Not 
tested 
= 0 
Normal 
=1 
Hypotonic 
=2 
Hypertonic 
=3 
Not 
tested 
= 0 
Normal 
=1 
Hypotonic 
=2 
Hypertonic 
=3 
Strength:  
Upper 
Limbs 
Not 
tested 
= 0 
1 2 3 4 5 
Not 
tested  
= 0 
1 2 3 4 5 
Lower 
limbs 
Not 
tested 
= 0 
1 2 3 4 5 
Not 
tested  
= 0 
1 2 3 4 5 
Tendon 
Reflexes:  
Left Right 
Upper 
Limbs 
Not tested =0 
Present/Normal =1 
Absent =2 
Depressed =3 
Brisk =4 
Hyperreflexic/Very Brisk =5 
Not tested =0 
Present/Normal =1 
Absent =2 
Depressed =3 
Brisk =4 
Hyperreflexic/Very Brisk =5 
Lower 
limbs 
Not tested =0 
Present/Normal =1 
Absent =2 
Depressed =3 
Brisk =4 
Hyperreflexic/Very Brisk =5 
Not tested =0 
Present/Normal =1 
Absent =2 
Depressed =3 
Brisk =4 
Hyperreflexic/Very Brisk =5 
Clonus:  
Upper 
Limbs 
Not tested 
= 0 
Absent =1 
 
Present =2 
 
Not tested  
= 0 
Absent =1 Present =2 
Lower 
limbs 
Not tested 
= 0 
Absent =1 Present =2 Not tested  
= 0 
Absent =1 Present =2 
 
Plantar reflexes: 
Not tested 
= 0 
Normal ↓ 
=1 
No 
response 
=2 
Abnormal 
↑=3 
Not 
tested 
= 0 
Normal ↓ 
=1 
No 
response 
=2 
Abnormal 
↑=3 
Cranial 
Nerves 
Not tested = 0, Normal = 1, Abnormal = 2 Comments 
II 0 1 2 
 
III, IV, VI 0 1 2 
V 0 1 2 
VII 0 1 2 
VIII 0 1 2 
IX, X, XII 0 1 2 
XI 0 1 2 
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Summary: 
 
Neurological Status Normal = 0 Unspecified signs = 1 Abnormal (signs of CP) = 2 
Cerebral palsy No =0 Possibly =1 Definitely =2 
Comments 
 
Patterns of motor impairment  
 
Motor type Primary Secondary 
 Spastic =1 Spastic =1 
dyskinetic- dystonic =2 dyskinetic- dystonic =2 
dyskinetic- choreoathetotic =3 dyskinetic- choreoathetotic =3 
Hypotonic =4 Hypotonic =4 
Ataxic =5 Ataxic =5 
Distribution Bilateral =1     /       unilateral =2 Bilateral =1     /       unilateral =2 
No of limbs   1   /   2   /   3   /   4 No of limbs   1   /   2   /   3   /   4 
 
Functional level 
Gross Motor Function Classification System for Cerebral Palsy (GMFCS) Before 2nd Birthday 
Level I  Infants move in and out of sitting and floor sit with both hands free to manipulate objects. Infants 
crawl on hands and knees, pull to stand and take steps holding on to furniture. Infants walk between 18 
months and 2 years of age without the need for any assistive mobility device. 
Level II  Infants maintain floor sitting but may need to use their hands for support to maintain balance. 
Infants creep on their stomach or crawl on hands and knees. Infants may pull to stand and take steps 
holding on to furniture. 
Level III Infants maintain floor sitting when the low back is supported. Infants roll and creep forward on 
their stomachs. 
Level IV Infants have head control but trunk support is required for floor sitting. Infants can roll to supine 
and may roll to prone. 
Level V  Physical impairments limit voluntary control of movement. Infants are unable to maintain 
antigravity head and trunk postures in prone and sitting. Infants require adult assistance to roll. 
 
GMFCS level (0-2 
years scale) 
I =1  /   II =2 /   III =3   /   IV= 4   /   V= 
5 
 
Upper limb/ 
Handedness 
Right predominant =0 
Left predominant =1 
Bilateral =2 
 
 
Recommendations: 
Suggest referral to GP for further management  
Suggest referral to General Paediatrician for further management  
Suggest referral to Community CDS for further assessment  
Suggest referral to Neuropaediatric clinic at RCH for further assessment  
Other:  
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Classification and Definition of Disorders Causing Hypertonia in Childhood 
References: Sanger et al (2003) Pediatrics 111(1), e89-e971 
  SCPE (2000) Dev Med and Child Neuro 42: 816-8242 
 
Spasticity1 is defined as hypertonia in which 1 or both of the following signs are present:  
1) resistance to externally imposed movement increases with increasing speed of stretch and varies with 
the direction of joint movement, and/or  
2) resistance to externally imposed movement rises rapidly above a threshold speed or joint angle. 
 
Dystonia1 is defined as a movement disorder in which involuntary sustained or intermittent muscle 
contractions cause twisting and repetitive movements, abnormal postures, or both.  Chorea means rapid 
involuntary, jerky often fragmented movements.  Athetosis means slower, constantly changing, writhing or 
contorting movements2 
 
Ataxia2 is characterized by:  
 Loss of orderly muscular coordination so that movements are performed with abnormal force, rhythm 
and accuracy. 
 Typical features are: trunk and gait ataxia- disturbed balance, past-pointing- over- or undershooting of 
goal-directed movements 
 
Rigidity 1 is defined as hypertonia in which all of the following are true:  
1) the resistance to externally imposed joint movement is present at very low speeds of movement, does 
not depend on imposed speed, and does not exhibit a speed or angle threshold;  
2) simultaneous co-contraction of agonists and antagonists may occur, and this is reflected in an 
immediate resistance to a reversal of the direction of movement about a joint;  
3) the limb does not tend to return toward a particular fixed posture or extreme joint angle; and  
4) voluntary activity in distant muscle groups does not lead to involuntary movements about the rigid 
joints, although rigidity may worsen. 
 
 
Is there persisting 
increased muscle tone 
in one or more limbs? 
 
Yes 
 
No 
Are both sides of 
the body involved? 
 
Yes 
 
No 
 
Spastic bilateral CP 
 
Spastic unilateral 
CP 
 
Is the tone varying? 
 
Yes  
 
No 
 
Dyskinetic CP 
Reduced activity:  
tone increased 
Increased activity: 
 tone decreased 
 
Dystonic CP 
 
Choreo-athetoic CP 
Is there a generalised 
hypotonia with signs 
of ataxia? 
 
Yes  
 
No 
 
Ataxia CP 
Hypotonia or non-
classifiable 
